{
    "5e2dadcffbd6abf43b000011": [
        {
            "text": "hallucination",
            "probability": 0.1068567100485042,
            "start_logit": 5.989735126495361,
            "end_logit": 5.718617916107178,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "hallucination, dizziness, orthostatic hypotension and pedal edema",
            "probability": 0.10657698679529842,
            "start_logit": 5.989735126495361,
            "end_logit": 5.715996742248535,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "hallucination, dizziness",
            "probability": 0.09900855666329604,
            "start_logit": 5.989735126495361,
            "end_logit": 5.642335414886475,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "pedal edema",
            "probability": 0.09739681816035105,
            "start_logit": 5.899661064147949,
            "end_logit": 5.715996742248535,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "hallucination, dizziness, orthostatic hypotension",
            "probability": 0.09425180522585005,
            "start_logit": 5.989735126495361,
            "end_logit": 5.593099117279053,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "dizziness, orthostatic hypotension and pedal edema",
            "probability": 0.09367217037758128,
            "start_logit": 5.860668659210205,
            "end_logit": 5.715996742248535,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "dizziness",
            "probability": 0.08702015948729946,
            "start_logit": 5.860668659210205,
            "end_logit": 5.642335414886475,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "dizziness, orthostatic hypotension",
            "probability": 0.08283937670772945,
            "start_logit": 5.860668659210205,
            "end_logit": 5.593099117279053,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "orthostatic hypotension and pedal edema",
            "probability": 0.07079261408370452,
            "start_logit": 5.58062219619751,
            "end_logit": 5.715996742248535,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "orthostatic hypotension",
            "probability": 0.06260574514891834,
            "start_logit": 5.58062219619751,
            "end_logit": 5.593099117279053,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "hallucination, dizziness, orthostatic hypotension and pedal edema.",
            "probability": 0.022289729085099123,
            "start_logit": 5.989735126495361,
            "end_logit": 4.151255130767822,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "pedal edema.",
            "probability": 0.020369769833281287,
            "start_logit": 5.899661064147949,
            "end_logit": 4.151255130767822,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "dizziness, orthostatic hypotension and pedal edema.",
            "probability": 0.019590789375006443,
            "start_logit": 5.860668659210205,
            "end_logit": 4.151255130767822,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "orthostatic hypotension and pedal edema.",
            "probability": 0.014805712157939868,
            "start_logit": 5.58062219619751,
            "end_logit": 4.151255130767822,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "hallucination, dizziness,",
            "probability": 0.006051133077920242,
            "start_logit": 5.989735126495361,
            "end_logit": 2.847374677658081,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "dizziness,",
            "probability": 0.005318434923864519,
            "start_logit": 5.860668659210205,
            "end_logit": 2.847374677658081,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "hypotension and pedal edema",
            "probability": 0.0037608305120349493,
            "start_logit": 2.645507335662842,
            "end_logit": 5.715996742248535,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "hypotension",
            "probability": 0.003325906235166606,
            "start_logit": 2.645507335662842,
            "end_logit": 5.593099117279053,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "hallucination,",
            "probability": 0.002680204312847385,
            "start_logit": 5.989735126495361,
            "end_logit": 2.033022165298462,
            "question_text": "What are the most common side effects of amantadine ER?"
        },
        {
            "text": "hypotension and pedal edema.",
            "probability": 0.0007865477883066936,
            "start_logit": 2.645507335662842,
            "end_logit": 4.151255130767822,
            "question_text": "What are the most common side effects of amantadine ER?"
        }
    ],
    "5e2f93bbfbd6abf43b00002e": [
        {
            "text": "hypotension",
            "probability": 0.08385365725508208,
            "start_logit": 4.190079212188721,
            "end_logit": 4.63239860534668,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "abdominal pain",
            "probability": 0.08196311430709102,
            "start_logit": 4.278075695037842,
            "end_logit": 4.5215983390808105,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "pulsatile abdominal mass and shock. The clinical onset was characterized by the unique syndrome: continuous abdominal bruit, abdominal and left flank pain",
            "probability": 0.062537553361439,
            "start_logit": 4.299297332763672,
            "end_logit": 4.229874610900879,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "pulsatile abdominal mass and shock",
            "probability": 0.05951668843425372,
            "start_logit": 4.299297332763672,
            "end_logit": 4.18036413192749,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "abdominal pain, pulsatile abdominal mass and shock",
            "probability": 0.05826695443668293,
            "start_logit": 4.278075695037842,
            "end_logit": 4.18036413192749,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "pulsatile abdominal mass.Some of these patients present with the classic triad of symptoms such as abdominal pain",
            "probability": 0.05700536731379281,
            "start_logit": 3.914951801300049,
            "end_logit": 4.5215983390808105,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "back pain and a pulsatile abdominal mass.Some of these patients present with the classic triad of symptoms such as abdominal pain",
            "probability": 0.055937607964785904,
            "start_logit": 3.896043300628662,
            "end_logit": 4.5215983390808105,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "hypotension, back pain",
            "probability": 0.05098638404876566,
            "start_logit": 3.976200819015503,
            "end_logit": 4.348762512207031,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "hypotension, and a pulsatile mass",
            "probability": 0.04864281394406388,
            "start_logit": 4.190079212188721,
            "end_logit": 4.08782958984375,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "pulsatile abdominal mass and shock. The clinical onset was characterized by the unique syndrome: continuous abdominal bruit",
            "probability": 0.04775103112562185,
            "start_logit": 4.299297332763672,
            "end_logit": 3.9601080417633057,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "back pain",
            "probability": 0.04705895132461833,
            "start_logit": 3.896043300628662,
            "end_logit": 4.348762512207031,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "pulsatile abdominal mass",
            "probability": 0.04699895283894418,
            "start_logit": 4.299297332763672,
            "end_logit": 3.944232702255249,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "abdominal pain, pulsatile abdominal mass and shock. The clinical onset was characterized by the unique syndrome: continuous abdominal bruit",
            "probability": 0.04674835290902933,
            "start_logit": 4.278075695037842,
            "end_logit": 3.9601080417633057,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "abdominal pain, pulsatile abdominal mass",
            "probability": 0.0460120667947393,
            "start_logit": 4.278075695037842,
            "end_logit": 3.944232702255249,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "pain, hypotension",
            "probability": 0.04297788542383892,
            "start_logit": 3.5216917991638184,
            "end_logit": 4.63239860534668,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "pulsatile mass",
            "probability": 0.04296016224254889,
            "start_logit": 4.065848350524902,
            "end_logit": 4.08782958984375,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "pulsatile abdominal mass.Some of these patients present with the classic triad of symptoms such as abdominal pain, pulsatile abdominal mass",
            "probability": 0.03200140442045112,
            "start_logit": 3.914951801300049,
            "end_logit": 3.944232702255249,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "left flank pain",
            "probability": 0.031993134862474806,
            "start_logit": 3.629051446914673,
            "end_logit": 4.229874610900879,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "pain",
            "probability": 0.030544334238007044,
            "start_logit": 3.5216917991638184,
            "end_logit": 4.290892124176025,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        },
        {
            "text": "shock. The clinical onset was characterized by the unique syndrome: continuous abdominal bruit, abdominal and left flank pain",
            "probability": 0.026243582753769257,
            "start_logit": 3.4309515953063965,
            "end_logit": 4.229874610900879,
            "question_text": "Which symptoms comprise Abdominal aortic aneurysm rupture Triad?"
        }
    ],
    "5e2f9596fbd6abf43b00002f": [
        {
            "text": "esophageal achalasia",
            "probability": 0.26010112735322455,
            "start_logit": 4.081845760345459,
            "end_logit": 4.399911880493164,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "esophageal achalasia, adrenocorticotropic hormone refractoriness, and alacrima",
            "probability": 0.15504380249357308,
            "start_logit": 4.081845760345459,
            "end_logit": 3.8825490474700928,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "adrenocorticotropic hormone refractoriness, and alacrima",
            "probability": 0.09160963633411794,
            "start_logit": 3.5556745529174805,
            "end_logit": 3.8825490474700928,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "alacrima",
            "probability": 0.09025109477615097,
            "start_logit": 3.540733814239502,
            "end_logit": 3.8825490474700928,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "achalasia",
            "probability": 0.08116945751298932,
            "start_logit": 2.917314291000366,
            "end_logit": 4.399911880493164,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "esophageal achalasia, adrenocorticotropic hormone refractoriness",
            "probability": 0.07542481967096973,
            "start_logit": 4.081845760345459,
            "end_logit": 3.161977767944336,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "achalasia, adrenocorticotropic hormone refractoriness, and alacrima",
            "probability": 0.04838433984203327,
            "start_logit": 2.917314291000366,
            "end_logit": 3.8825490474700928,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "adrenocorticotropic hormone refractoriness",
            "probability": 0.044565730390354566,
            "start_logit": 3.5556745529174805,
            "end_logit": 3.161977767944336,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "adrenocorticotropic hormone refractoriness, and alacrima. Background Triple A syndrome is characterized by achalasia",
            "probability": 0.03148275163047083,
            "start_logit": 3.5556745529174805,
            "end_logit": 2.8144524097442627,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "alacrima. Background Triple A syndrome is characterized by achalasia",
            "probability": 0.03101587250988188,
            "start_logit": 3.540733814239502,
            "end_logit": 2.8144524097442627,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "alacrima. Background Triple A syndrome is characterized by achalasia, alacrima",
            "probability": 0.02538840494893339,
            "start_logit": 3.540733814239502,
            "end_logit": 2.614245891571045,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "achalasia, adrenocorticotropic hormone refractoriness",
            "probability": 0.023537736102902596,
            "start_logit": 2.917314291000366,
            "end_logit": 3.161977767944336,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "achalasia, alacrima",
            "probability": 0.011006533631449409,
            "start_logit": 2.704930305480957,
            "end_logit": 2.614245891571045,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "alacrima. Background Triple A syndrome is characterized by achalasia, alacrima and adrenal insufficiency",
            "probability": 0.007872603097462625,
            "start_logit": 3.540733814239502,
            "end_logit": 1.4433420896530151,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "alacrima, achalasia",
            "probability": 0.0064124467564302574,
            "start_logit": 1.7811245918273926,
            "end_logit": 2.9978034496307373,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "adrenal insufficiency",
            "probability": 0.00425560022167717,
            "start_logit": 2.715832233428955,
            "end_logit": 1.6530907154083252,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "achalasia, alacrima and adrenal insufficiency",
            "probability": 0.00341297812657252,
            "start_logit": 2.704930305480957,
            "end_logit": 1.4433420896530151,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "achalasia, adrenal insufficiency",
            "probability": 0.0034096431088737893,
            "start_logit": 2.7117269039154053,
            "end_logit": 1.435567855834961,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "achalasia and adrenal insufficiency",
            "probability": 0.003182631820452108,
            "start_logit": 2.425304889678955,
            "end_logit": 1.6530907154083252,
            "question_text": "List symptoms of Allgrove syndrome."
        },
        {
            "text": "adrenal insufficiency, alacrima, achalasia",
            "probability": 0.002472789671479687,
            "start_logit": 0.828230619430542,
            "end_logit": 2.9978034496307373,
            "question_text": "List symptoms of Allgrove syndrome."
        }
    ],
    "5e2b109cfbd6abf43b000002": [
        {
            "text": "Charlson Comorbidity Index",
            "probability": 0.20361887355373953,
            "start_logit": 4.40283203125,
            "end_logit": 3.9109346866607666,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "length of stay, acuity of admission, Charlson Comorbidity Index",
            "probability": 0.11816652503334037,
            "start_logit": 3.8586769104003906,
            "end_logit": 3.9109346866607666,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "acuity of admission, Charlson Comorbidity Index",
            "probability": 0.10482953319688622,
            "start_logit": 3.738917589187622,
            "end_logit": 3.9109346866607666,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "length of stay, acuity of admission",
            "probability": 0.09728000394004414,
            "start_logit": 3.8586769104003906,
            "end_logit": 3.71643328666687,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "acuity of admission",
            "probability": 0.08630039175264563,
            "start_logit": 3.738917589187622,
            "end_logit": 3.71643328666687,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Comorbidity Index",
            "probability": 0.07460239005920662,
            "start_logit": 3.398754596710205,
            "end_logit": 3.9109346866607666,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "length of stay",
            "probability": 0.05621574463705196,
            "start_logit": 3.8586769104003906,
            "end_logit": 3.168036699295044,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Charlson Comorbidity Index, emergency department visits",
            "probability": 0.04480478270147205,
            "start_logit": 4.40283203125,
            "end_logit": 2.3969995975494385,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Charlson Comorbidity",
            "probability": 0.03059128687498869,
            "start_logit": 4.40283203125,
            "end_logit": 2.015399932861328,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "length of stay, acuity of admission, Charlson Comorbidity Index, emergency department visits",
            "probability": 0.026001644073085185,
            "start_logit": 3.8586769104003906,
            "end_logit": 2.3969995975494385,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "acuity of admission, Charlson Comorbidity Index, emergency department visits",
            "probability": 0.023066940571909368,
            "start_logit": 3.738917589187622,
            "end_logit": 2.3969995975494385,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Comorbidity, and Emergency visits",
            "probability": 0.02125646875718219,
            "start_logit": 3.112827777862549,
            "end_logit": 2.941350221633911,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "length of stay, acuity of admission, Charlson Comorbidity",
            "probability": 0.01775309922516296,
            "start_logit": 3.8586769104003906,
            "end_logit": 2.015399932861328,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Length of stay, Acuity of admission, Comorbidity, and Emergency visits",
            "probability": 0.017348974536579343,
            "start_logit": 2.9096999168395996,
            "end_logit": 2.941350221633911,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Comorbidity Index, emergency department visits",
            "probability": 0.016415687884311178,
            "start_logit": 3.398754596710205,
            "end_logit": 2.3969995975494385,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "acuity of admission, Charlson Comorbidity",
            "probability": 0.015749376602610134,
            "start_logit": 3.738917589187622,
            "end_logit": 2.015399932861328,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "emergency department visits",
            "probability": 0.012970660384516764,
            "start_logit": 3.1632070541381836,
            "end_logit": 2.3969995975494385,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Acuity of admission, Comorbidity, and Emergency visits",
            "probability": 0.011478246800578754,
            "start_logit": 2.4966201782226562,
            "end_logit": 2.941350221633911,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Comorbidity",
            "probability": 0.01120811188093856,
            "start_logit": 3.398754596710205,
            "end_logit": 2.015399932861328,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "comorbidity index",
            "probability": 0.010341257533750496,
            "start_logit": 2.9912028312683105,
            "end_logit": 2.3424553871154785,
            "question_text": "What is included in the LACE Index?"
        }
    ],
    "5e2f906ffbd6abf43b00002c": [
        {
            "text": "lidocaine",
            "probability": 0.177628138246201,
            "start_logit": 5.078014850616455,
            "end_logit": 5.008829593658447,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "Benzocaine and Lidocaine",
            "probability": 0.12360983023589674,
            "start_logit": 5.043340682983398,
            "end_logit": 4.680941581726074,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "lidocaine/ antacid",
            "probability": 0.09560548958392295,
            "start_logit": 5.078014850616455,
            "end_logit": 4.389367580413818,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "Benzocaine",
            "probability": 0.0908586485294894,
            "start_logit": 5.043340682983398,
            "end_logit": 4.373116493225098,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "Lidocaine",
            "probability": 0.08964553763073316,
            "start_logit": 4.722074031829834,
            "end_logit": 4.680941581726074,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "lidocaine/ antacid \u00b1 anticholinergic",
            "probability": 0.08963002205818417,
            "start_logit": 5.078014850616455,
            "end_logit": 4.324827671051025,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "anticholinergic",
            "probability": 0.06337919007498209,
            "start_logit": 4.731460094451904,
            "end_logit": 4.324827671051025,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "antacid",
            "probability": 0.058339444542241825,
            "start_logit": 4.5840630531311035,
            "end_logit": 4.389367580413818,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "antacid \u00b1 anticholinergic",
            "probability": 0.05469315333188409,
            "start_logit": 4.5840630531311035,
            "end_logit": 4.324827671051025,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "viscous lidocaine",
            "probability": 0.03720063536966317,
            "start_logit": 3.5146484375,
            "end_logit": 5.008829593658447,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "oral viscous lidocaine",
            "probability": 0.02186442804003298,
            "start_logit": 2.9831836223602295,
            "end_logit": 5.008829593658447,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "proton pump inhibitor",
            "probability": 0.0200536257377361,
            "start_logit": 4.239156246185303,
            "end_logit": 3.6664059162139893,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "viscous lidocaine/ antacid",
            "probability": 0.020022643892264713,
            "start_logit": 3.5146484375,
            "end_logit": 4.389367580413818,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "viscous lidocaine/ antacid \u00b1 anticholinergic",
            "probability": 0.018771202590323204,
            "start_logit": 3.5146484375,
            "end_logit": 4.324827671051025,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "oral viscous lidocaine/ antacid",
            "probability": 0.011768176865888607,
            "start_logit": 2.9831836223602295,
            "end_logit": 4.389367580413818,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "oral viscous lidocaine/ antacid \u00b1 anticholinergic",
            "probability": 0.011032650495956257,
            "start_logit": 2.9831836223602295,
            "end_logit": 4.324827671051025,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "Benzocaine and Lidocaine as the topical anesthetic in a gastrointestinal",
            "probability": 0.006273510721134658,
            "start_logit": 5.043340682983398,
            "end_logit": 1.7001476287841797,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "Lidocaine as the topical anesthetic in a gastrointestinal",
            "probability": 0.00454973718801342,
            "start_logit": 4.722074031829834,
            "end_logit": 1.7001476287841797,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "gastrointestinal (GI) cocktail (oral viscous lidocaine",
            "probability": 0.0032985456837433184,
            "start_logit": 1.0918042659759521,
            "end_logit": 5.008829593658447,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "gastrointestinal (GI) cocktail (oral viscous lidocaine/ antacid",
            "probability": 0.0017753891817078736,
            "start_logit": 1.0918042659759521,
            "end_logit": 4.389367580413818,
            "question_text": "Which drugs are included in GI cocktail?"
        }
    ],
    "5e307a05fbd6abf43b000036": [
        {
            "text": "HiTSelect",
            "probability": 0.9225944242514084,
            "start_logit": 3.7461836338043213,
            "end_logit": 3.5553500652313232,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "HiTSelect using data from both genome-wide RNAi and CRISPR/Cas9 screens. HiTSelect",
            "probability": 0.0290698116999421,
            "start_logit": 2.5256900787353516,
            "end_logit": 1.3183541297912598,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "MAGeCK",
            "probability": 0.01592619125622473,
            "start_logit": 1.3965569734573364,
            "end_logit": 1.8457520008087158,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "HiTSelect,",
            "probability": 0.010766897609410686,
            "start_logit": 3.7461836338043213,
            "end_logit": -0.8953632712364197,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "HiTS",
            "probability": 0.009073160322977175,
            "start_logit": 3.7461836338043213,
            "end_logit": -1.066519021987915,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "HiTSelect.MAGeCK",
            "probability": 0.006683487208725593,
            "start_logit": 1.2925480604171753,
            "end_logit": 1.0814357995986938,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "hitselect/, and the source code is available at https://github.com/diazlab/HiTSelect",
            "probability": 0.002507015786409902,
            "start_logit": 0.5008304119110107,
            "end_logit": 0.8926066756248474,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "hitselect",
            "probability": 0.000904861503685693,
            "start_logit": 0.5008304119110107,
            "end_logit": -0.12645982205867767,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "(MAGeCK",
            "probability": 0.0008266046514141685,
            "start_logit": -0.5871982574462891,
            "end_logit": 0.8711134791374207,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "HiTSelect, a comprehensive analysis pipeline",
            "probability": 0.0007416011497731629,
            "start_logit": 3.7461836338043213,
            "end_logit": -3.5707833766937256,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "HiTSelect using data from both genome-wide RNAi and CRISPR/Cas9 screens. HiTS",
            "probability": 0.00037234726695992626,
            "start_logit": 2.5256900787353516,
            "end_logit": -3.0392744541168213,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "HiTSelect.MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens.We propose the Model",
            "probability": 0.00018562623468339797,
            "start_logit": 1.2925480604171753,
            "end_logit": -2.5022242069244385,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "Model-based Analysis of Genome-wide CRISPR/Cas9 Knockout (MAGeCK",
            "probability": 7.90027297277558e-05,
            "start_logit": -2.935042381286621,
            "end_logit": 0.8711134791374207,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "diazlab/HiTSelect.MAGeCK",
            "probability": 5.3496589331068854e-05,
            "start_logit": -3.535229206085205,
            "end_logit": 1.0814357995986938,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens.We propose the Model",
            "probability": 5.169956767128447e-05,
            "start_logit": 1.3965569734573364,
            "end_logit": -3.88451886177063,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "diazlab/HiTSelect",
            "probability": 4.429132248104106e-05,
            "start_logit": -3.535229206085205,
            "end_logit": 0.8926066756248474,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "hitselect/, and the source code is available at https://github.com/diazlab/HiTS",
            "probability": 4.422303431273852e-05,
            "start_logit": 0.5008304119110107,
            "end_logit": -3.144995927810669,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "MAGeCK) method",
            "probability": 3.085962426963427e-05,
            "start_logit": 1.1416343450546265,
            "end_logit": -4.145596981048584,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "CK",
            "probability": 2.5480757765460795e-05,
            "start_logit": -5.0412397384643555,
            "end_logit": 1.8457520008087158,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        },
        {
            "text": "We propose the Model-based Analysis of Genome-wide CRISPR/Cas9 Knockout (MAGeCK",
            "probability": 1.8917432826295602e-05,
            "start_logit": -4.36444091796875,
            "end_logit": 0.8711134791374207,
            "question_text": "Which algorithms have been developed for analysing CRISPR/Cas9 knockout screens data?"
        }
    ],
    "5e48136dd14c9f295d000008": [
        {
            "text": "hemopoietic stem cells",
            "probability": 0.6234366061385699,
            "start_logit": 3.0806384086608887,
            "end_logit": 1.4058740139007568,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "hemopoietic stem",
            "probability": 0.27887385845125207,
            "start_logit": 3.0806384086608887,
            "end_logit": 0.6013864874839783,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "stem cells",
            "probability": 0.03572398939939837,
            "start_logit": 0.22121375799179077,
            "end_logit": 1.4058740139007568,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "stem",
            "probability": 0.01597995155399571,
            "start_logit": 0.22121375799179077,
            "end_logit": 0.6013864874839783,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "hemopoietic stem cells,",
            "probability": 0.011626952446646266,
            "start_logit": 3.0806384086608887,
            "end_logit": -2.57604718208313,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "hemopoietic",
            "probability": 0.007504004344409462,
            "start_logit": 3.0806384086608887,
            "end_logit": -3.0139362812042236,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "hem",
            "probability": 0.006876676967660203,
            "start_logit": 3.0806384086608887,
            "end_logit": -3.1012375354766846,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "stem cells at high radiation doses, and proliferation of stem cells",
            "probability": 0.005349526035614751,
            "start_logit": 0.4217604100704193,
            "end_logit": -0.6934871077537537,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "hemopoietic stem cells, the possible target cells",
            "probability": 0.004826781023293493,
            "start_logit": 3.0806384086608887,
            "end_logit": -3.455193281173706,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "stem cells at high radiation doses, and proliferation of stem",
            "probability": 0.002092613583279409,
            "start_logit": 0.4217604100704193,
            "end_logit": -1.6320812702178955,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "stem cells to a premalignant state, inactivation of stem cells",
            "probability": 0.0017523959712726258,
            "start_logit": -0.838977575302124,
            "end_logit": -0.5487731099128723,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "stem cells to a premalignant state, inactivation of stem cells at high radiation doses, and proliferation of stem cells",
            "probability": 0.0015162951831960618,
            "start_logit": -0.838977575302124,
            "end_logit": -0.6934871077537537,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "Number of hemopoietic stem cells",
            "probability": 0.0007217048127275746,
            "start_logit": -3.6807477474212646,
            "end_logit": 1.4058740139007568,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "stem cells,",
            "probability": 0.0006662443652835149,
            "start_logit": 0.22121375799179077,
            "end_logit": -2.57604718208313,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "stem cells to a premalignant state, inactivation of stem",
            "probability": 0.000651114444283893,
            "start_logit": -0.838977575302124,
            "end_logit": -1.5388269424438477,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "stem cells to a premalignant state, inactivation of stem cells at high radiation doses, and proliferation of stem",
            "probability": 0.0005931403783237377,
            "start_logit": -0.838977575302124,
            "end_logit": -1.6320812702178955,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "cells",
            "probability": 0.0005846296905710108,
            "start_logit": -3.891385316848755,
            "end_logit": 1.4058740139007568,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "proliferation of stem cells",
            "probability": 0.0005294883957219323,
            "start_logit": -1.8910915851593018,
            "end_logit": -0.6934871077537537,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "etic stem cells",
            "probability": 0.00037119590626256586,
            "start_logit": -4.3456339836120605,
            "end_logit": 1.4058740139007568,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "Number of hemopoietic stem",
            "probability": 0.00032283090823743244,
            "start_logit": -3.6807477474212646,
            "end_logit": 0.6013864874839783,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        }
    ],
    "5e482160d14c9f295d00000c": [
        {
            "text": "peroxiredoxin 1 (Prx1), GSH reductase",
            "probability": 0.1265075313883073,
            "start_logit": 5.142859935760498,
            "end_logit": 4.085499286651611,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "peroxiredoxin 1",
            "probability": 0.1025643731754435,
            "start_logit": 5.142859935760498,
            "end_logit": 3.875688076019287,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "peroxiredoxin 1 (Prx1)",
            "probability": 0.0802216455043261,
            "start_logit": 5.142859935760498,
            "end_logit": 3.629990816116333,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "peroxiredoxin 1 (Prx1), GSH reductase (GSR)",
            "probability": 0.079986583683595,
            "start_logit": 5.142859935760498,
            "end_logit": 3.627056360244751,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "thioredoxin 1 (Trx1), peroxiredoxin 1",
            "probability": 0.06610295562731795,
            "start_logit": 4.703582763671875,
            "end_logit": 3.875688076019287,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "peroxiredoxin 1 (Prx1",
            "probability": 0.060968415110695715,
            "start_logit": 5.142859935760498,
            "end_logit": 3.355553388595581,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "GSH reductase",
            "probability": 0.05570470887648823,
            "start_logit": 4.322622776031494,
            "end_logit": 4.085499286651611,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "thioredoxin 1 (Trx1), peroxiredoxin 1 (Prx1)",
            "probability": 0.05170302034656751,
            "start_logit": 4.703582763671875,
            "end_logit": 3.629990816116333,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "thioredoxin 1",
            "probability": 0.04371693530868356,
            "start_logit": 4.703582763671875,
            "end_logit": 3.462210178375244,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "peroxiredoxin",
            "probability": 0.04088700076398389,
            "start_logit": 5.142859935760498,
            "end_logit": 2.95600962638855,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "thioredoxin 1 (Trx1), peroxiredoxin 1 (Prx1",
            "probability": 0.0392942726012306,
            "start_logit": 4.703582763671875,
            "end_logit": 3.355553388595581,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "thioredoxin 1 (Trx1)",
            "probability": 0.03849181234234921,
            "start_logit": 4.703582763671875,
            "end_logit": 3.3349201679229736,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "GSH reductase (GSR)",
            "probability": 0.03522026956990596,
            "start_logit": 4.322622776031494,
            "end_logit": 3.627056360244751,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "peroxiredoxin 1 (Prx1), GSH reductase (GSR",
            "probability": 0.03518823216482353,
            "start_logit": 5.142859935760498,
            "end_logit": 2.8059091567993164,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "Prx1), GSH reductase",
            "probability": 0.029107277288069087,
            "start_logit": 3.673546314239502,
            "end_logit": 4.085499286651611,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "thioredoxin",
            "probability": 0.02635194702811145,
            "start_logit": 4.703582763671875,
            "end_logit": 2.956016778945923,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "thioredoxin 1 (Trx1), peroxiredoxin",
            "probability": 0.026351758544972508,
            "start_logit": 4.703582763671875,
            "end_logit": 2.95600962638855,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "phosphatase and tensin homolog (PTEN",
            "probability": 0.02233554438949355,
            "start_logit": 4.639387130737305,
            "end_logit": 2.8548495769500732,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "thioredoxin 1 (Trx1",
            "probability": 0.020838050923149182,
            "start_logit": 4.703582763671875,
            "end_logit": 2.721255302429199,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "Prx1)",
            "probability": 0.01845766536248624,
            "start_logit": 3.673546314239502,
            "end_logit": 3.629990816116333,
            "question_text": "List five proteins with antioxidant properties?"
        }
    ],
    "5c72c9207c78d6947100007b": [
        {
            "text": "reversible jump Markov Chain Monte Carlo (RJMCMC)",
            "probability": 0.20606687754007721,
            "start_logit": 5.035096645355225,
            "end_logit": 4.0266194343566895,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "reversible jump Markov Chain Monte Carlo (RJMCMC) method",
            "probability": 0.19485707384630513,
            "start_logit": 5.035096645355225,
            "end_logit": 3.9706850051879883,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "reversible jump Markov Chain Monte Carlo (RJMCMC",
            "probability": 0.16314175081693408,
            "start_logit": 5.035096645355225,
            "end_logit": 3.7930381298065186,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "RJMCMC)",
            "probability": 0.09008428396178665,
            "start_logit": 4.2076416015625,
            "end_logit": 4.0266194343566895,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "RJMCMC) method",
            "probability": 0.08518380140408277,
            "start_logit": 4.2076416015625,
            "end_logit": 3.9706850051879883,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "reversible jump Markov Chain Monte Carlo",
            "probability": 0.07723253287391407,
            "start_logit": 5.035096645355225,
            "end_logit": 3.0452394485473633,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "RJMCMC",
            "probability": 0.07131911727908556,
            "start_logit": 4.2076416015625,
            "end_logit": 3.7930381298065186,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "a reversible jump Markov Chain Monte Carlo (RJMCMC)",
            "probability": 0.014041062591870237,
            "start_logit": 2.348881959915161,
            "end_logit": 4.0266194343566895,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "a reversible jump Markov Chain Monte Carlo (RJMCMC) method",
            "probability": 0.013277244761533963,
            "start_logit": 2.348881959915161,
            "end_logit": 3.9706850051879883,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "Markov Chain Monte Carlo (RJMCMC)",
            "probability": 0.012607004734981574,
            "start_logit": 2.2411484718322754,
            "end_logit": 4.0266194343566895,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "Markov Chain Monte Carlo (RJMCMC) method",
            "probability": 0.011921198020517656,
            "start_logit": 2.2411484718322754,
            "end_logit": 3.9706850051879883,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "a reversible jump Markov Chain Monte Carlo (RJMCMC",
            "probability": 0.011116214123846089,
            "start_logit": 2.348881959915161,
            "end_logit": 3.7930381298065186,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "Markov Chain Monte Carlo (RJMCMC",
            "probability": 0.009980880234487302,
            "start_logit": 2.2411484718322754,
            "end_logit": 3.7930381298065186,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "jump Markov Chain Monte Carlo (RJMCMC)",
            "probability": 0.007712356159512712,
            "start_logit": 1.7497196197509766,
            "end_logit": 4.0266194343566895,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "jump Markov Chain Monte Carlo (RJMCMC) method",
            "probability": 0.007292812758862226,
            "start_logit": 1.7497196197509766,
            "end_logit": 3.9706850051879883,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "jump Markov Chain Monte Carlo (RJMCMC",
            "probability": 0.006105820119208462,
            "start_logit": 1.7497196197509766,
            "end_logit": 3.7930381298065186,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "a reversible jump Markov Chain Monte Carlo",
            "probability": 0.005262499442688925,
            "start_logit": 2.348881959915161,
            "end_logit": 3.0452394485473633,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "Markov Chain Monte Carlo",
            "probability": 0.004725023833326581,
            "start_logit": 2.2411484718322754,
            "end_logit": 3.0452394485473633,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "reversible jump",
            "probability": 0.004452958449889965,
            "start_logit": 5.035096645355225,
            "end_logit": 0.19198736548423767,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "Markov models",
            "probability": 0.0036194870470887754,
            "start_logit": 2.888998031616211,
            "end_logit": 2.130849599838257,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        }
    ],
    "5e2f972bfbd6abf43b000030": [
        {
            "text": "ochronosis",
            "probability": 0.22249172554645688,
            "start_logit": 3.8346073627471924,
            "end_logit": 3.152850389480591,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "ochronosis, and arthritis",
            "probability": 0.20613742089837436,
            "start_logit": 3.8346073627471924,
            "end_logit": 3.0765035152435303,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "homogentisic aciduria",
            "probability": 0.16377947300251688,
            "start_logit": 3.2878170013427734,
            "end_logit": 3.3932716846466064,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "homogentisic aciduria, ochronosis",
            "probability": 0.12877923103696481,
            "start_logit": 3.2878170013427734,
            "end_logit": 3.152850389480591,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "homogentisic aciduria, ochronosis, and arthritis",
            "probability": 0.11931328450995762,
            "start_logit": 3.2878170013427734,
            "end_logit": 3.0765035152435303,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "arthritis",
            "probability": 0.10085109954377268,
            "start_logit": 3.1197094917297363,
            "end_logit": 3.0765035152435303,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "ochronotic arthropathies. The condition is characterised by a clinical triad of symptoms; homogentisic aciduria",
            "probability": 0.013338425164660292,
            "start_logit": 1.2424397468566895,
            "end_logit": 2.930777072906494,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "ochronotic osteoarthropathy",
            "probability": 0.007454237005824559,
            "start_logit": 1.7152984142303467,
            "end_logit": 1.8760520219802856,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "aciduria",
            "probability": 0.0072628974583479385,
            "start_logit": 0.17207500338554382,
            "end_logit": 3.3932716846466064,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "aciduria, ochronosis",
            "probability": 0.005710791057265158,
            "start_logit": 0.17207500338554382,
            "end_logit": 3.152850389480591,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "aciduria, ochronosis, and arthritis",
            "probability": 0.005291018067943097,
            "start_logit": 0.17207500338554382,
            "end_logit": 3.0765035152435303,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "ochronosis,",
            "probability": 0.00439711741899808,
            "start_logit": 3.8346073627471924,
            "end_logit": -0.7710903286933899,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "ochronotic arthropathy",
            "probability": 0.0030680621986009203,
            "start_logit": 1.5752109289169312,
            "end_logit": 1.1284030675888062,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "homogentisic aciduria, ochronosis,",
            "probability": 0.002545071726182375,
            "start_logit": 3.2878170013427734,
            "end_logit": -0.7710903286933899,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "arthropathies. The condition is characterised by a clinical triad of symptoms; homogentisic aciduria",
            "probability": 0.0022962091773216634,
            "start_logit": -0.5169496536254883,
            "end_logit": 2.930777072906494,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "osteoarthropathy",
            "probability": 0.0020349318567720277,
            "start_logit": 0.4169781506061554,
            "end_logit": 1.8760520219802856,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "homogentisic aciduria,",
            "probability": 0.0017510651603047476,
            "start_logit": 3.2878170013427734,
            "end_logit": -1.1450248956680298,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "ochronosis then ochronotic arthropathy",
            "probability": 0.0012337902877935173,
            "start_logit": 0.6642557382583618,
            "end_logit": 1.1284030675888062,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "homogentisic aciduria from birth, ochronosis",
            "probability": 0.001147347837148391,
            "start_logit": 2.764246702194214,
            "end_logit": -1.044225811958313,
            "question_text": "List Alkaptonuria Triad."
        },
        {
            "text": "ochronotic arthropathies",
            "probability": 0.0011168010447938366,
            "start_logit": 1.2424397468566895,
            "end_logit": 0.45059648156166077,
            "question_text": "List Alkaptonuria Triad."
        }
    ],
    "5e369ecfb5b409ea53000002": [
        {
            "text": "uc.38",
            "probability": 0.8537511840445007,
            "start_logit": 3.7502171993255615,
            "end_logit": 3.8890128135681152,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "uc.63",
            "probability": 0.1246675979164646,
            "start_logit": 2.9850544929504395,
            "end_logit": 2.730186700820923,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "63",
            "probability": 0.008686377013358934,
            "start_logit": 0.3211594521999359,
            "end_logit": 2.730186700820923,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "38",
            "probability": 0.005074425853082081,
            "start_logit": -1.3752092123031616,
            "end_logit": 3.8890128135681152,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "uc.63 in breast cancer.We found that overexpression of one specific T-UCRs named uc.63",
            "probability": 0.0025456709349125062,
            "start_logit": -0.213801309466362,
            "end_logit": 2.037785768508911,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "overexpression of one specific T-UCRs named uc.63",
            "probability": 0.0014747826648387247,
            "start_logit": -1.4520858526229858,
            "end_logit": 2.730186700820923,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "uc.38,",
            "probability": 0.0011684307756492757,
            "start_logit": 3.7502171993255615,
            "end_logit": -2.704965353012085,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "uc.38, a T-UCR,",
            "probability": 0.000705238977298895,
            "start_logit": 3.7502171993255615,
            "end_logit": -3.209845542907715,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "63 in breast cancer.We found that overexpression of one specific T-UCRs named uc.63",
            "probability": 0.0004211673304843917,
            "start_logit": -2.012920618057251,
            "end_logit": 2.037785768508911,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "38, a T-UCR, was down-regulated in both breast cancer tissues and breast cancer cell lines. However, uc.38",
            "probability": 0.00026869352998964665,
            "start_logit": -1.3752092123031616,
            "end_logit": 0.9506155848503113,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "uc.63 in promoting breast cancer cells survival and offer the prospect to identify a signature associated with poor prognosis.uc.38",
            "probability": 0.0002533091322171442,
            "start_logit": 0.008343813940882683,
            "end_logit": -0.4918982684612274,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "one specific T-UCRs named uc.63",
            "probability": 0.0002050401188632185,
            "start_logit": -3.4251461029052734,
            "end_logit": 2.730186700820923,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "uc.63 is associated with bad outcome in luminal A subtype of breast cancer",
            "probability": 0.00019199107066104692,
            "start_logit": 2.9850544929504395,
            "end_logit": -3.7457706928253174,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "uc.63 is associated with bad outcome in luminal A subtype of breast cancer patients. uc.63",
            "probability": 0.00014340924080054484,
            "start_logit": 1.760701298713684,
            "end_logit": -2.813163995742798,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "uc.63 is associated with bad outcome in luminal A subtype of breast cancer patients",
            "probability": 0.00011375102618856739,
            "start_logit": 2.9850544929504395,
            "end_logit": -4.26920747756958,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "u",
            "probability": 0.00010997451647757111,
            "start_logit": 2.9850544929504395,
            "end_logit": -4.302970886230469,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "uc.38 suppressed breast cancer. Additional experiments revealed that uc.38",
            "probability": 0.00010176261863760861,
            "start_logit": 0.0008255300344899297,
            "end_logit": -1.3963477611541748,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "uc.38/PBX1",
            "probability": 4.773845565448581e-05,
            "start_logit": 1.0207515954971313,
            "end_logit": -3.1731793880462646,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "We found that overexpression of one specific T-UCRs named uc.63",
            "probability": 4.239235262002252e-05,
            "start_logit": -4.308982849121094,
            "end_logit": 2.037785768508911,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "uc.63 is associated with bad outcome in luminal A subtype of breast cancer patients.",
            "probability": 2.7062427299832412e-05,
            "start_logit": 1.760701298713684,
            "end_logit": -4.480720043182373,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        }
    ],
    "5e36ad01b5b409ea53000006": [
        {
            "text": "uc.160",
            "probability": 0.29372350622206667,
            "start_logit": 0.34307265281677246,
            "end_logit": 1.5680840015411377,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "160",
            "probability": 0.2527297545138124,
            "start_logit": 0.19275453686714172,
            "end_logit": 1.5680840015411377,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "Uc.160",
            "probability": 0.18929538796464043,
            "start_logit": 1.6809128522872925,
            "end_logit": -0.2090863734483719,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "uc.160 acts as a negative regulator in gastric cancer.uc.160",
            "probability": 0.0781791516080664,
            "start_logit": 0.34307265281677246,
            "end_logit": 0.24444814026355743,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "Uc.160+",
            "probability": 0.07099842037683388,
            "start_logit": 1.6809128522872925,
            "end_logit": -1.1897374391555786,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "160 acts as a negative regulator in gastric cancer.uc.160",
            "probability": 0.06726801694606889,
            "start_logit": 0.19275453686714172,
            "end_logit": 0.24444814026355743,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "RNA uc.160",
            "probability": 0.019105116234829862,
            "start_logit": -2.3896100521087646,
            "end_logit": 1.5680840015411377,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "Uc.160+,",
            "probability": 0.011018167888181472,
            "start_logit": 1.6809128522872925,
            "end_logit": -3.052849531173706,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "RNA uc.160 acts as a negative regulator in gastric cancer.uc.160",
            "probability": 0.005085128520436691,
            "start_logit": -2.3896100521087646,
            "end_logit": 0.24444814026355743,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "uc.160 acts as a negative regulator in gastric cancer.",
            "probability": 0.004220171754577151,
            "start_logit": 0.34307265281677246,
            "end_logit": -2.6746790409088135,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "160 acts as a negative regulator in gastric cancer.",
            "probability": 0.0036311801709667884,
            "start_logit": 0.19275453686714172,
            "end_logit": -2.6746790409088135,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "Uc.160+, a transcribed ultraconserved region, in gastric cancer.BACKGROUND: Transcribed ultraconserved regions",
            "probability": 0.0017008301779122654,
            "start_logit": 0.18527960777282715,
            "end_logit": -3.425645351409912,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "160+",
            "probability": 0.0007109256883805551,
            "start_logit": -2.9229321479797363,
            "end_logit": -1.1897374391555786,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "uc.160 acts as a negative regulator in gastric cancer.uc.160 was found to be a suppressive factor of cancer development,",
            "probability": 0.00047796291366446984,
            "start_logit": 0.34307265281677246,
            "end_logit": -4.852777004241943,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "160 acts as a negative regulator in gastric cancer.uc.160 was found to be a suppressive factor of cancer development,",
            "probability": 0.00041125564443521875,
            "start_logit": 0.19275453686714172,
            "end_logit": -4.852777004241943,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "gastric cancer (GC), indicating that T-UCRs could play an important role in GC biology. Uc.160",
            "probability": 0.00039771174480264174,
            "start_logit": -4.484423637390137,
            "end_logit": -0.2090863734483719,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "160+, a transcribed ultraconserved region, in gastric cancer.BACKGROUND: Transcribed ultraconserved regions",
            "probability": 0.0003579725182113717,
            "start_logit": -1.3731359243392944,
            "end_logit": -3.425645351409912,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "RNA uc.160 acts as a negative regulator in gastric cancer.",
            "probability": 0.0002744992150583455,
            "start_logit": -2.3896100521087646,
            "end_logit": -2.6746790409088135,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "uc.160 was found to be a suppressive factor of cancer development,",
            "probability": 0.0002588032837963947,
            "start_logit": -0.2703922390937805,
            "end_logit": -4.852777004241943,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "Transcribed ultraconserved regions",
            "probability": 0.00015603661325812708,
            "start_logit": -2.3260512351989746,
            "end_logit": -3.303095579147339,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        }
    ],
    "5e46e8c13f5415952900000c": [
        {
            "text": "pyrimidine-pyrimidone photoproducts",
            "probability": 0.22898221348581443,
            "start_logit": 3.6064612865448,
            "end_logit": 2.8459484577178955,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "cyclobutane pyrimidine dimers",
            "probability": 0.2090449124634501,
            "start_logit": 3.675658702850342,
            "end_logit": 2.6856558322906494,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "cyclobutane pyrimidine dimers (CPDs) and pyrimidine-pyrimidone",
            "probability": 0.1803016665821899,
            "start_logit": 3.675658702850342,
            "end_logit": 2.537738084793091,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "pyrimidine-pyrimidone",
            "probability": 0.16824713787656434,
            "start_logit": 3.6064612865448,
            "end_logit": 2.537738084793091,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "cyclobutane pyrimidine dimers (CPDs)",
            "probability": 0.11424523560053777,
            "start_logit": 3.675658702850342,
            "end_logit": 2.081454038619995,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "cyclobutane pyrimidine dimers (CPDs",
            "probability": 0.02704495944495814,
            "start_logit": 3.675658702850342,
            "end_logit": 0.6406073570251465,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "CPDs) and pyrimidine-pyrimidone photoproducts",
            "probability": 0.01396774486876033,
            "start_logit": 0.8095676898956299,
            "end_logit": 2.8459484577178955,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "CPDs) and pyrimidine-pyrimidone",
            "probability": 0.01026295038808584,
            "start_logit": 0.8095676898956299,
            "end_logit": 2.537738084793091,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "pyrimidine-pyrimidone photoproducts (6-4 PPs)",
            "probability": 0.008658765348774938,
            "start_logit": 3.6064612865448,
            "end_logit": -0.42912372946739197,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "cyclobutane pyrimidine dimer",
            "probability": 0.007861064183555918,
            "start_logit": 1.915248990058899,
            "end_logit": 1.1654384136199951,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "pyrimidine-pyrimidone photoproducts (6-4 PPs",
            "probability": 0.007527459371034704,
            "start_logit": 3.6064612865448,
            "end_logit": -0.5691382884979248,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "CPDs)",
            "probability": 0.006502952564273831,
            "start_logit": 0.8095676898956299,
            "end_logit": 2.081454038619995,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "cyclobutane pyrimidine dimer (CPD)",
            "probability": 0.003448507226890919,
            "start_logit": 1.915248990058899,
            "end_logit": 0.34145787358283997,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "photoproducts",
            "probability": 0.0033807793020737284,
            "start_logit": -0.6090767979621887,
            "end_logit": 2.8459484577178955,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "cyclobutane pyrimidine dimer (CPD) and a (6-4) photoproduct",
            "probability": 0.0021461333216014366,
            "start_logit": 1.915248990058899,
            "end_logit": -0.13281580805778503,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "pyrimidone photoproducts",
            "probability": 0.002010429855406298,
            "start_logit": -1.1288344860076904,
            "end_logit": 2.8459484577178955,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "(CPDs) and pyrimidine-pyrimidone photoproducts",
            "probability": 0.0017221976706098053,
            "start_logit": -1.2835818529129028,
            "end_logit": 2.8459484577178955,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "pyrimidine dimers (CPDs) and pyrimidine-pyrimidone photoproducts",
            "probability": 0.0016282795210433116,
            "start_logit": -1.3396590948104858,
            "end_logit": 2.8459484577178955,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "CPDs",
            "probability": 0.001539426020251863,
            "start_logit": 0.8095676898956299,
            "end_logit": 0.6406073570251465,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "pyrimidone",
            "probability": 0.0014771849041220813,
            "start_logit": -1.1288344860076904,
            "end_logit": 2.537738084793091,
            "question_text": "List types of DNA lesions caused by UV light."
        }
    ],
    "5cd96eb2a49efeb44c000003": [
        {
            "text": "SweeD",
            "probability": 0.5584301957054513,
            "start_logit": 4.082301616668701,
            "end_logit": 4.144908428192139,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "SweeD for multi-core processors.We present SweeD",
            "probability": 0.1606866902555172,
            "start_logit": 2.8366284370422363,
            "end_logit": 4.144908428192139,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "SweeD (Sweep Detector",
            "probability": 0.06907587432367546,
            "start_logit": 4.082301616668701,
            "end_logit": 2.0549843311309814,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "SweeD (Sweep Detector)",
            "probability": 0.06144709598290283,
            "start_logit": 4.082301616668701,
            "end_logit": 1.937955379486084,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "SweeD (Sweep Detector),",
            "probability": 0.02422248292035989,
            "start_logit": 4.082301616668701,
            "end_logit": 1.0070600509643555,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "SweeD for multi-core processors.We present SweeD (Sweep Detector",
            "probability": 0.019876385100479125,
            "start_logit": 2.8366284370422363,
            "end_logit": 2.0549843311309814,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "SweeD for multi-core processors.We present SweeD (Sweep Detector)",
            "probability": 0.017681225971014156,
            "start_logit": 2.8366284370422363,
            "end_logit": 1.937955379486084,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "SweepFinder and, more importantly, is able to analyze thousands of sequences. We also provide a parallel implementation of SweeD",
            "probability": 0.015848058126075364,
            "start_logit": 1.9855047464370728,
            "end_logit": 2.6796226501464844,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "SweepFinder programThe sequential version of SweeD",
            "probability": 0.010624854414654066,
            "start_logit": 1.911848545074463,
            "end_logit": 2.3534278869628906,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "Sweep Detector",
            "probability": 0.010367187942110195,
            "start_logit": 2.185741901397705,
            "end_logit": 2.0549843311309814,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "Sweep Detector)",
            "probability": 0.009222229885453619,
            "start_logit": 2.185741901397705,
            "end_logit": 1.937955379486084,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "SweepFinder",
            "probability": 0.009174078057279166,
            "start_logit": 1.911848545074463,
            "end_logit": 2.206613779067993,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "SweeD is up to 22 times faster than SweepFinder",
            "probability": 0.00809052086978519,
            "start_logit": 2.3708558082580566,
            "end_logit": 1.621917724609375,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "SweeD for multi-core processors.We present SweeD (Sweep Detector),",
            "probability": 0.006969950121208014,
            "start_logit": 2.8366284370422363,
            "end_logit": 1.0070600509643555,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "SweeD: likelihood",
            "probability": 0.0060870537963511355,
            "start_logit": 3.8542299270629883,
            "end_logit": -0.14598532021045685,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "SweepFinder programThe sequential version of SweeD is up to 22 times faster than SweepFinder",
            "probability": 0.005112486343733004,
            "start_logit": 1.911848545074463,
            "end_logit": 1.621917724609375,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "Sweep Detector),",
            "probability": 0.0036354086765986136,
            "start_logit": 2.185741901397705,
            "end_logit": 1.0070600509643555,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "gPLINK",
            "probability": 0.0015362119559200254,
            "start_logit": 1.5404514074325562,
            "end_logit": 0.7909486293792725,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "SweeD:",
            "probability": 0.0009761022582411232,
            "start_logit": 3.8542299270629883,
            "end_logit": -1.9763374328613281,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "gPLINK software",
            "probability": 0.0009359072931903346,
            "start_logit": 1.5404514074325562,
            "end_logit": 0.29539015889167786,
            "question_text": "Which software are used for the detection of selective sweeps?"
        }
    ],
    "5c70273c7c78d69471000061": [
        {
            "text": "renal, peripheral vascular, and musculoskeletal",
            "probability": 0.22978815213252848,
            "start_logit": 4.853160381317139,
            "end_logit": 4.357873439788818,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "musculoskeletal",
            "probability": 0.20307569301091832,
            "start_logit": 4.729581356048584,
            "end_logit": 4.357873439788818,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "renal",
            "probability": 0.1776674770382811,
            "start_logit": 4.853160381317139,
            "end_logit": 4.1006293296813965,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "renal, peripheral vascular",
            "probability": 0.15913070805371807,
            "start_logit": 4.853160381317139,
            "end_logit": 3.9904415607452393,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "peripheral vascular, and musculoskeletal",
            "probability": 0.12545797821305082,
            "start_logit": 4.247973442077637,
            "end_logit": 4.357873439788818,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "peripheral vascular",
            "probability": 0.08688096718109517,
            "start_logit": 4.247973442077637,
            "end_logit": 3.9904415607452393,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "renal, peripheral vascular, and musculoskeletal damage",
            "probability": 0.003650271161905131,
            "start_logit": 4.853160381317139,
            "end_logit": 0.2155170887708664,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "musculoskeletal damage",
            "probability": 0.0032259337089500005,
            "start_logit": 4.729581356048584,
            "end_logit": 0.2155170887708664,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "peripheral vascular, and musculoskeletal damage",
            "probability": 0.0019929471369694437,
            "start_logit": 4.247973442077637,
            "end_logit": 0.2155170887708664,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "cardiovascular system",
            "probability": 0.001958668899171913,
            "start_logit": 2.945333957672119,
            "end_logit": 1.5008071660995483,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "renal, peripheral vascular,",
            "probability": 0.001826852574141251,
            "start_logit": 4.853160381317139,
            "end_logit": -0.47668978571891785,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "renal,",
            "probability": 0.001468212737669006,
            "start_logit": 4.853160381317139,
            "end_logit": -0.6952385306358337,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "peripheral vascular,",
            "probability": 0.0009974109992967938,
            "start_logit": 4.247973442077637,
            "end_logit": -0.47668978571891785,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "vascular, and musculoskeletal",
            "probability": 0.0006969501234989215,
            "start_logit": -0.9450388550758362,
            "end_logit": 4.357873439788818,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "renal systems",
            "probability": 0.0006947328409578767,
            "start_logit": 3.2650041580200195,
            "end_logit": 0.14464394748210907,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "vascular",
            "probability": 0.00048264527827590245,
            "start_logit": -0.9450388550758362,
            "end_logit": 3.9904415607452393,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "cardiovascular",
            "probability": 0.0003413955913693342,
            "start_logit": 2.945333957672119,
            "end_logit": -0.24617132544517517,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "neuropsychiatric and renal",
            "probability": 0.00023948905535532588,
            "start_logit": 1.1157327890396118,
            "end_logit": 1.228895664215088,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "re",
            "probability": 0.00023608417549664774,
            "start_logit": 4.853160381317139,
            "end_logit": -2.5228512287139893,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "renal, peripheral vascular, and musculoskeletal damage (24, 19, 38% of patients, respectively)",
            "probability": 0.00018743008735067881,
            "start_logit": 4.853160381317139,
            "end_logit": -2.753633737564087,
            "question_text": "Which organs are primarily damaged in SLE?"
        }
    ],
    "5c7a4ed5d774d04240000008": [
        {
            "text": "non-invasive and repeatable way for the detection and follow-up",
            "probability": 0.3459458813126135,
            "start_logit": 5.143928050994873,
            "end_logit": 4.91417932510376,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "follow-up",
            "probability": 0.13633430295954405,
            "start_logit": 4.2127556800842285,
            "end_logit": 4.91417932510376,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "detection and follow-up",
            "probability": 0.11359350228166523,
            "start_logit": 4.030272006988525,
            "end_logit": 4.91417932510376,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "non-invasive",
            "probability": 0.0883912942243484,
            "start_logit": 5.143928050994873,
            "end_logit": 3.549670457839966,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "repeatable way for the detection and follow-up",
            "probability": 0.08394922296697774,
            "start_logit": 3.727857828140259,
            "end_logit": 4.91417932510376,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "non-invasive and repeatable",
            "probability": 0.05872368756715737,
            "start_logit": 5.143928050994873,
            "end_logit": 3.140740156173706,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "non-invasive and repeatable way for the detection and follow-up of these biomarkers",
            "probability": 0.04082564344974121,
            "start_logit": 5.143928050994873,
            "end_logit": 2.777207374572754,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "non-invasive and repeatable way",
            "probability": 0.030118067710859942,
            "start_logit": 5.143928050994873,
            "end_logit": 2.473022222518921,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "non-invasive and repeatable way for the detection",
            "probability": 0.016497485593180986,
            "start_logit": 5.143928050994873,
            "end_logit": 1.8711049556732178,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "follow-up of these biomarkers",
            "probability": 0.016089035722803402,
            "start_logit": 4.2127556800842285,
            "end_logit": 2.777207374572754,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "repeatable",
            "probability": 0.014250228741886998,
            "start_logit": 3.727857828140259,
            "end_logit": 3.140740156173706,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "detection and follow-up of these biomarkers",
            "probability": 0.013405356366037886,
            "start_logit": 4.030272006988525,
            "end_logit": 2.777207374572754,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "repeatable way for the detection and follow-up of these biomarkers",
            "probability": 0.00990698612085976,
            "start_logit": 3.727857828140259,
            "end_logit": 2.777207374572754,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "repeatable way",
            "probability": 0.007308624031019291,
            "start_logit": 3.727857828140259,
            "end_logit": 2.473022222518921,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "detection",
            "probability": 0.0054170529802530015,
            "start_logit": 4.030272006988525,
            "end_logit": 1.8711049556732178,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "plasma-isolated exosomes can be used as a non-invasive and repeatable way for the detection and follow-up",
            "probability": 0.004169357302537724,
            "start_logit": 0.725407600402832,
            "end_logit": 4.91417932510376,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "exosomes can be used as a non-invasive and repeatable way for the detection and follow-up",
            "probability": 0.004039092517306029,
            "start_logit": 0.6936657428741455,
            "end_logit": 4.91417932510376,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "repeatable way for the detection",
            "probability": 0.0040033750111478986,
            "start_logit": 3.727857828140259,
            "end_logit": 1.8711049556732178,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "can be used as a non-invasive and repeatable way for the detection and follow-up",
            "probability": 0.003720272303069075,
            "start_logit": 0.6114425659179688,
            "end_logit": 4.91417932510376,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "a non-invasive and repeatable way for the detection and follow-up",
            "probability": 0.0033115308369905607,
            "start_logit": 0.49505627155303955,
            "end_logit": 4.91417932510376,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        }
    ],
    "5e2b0d167d50947c2f000002": [
        {
            "text": "acromelic frontonasal dysostosis",
            "probability": 0.345311020484883,
            "start_logit": 5.028463363647461,
            "end_logit": 4.979211330413818,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "frontonasal dysostosis",
            "probability": 0.19863167334295087,
            "start_logit": 4.475470066070557,
            "end_logit": 4.979211330413818,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "acromelic frontonasal dysostosis.Acromelic frontonasal dysostosis",
            "probability": 0.10947251556032658,
            "start_logit": 5.028463363647461,
            "end_logit": 3.830439329147339,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "acromelic frontonasal dysostosis.Acromelic frontonasal dysostosis (AFND)",
            "probability": 0.07125598362447652,
            "start_logit": 5.028463363647461,
            "end_logit": 3.4010446071624756,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "frontonasal dysostosis.Acromelic frontonasal dysostosis",
            "probability": 0.06297137264914439,
            "start_logit": 4.475470066070557,
            "end_logit": 3.830439329147339,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "acromelic frontonasal dysostosis (AFND)",
            "probability": 0.05404548552510826,
            "start_logit": 4.70453405380249,
            "end_logit": 3.448521137237549,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "frontonasal dysostosis.Acromelic frontonasal dysostosis (AFND)",
            "probability": 0.0409882523967905,
            "start_logit": 4.475470066070557,
            "end_logit": 3.4010446071624756,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "Acromelic frontonasal dysostosis",
            "probability": 0.03902876989569363,
            "start_logit": 3.99708890914917,
            "end_logit": 3.830439329147339,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "Acromelic frontonasal dysostosis (AFND)",
            "probability": 0.02540394156776707,
            "start_logit": 3.99708890914917,
            "end_logit": 3.4010446071624756,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "frontonasal dysostosis (AFND)",
            "probability": 0.024037676757668183,
            "start_logit": 3.8943305015563965,
            "end_logit": 3.448521137237549,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "acromelic frontonasal dysostosis (AFND),",
            "probability": 0.00681617905531954,
            "start_logit": 4.70453405380249,
            "end_logit": 1.377994179725647,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "acromelic",
            "probability": 0.005465329712541289,
            "start_logit": 5.028463363647461,
            "end_logit": 0.8331902623176575,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "acromelic frontonasal dysostosis.",
            "probability": 0.004459393157912245,
            "start_logit": 5.028463363647461,
            "end_logit": 0.6297785043716431,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "dysostosis",
            "probability": 0.003056121426087012,
            "start_logit": 0.301164448261261,
            "end_logit": 4.979211330413818,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "frontonasal dysostosis (AFND),",
            "probability": 0.003031615078710702,
            "start_logit": 3.8943305015563965,
            "end_logit": 1.377994179725647,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "frontonasal dysostosis.",
            "probability": 0.0025651562577018675,
            "start_logit": 4.475470066070557,
            "end_logit": 0.6297785043716431,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "AFND)",
            "probability": 0.001296687897316002,
            "start_logit": 1.0219978094100952,
            "end_logit": 3.4010446071624756,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "dysostosis.Acromelic frontonasal dysostosis",
            "probability": 0.0009688694554311347,
            "start_logit": 0.301164448261261,
            "end_logit": 3.830439329147339,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "dysostosis.Acromelic frontonasal dysostosis (AFND)",
            "probability": 0.0006306399893808237,
            "start_logit": 0.301164448261261,
            "end_logit": 3.4010446071624756,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        },
        {
            "text": "acromelic frontonasal",
            "probability": 0.0005633161647901669,
            "start_logit": 5.028463363647461,
            "end_logit": -1.4391484260559082,
            "question_text": "Which disorders are caused by de novo mutations in ZSWIM6?"
        }
    ],
    "5e2f9ceefbd6abf43b000033": [
        {
            "text": "hydrochlorothiazide",
            "probability": 0.16407388160839165,
            "start_logit": 5.108373165130615,
            "end_logit": 5.048084259033203,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "enalapril",
            "probability": 0.15481818208133097,
            "start_logit": 5.332767963409424,
            "end_logit": 4.765624046325684,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "enalapril (ENA), and atorvastatin",
            "probability": 0.13383787188965074,
            "start_logit": 5.332767963409424,
            "end_logit": 4.620001792907715,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "atorvastatin",
            "probability": 0.125731982848363,
            "start_logit": 5.270291328430176,
            "end_logit": 4.620001792907715,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "hydrochlorothiazide (HCT), enalapril",
            "probability": 0.12369966995483712,
            "start_logit": 5.108373165130615,
            "end_logit": 4.765624046325684,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "hydrochlorothiazide (HCT), enalapril (ENA), and atorvastatin",
            "probability": 0.10693640990765751,
            "start_logit": 5.108373165130615,
            "end_logit": 4.620001792907715,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "acetylsalicylic acid, hydrochlorothiazide",
            "probability": 0.08004867916863907,
            "start_logit": 4.39069128036499,
            "end_logit": 5.048084259033203,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "acetylsalicylic acid, hydrochlorothiazide (HCT), enalapril",
            "probability": 0.06035083156693512,
            "start_logit": 4.39069128036499,
            "end_logit": 4.765624046325684,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "acetylsalicylic acid",
            "probability": 0.017863557282825623,
            "start_logit": 4.39069128036499,
            "end_logit": 3.5482120513916016,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "enalapril (ENA)",
            "probability": 0.008965994818915343,
            "start_logit": 5.332767963409424,
            "end_logit": 1.9168117046356201,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "hydrochlorothiazide (HCT), enalapril (ENA)",
            "probability": 0.007163826528682312,
            "start_logit": 5.108373165130615,
            "end_logit": 1.9168117046356201,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "enalapril (ENA), and atorvastatin (ATR)",
            "probability": 0.003730939608310277,
            "start_logit": 4.750545978546143,
            "end_logit": 1.622254729270935,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "atorvastatin (ATR)",
            "probability": 0.0035559918393252557,
            "start_logit": 4.70251989364624,
            "end_logit": 1.622254729270935,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "acetylsalicylic acid, hydrochlorothiazide (HCT), enalapril (ENA)",
            "probability": 0.0034951013884280905,
            "start_logit": 4.39069128036499,
            "end_logit": 1.9168117046356201,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "hydrochlorothiazide (HCT)",
            "probability": 0.0018803937043380303,
            "start_logit": 5.108373165130615,
            "end_logit": 0.5792486071586609,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "acetylsalicylic acid, hydrochlorothiazide (HCT)",
            "probability": 0.0009174100769344216,
            "start_logit": 4.39069128036499,
            "end_logit": 0.5792486071586609,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "atorvastatin and hydrochlorthiazide",
            "probability": 0.0009058801360773724,
            "start_logit": 2.819675922393799,
            "end_logit": 2.1376163959503174,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "valsartan, atorvastatin",
            "probability": 0.0006822422964230128,
            "start_logit": 2.506056308746338,
            "end_logit": 2.1677138805389404,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "enalapril (ENA),",
            "probability": 0.0006791388439252841,
            "start_logit": 5.332767963409424,
            "end_logit": -0.6635570526123047,
            "question_text": "Which drugs are included in PolyIran?"
        },
        {
            "text": "valsartan, atorvastatin and hydrochlorthiazide",
            "probability": 0.0006620144500095236,
            "start_logit": 2.506056308746338,
            "end_logit": 2.1376163959503174,
            "question_text": "Which drugs are included in PolyIran?"
        }
    ],
    "5e2a120c76af173751000001": [
        {
            "text": "vasodilation",
            "probability": 0.2124729637154523,
            "start_logit": 5.971279144287109,
            "end_logit": 6.2916951179504395,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "vasodilation, blood flow upregulation, and neovessel formation",
            "probability": 0.16240568962081559,
            "start_logit": 5.971279144287109,
            "end_logit": 6.022977828979492,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "neovessel formation",
            "probability": 0.1535065774362667,
            "start_logit": 5.9149250984191895,
            "end_logit": 6.022977828979492,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "blood flow upregulation, and neovessel formation",
            "probability": 0.15014320842727671,
            "start_logit": 5.892771244049072,
            "end_logit": 6.022977828979492,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "vasodilation, blood flow upregulation",
            "probability": 0.12578352023865338,
            "start_logit": 5.971279144287109,
            "end_logit": 5.76744270324707,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "blood flow upregulation",
            "probability": 0.11628620487374937,
            "start_logit": 5.892771244049072,
            "end_logit": 5.76744270324707,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "vasodilation, blood flow",
            "probability": 0.010241052192139815,
            "start_logit": 5.971279144287109,
            "end_logit": 3.259284734725952,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "pronounced, sustained and dose-dependent vasodilation",
            "probability": 0.009579936917804309,
            "start_logit": 2.8721354007720947,
            "end_logit": 6.2916951179504395,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "blood flow",
            "probability": 0.009467799049338168,
            "start_logit": 5.892771244049072,
            "end_logit": 3.259284734725952,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "pronounced, sustained and dose-dependent vasodilation, blood flow upregulation, and neovessel formation",
            "probability": 0.007322514048156846,
            "start_logit": 2.8721354007720947,
            "end_logit": 6.022977828979492,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "sustained and dose-dependent vasodilation",
            "probability": 0.0059902621725631145,
            "start_logit": 2.402599573135376,
            "end_logit": 6.2916951179504395,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "pronounced, sustained and dose-dependent vasodilation, blood flow upregulation",
            "probability": 0.005671301271061558,
            "start_logit": 2.8721354007720947,
            "end_logit": 5.76744270324707,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "vasodilation, blood flow upregulation, and neovessel formation,",
            "probability": 0.0046036602260572665,
            "start_logit": 5.971279144287109,
            "end_logit": 2.4597320556640625,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "sustained and dose-dependent vasodilation, blood flow upregulation, and neovessel formation",
            "probability": 0.004578712708349377,
            "start_logit": 2.402599573135376,
            "end_logit": 6.022977828979492,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "neovessel formation,",
            "probability": 0.004351400044121015,
            "start_logit": 5.9149250984191895,
            "end_logit": 2.4597320556640625,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "blood flow upregulation, and neovessel formation,",
            "probability": 0.004256059738197052,
            "start_logit": 5.892771244049072,
            "end_logit": 2.4597320556640625,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "vasodilation, blood flow upregulation,",
            "probability": 0.004140577583103671,
            "start_logit": 5.971279144287109,
            "end_logit": 2.353715658187866,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "blood flow upregulation,",
            "probability": 0.003827942263111227,
            "start_logit": 5.892771244049072,
            "end_logit": 2.353715658187866,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "sustained and dose-dependent vasodilation, blood flow upregulation",
            "probability": 0.0035462218347295307,
            "start_logit": 2.402599573135376,
            "end_logit": 5.76744270324707,
            "question_text": "What are the in vivo effects of AZD8601?"
        },
        {
            "text": "vasodilation, blood flow upregulation, and neovessel",
            "probability": 0.0018243956390527581,
            "start_logit": 5.971279144287109,
            "end_logit": 1.5341291427612305,
            "question_text": "What are the in vivo effects of AZD8601?"
        }
    ],
    "5c7006037c78d6947100005d": [
        {
            "text": "central nervous system and vascular",
            "probability": 0.14077072570196855,
            "start_logit": 2.843226432800293,
            "end_logit": 2.20501971244812,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "central nervous system and vascular, 4 for renal and musculoskeletal",
            "probability": 0.13224381339340321,
            "start_logit": 2.843226432800293,
            "end_logit": 2.1425344944000244,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "central nervous system",
            "probability": 0.11647814999837719,
            "start_logit": 2.843226432800293,
            "end_logit": 2.0155909061431885,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "central nervous system and vascular, 4 for renal",
            "probability": 0.09681969035933267,
            "start_logit": 2.843226432800293,
            "end_logit": 1.830737590789795,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "renal and musculoskeletal",
            "probability": 0.08419061505368833,
            "start_logit": 2.39166259765625,
            "end_logit": 2.1425344944000244,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "musculoskeletal",
            "probability": 0.06634377187210848,
            "start_logit": 2.1534290313720703,
            "end_logit": 2.1425344944000244,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "renal",
            "probability": 0.06163849235359764,
            "start_logit": 2.39166259765625,
            "end_logit": 1.830737590789795,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "central nervous system and vascular, 4 for renal and musculoskeletal, 2 for serosal",
            "probability": 0.04304602509747549,
            "start_logit": 2.843226432800293,
            "end_logit": 1.0201570987701416,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "central nervous system and vascular, 4 for renal and musculoskeletal, 2 for serosal, dermal",
            "probability": 0.038970750545485544,
            "start_logit": 2.843226432800293,
            "end_logit": 0.9206985831260681,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "renal and musculoskeletal, 2 for serosal",
            "probability": 0.02740446782029765,
            "start_logit": 2.39166259765625,
            "end_logit": 1.0201570987701416,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "renal and musculoskeletal, 2 for serosal, dermal",
            "probability": 0.024810018505500495,
            "start_logit": 2.39166259765625,
            "end_logit": 0.9206985831260681,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "renal, immunological and hematologic",
            "probability": 0.0246800533599785,
            "start_logit": 2.090146541595459,
            "end_logit": 1.216962456703186,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "renal and musculoskeletal, 2 for serosal, dermal, immunologic",
            "probability": 0.022536269609061296,
            "start_logit": 2.39166259765625,
            "end_logit": 0.8245770335197449,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "renal, immunological",
            "probability": 0.021706320799015515,
            "start_logit": 2.090146541595459,
            "end_logit": 1.0885705947875977,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "musculoskeletal, 2 for serosal",
            "probability": 0.02159523077705221,
            "start_logit": 2.1534290313720703,
            "end_logit": 1.0201570987701416,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "musculoskeletal, 2 for serosal, dermal",
            "probability": 0.019550756421271742,
            "start_logit": 2.1534290313720703,
            "end_logit": 0.9206985831260681,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "musculoskeletal, 2 for serosal, dermal, immunologic",
            "probability": 0.01775899996500136,
            "start_logit": 2.1534290313720703,
            "end_logit": 0.8245770335197449,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "vascular",
            "probability": 0.013863829984032523,
            "start_logit": 0.5253772139549255,
            "end_logit": 2.20501971244812,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "vascular, 4 for renal and musculoskeletal",
            "probability": 0.013024055507164489,
            "start_logit": 0.5253772139549255,
            "end_logit": 2.1425344944000244,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "renal and musculoskeletal, 2 for serosal, dermal, immunologic, and 1 for constitutional",
            "probability": 0.01256796287618705,
            "start_logit": 2.39166259765625,
            "end_logit": 0.24060198664665222,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        }
    ],
    "5e2f992cfbd6abf43b000031": [
        {
            "text": "aspirin",
            "probability": 0.11499844498706575,
            "start_logit": 6.18372917175293,
            "end_logit": 5.913946151733398,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "aspirin [acetylsalicylic acid], ramipril, simvastatin",
            "probability": 0.08239274410862836,
            "start_logit": 6.18372917175293,
            "end_logit": 5.580524921417236,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "aspirin [acetylsalicylic acid], ramipril, simvastatin, atenolol",
            "probability": 0.07878971345493183,
            "start_logit": 6.18372917175293,
            "end_logit": 5.5358099937438965,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "aspirin [acetylsalicylic acid], ramipril",
            "probability": 0.07596298876202792,
            "start_logit": 6.18372917175293,
            "end_logit": 5.499273777008057,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "ramipril, simvastatin, atenolol, and hydrochlorothiazide",
            "probability": 0.0753298378312076,
            "start_logit": 6.011159420013428,
            "end_logit": 5.663473606109619,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "ramipril, simvastatin",
            "probability": 0.06933346044442376,
            "start_logit": 6.011159420013428,
            "end_logit": 5.580524921417236,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "ramipril, simvastatin, atenolol",
            "probability": 0.06630151162404269,
            "start_logit": 6.011159420013428,
            "end_logit": 5.5358099937438965,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "ramipril",
            "probability": 0.06392282395193001,
            "start_logit": 6.011159420013428,
            "end_logit": 5.499273777008057,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "simvastatin, atenolol, and hydrochlorothiazide",
            "probability": 0.05926537921428235,
            "start_logit": 5.771308422088623,
            "end_logit": 5.663473606109619,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "atenolol, and hydrochlorothiazide",
            "probability": 0.059152390796712216,
            "start_logit": 5.769400119781494,
            "end_logit": 5.663473606109619,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "simvastatin",
            "probability": 0.05454775881350583,
            "start_logit": 5.771308422088623,
            "end_logit": 5.580524921417236,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "simvastatin, atenolol",
            "probability": 0.05216238799934302,
            "start_logit": 5.771308422088623,
            "end_logit": 5.5358099937438965,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "atenolol",
            "probability": 0.052062941311329505,
            "start_logit": 5.769400119781494,
            "end_logit": 5.5358099937438965,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "hydrochlorothiazide",
            "probability": 0.04526135283113116,
            "start_logit": 5.501736640930176,
            "end_logit": 5.663473606109619,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "acetylsalicylic acid], ramipril, simvastatin",
            "probability": 0.011358872250932236,
            "start_logit": 4.202230930328369,
            "end_logit": 5.580524921417236,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "acetylsalicylic acid], ramipril, simvastatin, atenolol",
            "probability": 0.010862149325214728,
            "start_logit": 4.202230930328369,
            "end_logit": 5.5358099937438965,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "acetylsalicylic acid], ramipril",
            "probability": 0.01047244990419631,
            "start_logit": 4.202230930328369,
            "end_logit": 5.499273777008057,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "simvastatin (20 mg), and aspirin",
            "probability": 0.0070394782444435835,
            "start_logit": 4.8548054695129395,
            "end_logit": 4.4494853019714355,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "ramipril, 5 mg) at low doses, simvastatin",
            "probability": 0.005421819054343346,
            "start_logit": 4.58251428604126,
            "end_logit": 4.460673809051514,
            "question_text": "Which medication are included in the Polycap polypill?"
        },
        {
            "text": "ramipril, 5 mg) at low doses, simvastatin (20 mg), and aspirin",
            "probability": 0.0053614950903079755,
            "start_logit": 4.58251428604126,
            "end_logit": 4.4494853019714355,
            "question_text": "Which medication are included in the Polycap polypill?"
        }
    ],
    "5c74305d7c78d694710000a4": [
        {
            "text": "nuclear localization signal",
            "probability": 0.21054597612608078,
            "start_logit": -2.108052968978882,
            "end_logit": -2.7113754749298096,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "nuclear localization signal (NLS)",
            "probability": 0.1809883564050988,
            "start_logit": -2.108052968978882,
            "end_logit": -2.8626468181610107,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "nuclear localization signal (NLS) and causing cytoplasmic mislocalization",
            "probability": 0.16773842692200405,
            "start_logit": -2.108052968978882,
            "end_logit": -2.938673734664917,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "nuclear",
            "probability": 0.057650368881435154,
            "start_logit": -2.108052968978882,
            "end_logit": -4.006682872772217,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "short deletions affecting nuclear localization signal",
            "probability": 0.051541097061912414,
            "start_logit": -3.5153775215148926,
            "end_logit": -2.7113754749298096,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "cytoplasmic mislocalization",
            "probability": 0.04820109430121043,
            "start_logit": -3.355077028274536,
            "end_logit": -2.938673734664917,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "short deletions affecting nuclear localization signal (NLS)",
            "probability": 0.04430547007445598,
            "start_logit": -3.5153775215148926,
            "end_logit": -2.8626468181610107,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "short deletions affecting nuclear localization signal (NLS) and causing cytoplasmic mislocalization",
            "probability": 0.04106192244596683,
            "start_logit": -3.5153775215148926,
            "end_logit": -2.938673734664917,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "nuclear localization",
            "probability": 0.028541587791240077,
            "start_logit": -2.108052968978882,
            "end_logit": -4.709717273712158,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "nuclear localization signal (NLS) and causing cytoplasmic mislocalization can be",
            "probability": 0.027146706160660172,
            "start_logit": -2.108052968978882,
            "end_logit": -4.759823799133301,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "nuclear localization signal (NLS) and causing cytoplasmic mislocalization can be sequestered into stress granules",
            "probability": 0.020601422430174945,
            "start_logit": -2.108052968978882,
            "end_logit": -5.035719394683838,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "deletions affecting nuclear localization signal",
            "probability": 0.020587350129077822,
            "start_logit": -4.433080196380615,
            "end_logit": -2.7113754749298096,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "deletions affecting nuclear localization signal (NLS)",
            "probability": 0.01769718296761378,
            "start_logit": -4.433080196380615,
            "end_logit": -2.8626468181610107,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "deletions affecting nuclear localization signal (NLS) and causing cytoplasmic mislocalization",
            "probability": 0.016401594505307024,
            "start_logit": -4.433080196380615,
            "end_logit": -2.938673734664917,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "short deletions affecting nuclear",
            "probability": 0.014112657543233074,
            "start_logit": -3.5153775215148926,
            "end_logit": -4.006682872772217,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "short deletions",
            "probability": 0.01361280380186227,
            "start_logit": -3.5153775215148926,
            "end_logit": -4.042744159698486,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "cytoplasmic mislocalization can be sequestered into stress granules (SGs) By",
            "probability": 0.012274717663662716,
            "start_logit": -3.355077028274536,
            "end_logit": -4.306513786315918,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "we have demonstrated that transcript localization at the endoplasmic reticulum",
            "probability": 0.01220351785765045,
            "start_logit": -3.890146255493164,
            "end_logit": -3.777261972427368,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "cytoplasmic mislocalization can be",
            "probability": 0.007800841868069176,
            "start_logit": -3.355077028274536,
            "end_logit": -4.759823799133301,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "short deletions affecting nuclear localization",
            "probability": 0.006986905063284063,
            "start_logit": -3.5153775215148926,
            "end_logit": -4.709717273712158,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        }
    ],
    "5c7a4a31d774d04240000006": [
        {
            "text": "variable detection antibodies, differing IHC cutoffs, tissue preparation, processing variability, primary versus metastatic biopsies",
            "probability": 0.24744751878204777,
            "start_logit": 3.3550937175750732,
            "end_logit": 2.738320827484131,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "variable detection antibodies, differing IHC cutoffs, tissue preparation, processing variability",
            "probability": 0.23656781616693623,
            "start_logit": 3.3550937175750732,
            "end_logit": 2.693357229232788,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "primary versus metastatic biopsies",
            "probability": 0.06943738018017742,
            "start_logit": 2.084320545196533,
            "end_logit": 2.738320827484131,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "variable detection antibodies",
            "probability": 0.04935565628688701,
            "start_logit": 3.3550937175750732,
            "end_logit": 1.1261746883392334,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "tissue preparation, processing variability, primary versus metastatic biopsies",
            "probability": 0.04789622388630207,
            "start_logit": 1.7129318714141846,
            "end_logit": 2.738320827484131,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "tissue preparation, processing variability",
            "probability": 0.04579033624259225,
            "start_logit": 1.7129318714141846,
            "end_logit": 2.693357229232788,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "differing IHC cutoffs, tissue preparation, processing variability, primary versus metastatic biopsies",
            "probability": 0.04514798708757958,
            "start_logit": 1.6538408994674683,
            "end_logit": 2.738320827484131,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "differing IHC cutoffs, tissue preparation, processing variability",
            "probability": 0.043162933143205996,
            "start_logit": 1.6538408994674683,
            "end_logit": 2.693357229232788,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "variable detection antibodies, differing IHC cutoffs, tissue preparation",
            "probability": 0.032461547005985594,
            "start_logit": 3.3550937175750732,
            "end_logit": 0.70717853307724,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "variable detection antibodies, differing IHC cutoffs",
            "probability": 0.025448131565904284,
            "start_logit": 3.3550937175750732,
            "end_logit": 0.46376463770866394,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "primary versus metastatic biopsies, oncogenic versus induced PD-L1 expression",
            "probability": 0.02539238940353585,
            "start_logit": 2.084320545196533,
            "end_logit": 1.7323449850082397,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "processing variability, primary versus metastatic biopsies",
            "probability": 0.022154831401247466,
            "start_logit": 0.941950798034668,
            "end_logit": 2.738320827484131,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "processing variability",
            "probability": 0.021180734031753072,
            "start_logit": 0.941950798034668,
            "end_logit": 2.693357229232788,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "primary versus metastatic biopsies, oncogenic versus induced PD-L1 expression, and staining of tumor versus immune cells",
            "probability": 0.019045956528599292,
            "start_logit": 2.084320545196533,
            "end_logit": 1.4447503089904785,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "tissue preparation, processing variability, primary versus metastatic biopsies, oncogenic versus induced PD-L1 expression",
            "probability": 0.017515055503593308,
            "start_logit": 1.7129318714141846,
            "end_logit": 1.7323449850082397,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "oncogenic versus induced PD-L1 expression",
            "probability": 0.013340557909932245,
            "start_logit": 1.440679907798767,
            "end_logit": 1.7323449850082397,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "staining of tumor versus immune cells",
            "probability": 0.011132111965728228,
            "start_logit": 1.5472996234893799,
            "end_logit": 1.4447503089904785,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "oncogenic versus induced PD-L1 expression, and staining of tumor versus immune cells",
            "probability": 0.010006292908553543,
            "start_logit": 1.440679907798767,
            "end_logit": 1.4447503089904785,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "variable detection antibodies,",
            "probability": 0.00941479271792556,
            "start_logit": 3.3550937175750732,
            "end_logit": -0.5305955410003662,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "processing variability, primary versus metastatic biopsies, oncogenic versus induced PD-L1 expression",
            "probability": 0.008101747281513322,
            "start_logit": 0.941950798034668,
            "end_logit": 1.7323449850082397,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        }
    ],
    "5e360f3d158f994d3a000009": [
        {
            "text": "hearing loss, heterochromia iridis, and dystopia canthorum",
            "probability": 0.16774276653967374,
            "start_logit": 5.114737033843994,
            "end_logit": 4.929543495178223,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "dystopia canthorum",
            "probability": 0.157498015095041,
            "start_logit": 5.051718235015869,
            "end_logit": 4.929543495178223,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "heterochromia iridis, and dystopia canthorum",
            "probability": 0.12547373779397267,
            "start_logit": 4.82440185546875,
            "end_logit": 4.929543495178223,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "hearing loss, heterochromia iridis",
            "probability": 0.12073834075559915,
            "start_logit": 5.114737033843994,
            "end_logit": 4.600737571716309,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "hearing loss",
            "probability": 0.11790725183297532,
            "start_logit": 5.114737033843994,
            "end_logit": 4.577010154724121,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "heterochromia iridis",
            "probability": 0.0903138252823813,
            "start_logit": 4.82440185546875,
            "end_logit": 4.600737571716309,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "sensorineural deafness",
            "probability": 0.03202643622136764,
            "start_logit": 4.217824459075928,
            "end_logit": 4.170586109161377,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "sensorineural hearing loss",
            "probability": 0.02748187041908476,
            "start_logit": 3.757600784301758,
            "end_logit": 4.477774620056152,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "congenital sensorineural hearing loss",
            "probability": 0.02360797912729471,
            "start_logit": 3.605659008026123,
            "end_logit": 4.477774620056152,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "dystopia canthorum, and abnormal iris pigmentation",
            "probability": 0.023510485713949453,
            "start_logit": 4.424718856811523,
            "end_logit": 3.654576539993286,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "sensorineural hearing loss, dystopia canthorum",
            "probability": 0.01945351878154676,
            "start_logit": 3.757600784301758,
            "end_logit": 4.1322760581970215,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "abnormal iris pigmentation.Waardenburg Syndrome (WS) is a condition characterized by pigmentary changes of the hair or skin, hearing loss",
            "probability": 0.01775619790924932,
            "start_logit": 3.2215733528137207,
            "end_logit": 4.577010154724121,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "congenital sensorineural hearing loss, dystopia canthorum",
            "probability": 0.016711317619351705,
            "start_logit": 3.605659008026123,
            "end_logit": 4.1322760581970215,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "hearing loss, dystopia canthorum",
            "probability": 0.013596454491638611,
            "start_logit": 3.3993818759918213,
            "end_logit": 4.1322760581970215,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "sensorineural hearing loss, dystopia canthorum, and abnormal iris pigmentation",
            "probability": 0.012065238293813521,
            "start_logit": 3.757600784301758,
            "end_logit": 3.654576539993286,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "congenital sensorineural hearing loss, dystopia canthorum, and abnormal iris pigmentation",
            "probability": 0.010364501741059897,
            "start_logit": 3.605659008026123,
            "end_logit": 3.654576539993286,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "hearing loss, dystopia canthorum, and abnormal iris pigmentation",
            "probability": 0.00843263705835165,
            "start_logit": 3.3993818759918213,
            "end_logit": 3.654576539993286,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "abnormal iris pigmentation",
            "probability": 0.007058983198291868,
            "start_logit": 3.2215733528137207,
            "end_logit": 3.654576539993286,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "deafness",
            "probability": 0.004618836908142174,
            "start_logit": 2.2814056873321533,
            "end_logit": 4.170586109161377,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "hearing loss, heterochromia",
            "probability": 0.00364160521721475,
            "start_logit": 5.114737033843994,
            "end_logit": 1.099536418914795,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        }
    ],
    "5e493bc06d0a277941000003": [
        {
            "text": "glioblastoma",
            "probability": 0.8745005952894599,
            "start_logit": 4.733560085296631,
            "end_logit": 4.788733959197998,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "pancreatic cancer",
            "probability": 0.10204100464134196,
            "start_logit": 3.594651699066162,
            "end_logit": 3.7793641090393066,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "glioblastoma tumorigenesis.Breast cancer",
            "probability": 0.0061710893535476255,
            "start_logit": 4.383210182189941,
            "end_logit": 0.18530626595020294,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "pancreatic",
            "probability": 0.005899219030971028,
            "start_logit": 3.594651699066162,
            "end_logit": 0.9288093447685242,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "carcinoma of the ampulla of Vater (CAV) and cholangiocarcinoma",
            "probability": 0.003702264012251905,
            "start_logit": 1.9324151277542114,
            "end_logit": 2.1251704692840576,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "cholangiocarcinoma",
            "probability": 0.0025167603642097755,
            "start_logit": 1.5464431047439575,
            "end_logit": 2.1251704692840576,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "lioblastoma",
            "probability": 0.002124074916922994,
            "start_logit": -1.2867565155029297,
            "end_logit": 4.788733959197998,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "g",
            "probability": 0.0005413226490256947,
            "start_logit": 4.733560085296631,
            "end_logit": -2.598658800125122,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "carcinoma of the ampulla of Vater",
            "probability": 0.0004606917100086623,
            "start_logit": 1.9324151277542114,
            "end_logit": 0.04119974002242088,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "oma",
            "probability": 0.0004066681920896836,
            "start_logit": -2.9398505687713623,
            "end_logit": 4.788733959197998,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "blastoma",
            "probability": 0.0002769265871856599,
            "start_logit": -3.3240957260131836,
            "end_logit": 4.788733959197998,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "glioblast",
            "probability": 0.00027033763817637627,
            "start_logit": 4.733560085296631,
            "end_logit": -3.2930026054382324,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "glioblastoma cell proliferation in vitro and in vivo.",
            "probability": 0.00022880033711049873,
            "start_logit": 4.733560085296631,
            "end_logit": -3.459824562072754,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "cancer",
            "probability": 0.00018744912627578745,
            "start_logit": -2.7049708366394043,
            "end_logit": 3.7793641090393066,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "glioblastoma tumorigenesis",
            "probability": 0.00016151471359253472,
            "start_logit": 4.383210182189941,
            "end_logit": -3.457728147506714,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "glioblastoma cell proliferation",
            "probability": 0.00014037115334683916,
            "start_logit": 4.733560085296631,
            "end_logit": -3.9483842849731445,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "glio",
            "probability": 0.00013226701156207572,
            "start_logit": 4.733560085296631,
            "end_logit": -4.007851600646973,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "suppresses glioblastoma",
            "probability": 8.886989143536444e-05,
            "start_logit": -4.46067476272583,
            "end_logit": 4.788733959197998,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "pancreatic cancer.Long intergenic non-protein coding RNA, p53 induced transcript (Linc-pint",
            "probability": 8.087826625516796e-05,
            "start_logit": 3.594651699066162,
            "end_logit": -3.360820770263672,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "carcinoma",
            "probability": 6.889511523082809e-05,
            "start_logit": 1.9324151277542114,
            "end_logit": -1.858944058418274,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        }
    ],
    "5e2f43bafbd6abf43b000029": [
        {
            "text": "Middle East respiratory syndrome coronavirus (MERS-CoV).First identified in 2012 , Middle East respiratory syndrome",
            "probability": 0.15625480800398459,
            "start_logit": 5.47347354888916,
            "end_logit": 5.78005838394165,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "severe acute respiratory syndrome",
            "probability": 0.1486785875620032,
            "start_logit": 5.527589321136475,
            "end_logit": 5.676241397857666,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "Middle East respiratory syndrome",
            "probability": 0.13740650590434397,
            "start_logit": 5.344929218292236,
            "end_logit": 5.78005838394165,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome",
            "probability": 0.11582573488899005,
            "start_logit": 5.527589321136475,
            "end_logit": 5.426541328430176,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "severe acute respiratory syndrome CoV (SARS-CoV) and Middle East respiratory syndrome",
            "probability": 0.09989774312895727,
            "start_logit": 5.330239772796631,
            "end_logit": 5.475951194763184,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "Middle East respiratory syndrome ( MERS ) is caused by an emerging human coronavirus , which is distinct from the severe acute respiratory syndrome",
            "probability": 0.06465387032158837,
            "start_logit": 5.344929218292236,
            "end_logit": 5.026162624359131,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "severe acute respiratory syndrome coronavirus",
            "probability": 0.05786108474532341,
            "start_logit": 5.527589321136475,
            "end_logit": 4.732499599456787,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus",
            "probability": 0.046511912610112324,
            "start_logit": 5.527589321136475,
            "end_logit": 4.514163017272949,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "Middle East respiratory syndrome coronavirus",
            "probability": 0.04406177791528026,
            "start_logit": 5.47347354888916,
            "end_logit": 4.514163017272949,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome",
            "probability": 0.04247267690067753,
            "start_logit": 4.725775241851807,
            "end_logit": 5.2251296043396,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "Middle East respiratory syndrome coronavirus (MERS-CoV).First identified in 2012 , Middle East respiratory syndrome ( MERS )",
            "probability": 0.021517173187963874,
            "start_logit": 5.47347354888916,
            "end_logit": 3.79742169380188,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "Middle East Respiratory Syndrome",
            "probability": 0.019245888660291283,
            "start_logit": 4.6138482093811035,
            "end_logit": 4.545493125915527,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "Middle East respiratory syndrome ( MERS )",
            "probability": 0.018921655099543275,
            "start_logit": 5.344929218292236,
            "end_logit": 3.79742169380188,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "Middle East respiratory syndrome ( MERS ) is caused by an emerging human coronavirus , which is distinct from the severe acute respiratory syndrome coronavirus",
            "probability": 0.0057369632548467,
            "start_logit": 5.344929218292236,
            "end_logit": 2.6040446758270264,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "coronavirus (SARS-CoV) and Middle East respiratory syndrome",
            "probability": 0.004957714727607642,
            "start_logit": 2.3764474391937256,
            "end_logit": 5.426541328430176,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "Middle East respiratory syndrome CoV (MERS-CoV)",
            "probability": 0.004059374948687707,
            "start_logit": 5.417666912078857,
            "end_logit": 2.185405969619751,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "severe acute respiratory syndrome CoV (SARS-CoV) and Middle East respiratory syndrome CoV (MERS-CoV)",
            "probability": 0.003719546934081189,
            "start_logit": 5.330239772796631,
            "end_logit": 2.185405969619751,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "coronavirus (MERS-CoV).First identified in 2012 , Middle East respiratory syndrome",
            "probability": 0.003175238570730636,
            "start_logit": 1.5773682594299316,
            "end_logit": 5.78005838394165,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "Middle East respiratory syndrome CoV",
            "probability": 0.0025651017375888123,
            "start_logit": 5.417666912078857,
            "end_logit": 1.7263751029968262,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "coronavirus",
            "probability": 0.0024766408973979355,
            "start_logit": 2.3764474391937256,
            "end_logit": 4.732499599456787,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        }
    ],
    "5e2f9e0dfbd6abf43b000034": [
        {
            "text": "dementia",
            "probability": 0.27467159591802454,
            "start_logit": 6.110071659088135,
            "end_logit": 6.068983554840088,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "urinary incontinence and dementia",
            "probability": 0.20692499261522346,
            "start_logit": 5.826851844787598,
            "end_logit": 6.068983554840088,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "urinary incontinence",
            "probability": 0.1957604325089008,
            "start_logit": 5.826851844787598,
            "end_logit": 6.013518810272217,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "gait disturbance, urinary incontinence and dementia",
            "probability": 0.11361149257673996,
            "start_logit": 5.227280139923096,
            "end_logit": 6.068983554840088,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "gait disturbance, urinary incontinence",
            "probability": 0.10748162724915879,
            "start_logit": 5.227280139923096,
            "end_logit": 6.013518810272217,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "gait disturbance",
            "probability": 0.05419555698336853,
            "start_logit": 5.227280139923096,
            "end_logit": 5.328797817230225,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "cognitive dysfunction, and urinary incontinence",
            "probability": 0.011553181414675987,
            "start_logit": 4.256250381469727,
            "end_logit": 4.754189491271973,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "gait disturbance, cognitive dysfunction, and urinary incontinence",
            "probability": 0.010881300662103155,
            "start_logit": 4.196335315704346,
            "end_logit": 4.754189491271973,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "cognitive dysfunction",
            "probability": 0.006903843473399159,
            "start_logit": 4.256250381469727,
            "end_logit": 4.239306926727295,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "gait disturbance, cognitive dysfunction",
            "probability": 0.006502347177092402,
            "start_logit": 4.196335315704346,
            "end_logit": 4.239306926727295,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "Normal pressure hydrocephalus is a frequently missed clinical entity with the typical symptom triad of gait disturbance",
            "probability": 0.002156435479562631,
            "start_logit": 2.0031378269195557,
            "end_logit": 5.328797817230225,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "gait",
            "probability": 0.0019934968442445215,
            "start_logit": 5.227280139923096,
            "end_logit": 2.0260891914367676,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "gait disturbance,",
            "probability": 0.0014435032610182338,
            "start_logit": 5.227280139923096,
            "end_logit": 1.7032718658447266,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "gait disorders, urinary incontinence",
            "probability": 0.0010939753364348896,
            "start_logit": 2.823753833770752,
            "end_logit": 3.829543352127075,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "gait disturbances and urinary incontinence",
            "probability": 0.0010869717726401773,
            "start_logit": 3.3229260444641113,
            "end_logit": 3.323948621749878,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "dementia, gait disturbances and urinary incontinence",
            "probability": 0.001025724189840597,
            "start_logit": 3.2649292945861816,
            "end_logit": 3.323948621749878,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "gait disorders, urinary incontinence and dementia",
            "probability": 0.0008539386866095547,
            "start_logit": 2.823753833770752,
            "end_logit": 3.581829309463501,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "gait disturbances",
            "probability": 0.0006827267714267168,
            "start_logit": 3.3229260444641113,
            "end_logit": 2.8588924407958984,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "dementia, gait disturbances",
            "probability": 0.00064425717588158,
            "start_logit": 3.2649292945861816,
            "end_logit": 2.8588924407958984,
            "question_text": "List symptoms of the Hakim Triad?"
        },
        {
            "text": "incontinence and dementia",
            "probability": 0.0005325999036545043,
            "start_logit": -0.1354893147945404,
            "end_logit": 6.068983554840088,
            "question_text": "List symptoms of the Hakim Triad?"
        }
    ],
    "5e36e093b5b409ea5300000f": [
        {
            "text": "Aip1, Ede1",
            "probability": 0.32402890293028924,
            "start_logit": 2.077216148376465,
            "end_logit": 2.1661031246185303,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Ede1",
            "probability": 0.23753031582853001,
            "start_logit": 1.7666786909103394,
            "end_logit": 2.1661031246185303,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Aip1",
            "probability": 0.19381608024510977,
            "start_logit": 2.077216148376465,
            "end_logit": 1.6521800756454468,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Aip1, Ede1 and Inn1",
            "probability": 0.08943152443150156,
            "start_logit": 2.077216148376465,
            "end_logit": 0.8787436485290527,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Inn1",
            "probability": 0.08002024338546664,
            "start_logit": 2.04457688331604,
            "end_logit": 0.8001893162727356,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Ede1 and Inn1",
            "probability": 0.06555803525900762,
            "start_logit": 1.7666786909103394,
            "end_logit": 0.8787436485290527,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Aip1, Ede1 and Inn",
            "probability": 0.0017741015285081497,
            "start_logit": 2.077216148376465,
            "end_logit": -3.041435480117798,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Inn",
            "probability": 0.0013821126535878009,
            "start_logit": 1.8275352716445923,
            "end_logit": -3.041435480117798,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Aip",
            "probability": 0.0013563274905535833,
            "start_logit": 2.077216148376465,
            "end_logit": -3.3099489212036133,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Ede1 and Inn",
            "probability": 0.0013005102093286973,
            "start_logit": 1.7666786909103394,
            "end_logit": -3.041435480117798,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Cdc14",
            "probability": 0.0008836316375792139,
            "start_logit": -0.41621115803718567,
            "end_logit": -1.2450172901153564,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Aip1, Ede",
            "probability": 0.0007037015824178231,
            "start_logit": 2.077216148376465,
            "end_logit": -3.966130495071411,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Aip1, Ede1 and Inn1 as cytokinetic regulators. Our results suggest that cytokinesis",
            "probability": 0.0006177825823585044,
            "start_logit": 2.077216148376465,
            "end_logit": -4.096348285675049,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Ede",
            "probability": 0.000515850461514855,
            "start_logit": 1.7666786909103394,
            "end_logit": -3.966130495071411,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Inn1 as cytokinetic regulators. Our results suggest that cytokinesis",
            "probability": 0.0004812831230475512,
            "start_logit": 1.8275352716445923,
            "end_logit": -4.096348285675049,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "Ede1 and Inn1 as cytokinetic regulators. Our results suggest that cytokinesis",
            "probability": 0.0004528672923123469,
            "start_logit": 1.7666786909103394,
            "end_logit": -4.096348285675049,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "mitotic exit to identify Cdk targets that are dephosphorylated at the time of cytokinesis",
            "probability": 6.0754624774206845e-05,
            "start_logit": -2.548433780670166,
            "end_logit": -1.7899917364120483,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "analysis of mitotic exit to identify Cdk targets that are dephosphorylated at the time of cytokinesis",
            "probability": 3.662849451012265e-05,
            "start_logit": -3.054450511932373,
            "end_logit": -1.7899917364120483,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "phosphoproteome analysis",
            "probability": 2.5326908478931512e-05,
            "start_logit": -2.667740821838379,
            "end_logit": -2.5456604957580566,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        },
        {
            "text": "cytokinesis",
            "probability": 2.40193311236722e-05,
            "start_logit": -3.4764180183410645,
            "end_logit": -1.7899917364120483,
            "question_text": "List Cdk targets that are dephosphorylated during cytokinesis"
        }
    ],
    "5d2f3a5db3a6380763000001": [
        {
            "text": "rituximab",
            "probability": 0.37359590406717624,
            "start_logit": 5.538231372833252,
            "end_logit": 5.673085689544678,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "rituximab and cyclophosphamide",
            "probability": 0.3296986430676148,
            "start_logit": 5.538231372833252,
            "end_logit": 5.548089981079102,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "cyclophosphamide",
            "probability": 0.2903432328796642,
            "start_logit": 5.411116123199463,
            "end_logit": 5.548089981079102,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "epratuzumab",
            "probability": 0.005760168179560763,
            "start_logit": 3.2720541954040527,
            "end_logit": 3.767054796218872,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "mide",
            "probability": 8.775518858082198e-05,
            "start_logit": -2.6931519508361816,
            "end_logit": 5.548089981079102,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "b",
            "probability": 7.940579501542666e-05,
            "start_logit": -2.9181272983551025,
            "end_logit": 5.673085689544678,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "de",
            "probability": 7.271843254551414e-05,
            "start_logit": -2.881108045578003,
            "end_logit": 5.548089981079102,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "b and cyclophosphamide",
            "probability": 7.007566887988131e-05,
            "start_logit": -2.9181272983551025,
            "end_logit": 5.548089981079102,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "lophosphamide",
            "probability": 6.130674165476543e-05,
            "start_logit": -3.0518131256103516,
            "end_logit": 5.548089981079102,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "yclophosphamide",
            "probability": 4.543199061883258e-05,
            "start_logit": -3.3514864444732666,
            "end_logit": 5.548089981079102,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "r",
            "probability": 3.3731815292118965e-05,
            "start_logit": 5.538231372833252,
            "end_logit": -3.6394028663635254,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "rituximab and c",
            "probability": 3.2872195245622865e-05,
            "start_logit": 5.538231372833252,
            "end_logit": -3.665217161178589,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "c",
            "probability": 2.8948312770302582e-05,
            "start_logit": 5.411116123199463,
            "end_logit": -3.665217161178589,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "clophosphamide",
            "probability": 1.8149383746789908e-05,
            "start_logit": -4.269066333770752,
            "end_logit": 5.548089981079102,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "rit",
            "probability": 1.788959815558744e-05,
            "start_logit": 5.538231372833252,
            "end_logit": -4.273624897003174,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "uximab",
            "probability": 1.3259005848754116e-05,
            "start_logit": -4.708021640777588,
            "end_logit": 5.673085689544678,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "uximab and cyclophosphamide",
            "probability": 1.1701081808364167e-05,
            "start_logit": -4.708021640777588,
            "end_logit": 5.548089981079102,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "hosphamide",
            "probability": 1.046112050345255e-05,
            "start_logit": -4.820037364959717,
            "end_logit": 5.548089981079102,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "0.91 min-u). Both syndromes were refractory to conventional treatment but responded to rituximab",
            "probability": 9.290640632421885e-06,
            "start_logit": -5.063691139221191,
            "end_logit": 5.673085689544678,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        },
        {
            "text": "mide.Although some Fc-independent loss of CD22 is expected from internalization by epratuzumab",
            "probability": 9.054834685141593e-06,
            "start_logit": -2.6931519508361816,
            "end_logit": 3.2768378257751465,
            "question_text": "Which drugs used in the treatment of Systemic Lupus Erythematosus are targeting granulocytes?"
        }
    ],
    "5e49c88c6d0a277941000013": [
        {
            "text": "ncRNA, a circular RNA, and two microRNAs",
            "probability": 0.26450851094459427,
            "start_logit": 1.8060437440872192,
            "end_logit": 2.1472373008728027,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "RNA, and two microRNAs",
            "probability": 0.13898525592078312,
            "start_logit": 1.1625381708145142,
            "end_logit": 2.1472373008728027,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "ncRNA, a circular RNA",
            "probability": 0.13258972186438914,
            "start_logit": 1.8060437440872192,
            "end_logit": 1.4566234350204468,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "ncRNA",
            "probability": 0.08168079751453201,
            "start_logit": 1.8060437440872192,
            "end_logit": 0.9721828103065491,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "RNA",
            "probability": 0.06966889783613665,
            "start_logit": 1.1625381708145142,
            "end_logit": 1.4566234350204468,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "microRNAs",
            "probability": 0.06171374071655084,
            "start_logit": 0.35067692399024963,
            "end_logit": 2.1472373008728027,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "two microRNAs",
            "probability": 0.05523729272964704,
            "start_logit": 0.23980863392353058,
            "end_logit": 2.1472373008728027,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "a long ncRNA, a circular RNA, and two microRNAs",
            "probability": 0.046926173803098783,
            "start_logit": 0.0767459124326706,
            "end_logit": 2.1472373008728027,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "a circular RNA, and two microRNAs",
            "probability": 0.04002280152277346,
            "start_logit": -0.08238035440444946,
            "end_logit": 2.1472373008728027,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "a long ncRNA, a circular RNA",
            "probability": 0.02352260163763176,
            "start_logit": 0.0767459124326706,
            "end_logit": 1.4566234350204468,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "a circular RNA",
            "probability": 0.020062160204930953,
            "start_logit": -0.08238035440444946,
            "end_logit": 1.4566234350204468,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "circular RNA, and two microRNAs",
            "probability": 0.017463331305369763,
            "start_logit": -0.9117263555526733,
            "end_logit": 2.1472373008728027,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "a long ncRNA",
            "probability": 0.014490903475486,
            "start_logit": 0.0767459124326706,
            "end_logit": 0.9721828103065491,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "circular RNA",
            "probability": 0.008753813751912382,
            "start_logit": -0.9117263555526733,
            "end_logit": 1.4566234350204468,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "long ncRNA, a circular RNA, and two microRNAs",
            "probability": 0.007675044404447668,
            "start_logit": -1.7338556051254272,
            "end_logit": 2.1472373008728027,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "ncRNAs-a long ncRNA, a circular RNA, and two microRNAs",
            "probability": 0.004142580275019241,
            "start_logit": -2.350510835647583,
            "end_logit": 2.1472373008728027,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "centered on four ncRNAs-a long ncRNA, a circular RNA, and two microRNAs",
            "probability": 0.003952552584484399,
            "start_logit": -2.397468090057373,
            "end_logit": 2.1472373008728027,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "long ncRNA, a circular RNA",
            "probability": 0.0038472561780657126,
            "start_logit": -1.7338556051254272,
            "end_logit": 1.4566234350204468,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "four ncRNAs-a long ncRNA, a circular RNA, and two microRNAs",
            "probability": 0.0023864930980930566,
            "start_logit": -2.9020047187805176,
            "end_logit": 2.1472373008728027,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        },
        {
            "text": "long ncRNA",
            "probability": 0.002370070232054073,
            "start_logit": -1.7338556051254272,
            "end_logit": 0.9721828103065491,
            "question_text": "List the members of a network of noncoding regulatory RNAs that play a role in the mammalian brain"
        }
    ],
    "5e5cbf4e1af46fc130000004": [
        {
            "text": "palifermin",
            "probability": 0.31535188539210457,
            "start_logit": 1.615891695022583,
            "end_logit": 1.0845398902893066,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "amifostine",
            "probability": 0.2901946998357625,
            "start_logit": 1.5236462354660034,
            "end_logit": 1.0936483144760132,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "amifostine and palifermin",
            "probability": 0.28756348471582943,
            "start_logit": 1.5236462354660034,
            "end_logit": 1.0845398902893066,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "palifermin,",
            "probability": 0.028379246614731495,
            "start_logit": 1.615891695022583,
            "end_logit": -1.323491096496582,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "amifostine and palifermin,",
            "probability": 0.025878504071713465,
            "start_logit": 1.5236462354660034,
            "end_logit": -1.323491096496582,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "palifermin, currently have the US FDA approval",
            "probability": 0.008182983399290026,
            "start_logit": 1.615891695022583,
            "end_logit": -2.5670924186706543,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "palifermin, currently have the US FDA approval for use in radiation therapy",
            "probability": 0.0076166194265829485,
            "start_logit": 1.615891695022583,
            "end_logit": -2.6388165950775146,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "amifostine and palifermin, currently have the US FDA approval",
            "probability": 0.007461909475333484,
            "start_logit": 1.5236462354660034,
            "end_logit": -2.5670924186706543,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "amifostine and palifermin, currently have the US FDA approval for use in radiation therapy",
            "probability": 0.006945452764105506,
            "start_logit": 1.5236462354660034,
            "end_logit": -2.6388165950775146,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "Only two radioprotective compounds, amifostine",
            "probability": 0.0036973158700227154,
            "start_logit": -2.839298725128174,
            "end_logit": 1.0936483144760132,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "Only two radioprotective compounds, amifostine and palifermin",
            "probability": 0.0036637920550602844,
            "start_logit": -2.839298725128174,
            "end_logit": 1.0845398902893066,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "palifermin, currently have the US FDA approval for use in radiation therapy.",
            "probability": 0.0023585321147899605,
            "start_logit": 1.615891695022583,
            "end_logit": -3.811109781265259,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "amifostine and palifermin, currently have the US FDA approval for use in radiation therapy.",
            "probability": 0.0021507013122813454,
            "start_logit": 1.5236462354660034,
            "end_logit": -3.811109781265259,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "radioprotective compounds, amifostine",
            "probability": 0.0017514033058447904,
            "start_logit": -3.5864884853363037,
            "end_logit": 1.0936483144760132,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "radioprotective compounds, amifostine and palifermin",
            "probability": 0.0017355232127140485,
            "start_logit": -3.5864884853363037,
            "end_logit": 1.0845398902893066,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "palifermin, currently have the US FDA approval for use in radiation",
            "probability": 0.001549919753314614,
            "start_logit": 1.615891695022583,
            "end_logit": -4.230946063995361,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "palifermin, currently have the US FDA",
            "probability": 0.001467042034156006,
            "start_logit": 1.615891695022583,
            "end_logit": -4.285901069641113,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "amifostine and palifermin, currently have the US FDA approval for use in radiation",
            "probability": 0.0014133428272955178,
            "start_logit": 1.5236462354660034,
            "end_logit": -4.230946063995361,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "amifostine and palifermin, currently have the US FDA",
            "probability": 0.0013377681856633107,
            "start_logit": 1.5236462354660034,
            "end_logit": -4.285901069641113,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "two radioprotective compounds, amifostine",
            "probability": 0.0012998736334037353,
            "start_logit": -3.884638786315918,
            "end_logit": 1.0936483144760132,
            "question_text": "List approved radioprotective compounds"
        }
    ],
    "5e48100bd14c9f295d000007": [
        {
            "text": "thyroid have also been demonstrated. Radiation-induced leukaemia",
            "probability": 0.11134083322349901,
            "start_logit": 3.4473183155059814,
            "end_logit": 3.8860416412353516,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "leukaemia",
            "probability": 0.10974024791690334,
            "start_logit": 3.4328384399414062,
            "end_logit": 3.8860416412353516,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "leukemia",
            "probability": 0.10620946912164259,
            "start_logit": 3.3294482231140137,
            "end_logit": 3.956728935241699,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "skin carcinomas leukemia",
            "probability": 0.10033491302179735,
            "start_logit": 3.2725486755371094,
            "end_logit": 3.956728935241699,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "breast, stomach and thyroid have also been demonstrated. Radiation-induced leukaemia",
            "probability": 0.0691310351633486,
            "start_logit": 2.9707260131835938,
            "end_logit": 3.8860416412353516,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "lung, breast, stomach and thyroid have also been demonstrated. Radiation-induced leukaemia",
            "probability": 0.05726203437233817,
            "start_logit": 2.782360076904297,
            "end_logit": 3.8860416412353516,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "thyroid",
            "probability": 0.0538907767609629,
            "start_logit": 3.4473183155059814,
            "end_logit": 3.160404920578003,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "stomach and thyroid have also been demonstrated. Radiation-induced leukaemia",
            "probability": 0.053762572361697215,
            "start_logit": 2.719299793243408,
            "end_logit": 3.8860416412353516,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "skin carcinoma",
            "probability": 0.03823477909997145,
            "start_logit": 3.2725486755371094,
            "end_logit": 2.9919607639312744,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "cancers of the lung, breast, stomach and thyroid have also been demonstrated. Radiation-induced leukaemia",
            "probability": 0.03662186368192998,
            "start_logit": 2.3353676795959473,
            "end_logit": 3.8860416412353516,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "leukemia (1952)esides the well-known increase in leukaemia, increases in solid cancer such as cancers of the lung",
            "probability": 0.035054131303040005,
            "start_logit": 3.3294482231140137,
            "end_logit": 2.8482091426849365,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "breast, stomach and thyroid",
            "probability": 0.03346054700133146,
            "start_logit": 2.9707260131835938,
            "end_logit": 3.160404920578003,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "breast",
            "probability": 0.028162454648227347,
            "start_logit": 2.9707260131835938,
            "end_logit": 2.988027572631836,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "lung, breast, stomach and thyroid",
            "probability": 0.027715757300323197,
            "start_logit": 2.782360076904297,
            "end_logit": 3.160404920578003,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "stomach and thyroid",
            "probability": 0.026021960689152163,
            "start_logit": 2.719299793243408,
            "end_logit": 3.160404920578003,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "leukemia (1952)esides the well-known increase in leukaemia",
            "probability": 0.02404130082250786,
            "start_logit": 3.3294482231140137,
            "end_logit": 2.4710888862609863,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "lung, breast",
            "probability": 0.02332728625089628,
            "start_logit": 2.782360076904297,
            "end_logit": 2.988027572631836,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "skin carcinomas leukemia (1952)esides the well-known increase in leukaemia",
            "probability": 0.02271155149259337,
            "start_logit": 3.2725486755371094,
            "end_logit": 2.4710888862609863,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "breast, stomach",
            "probability": 0.0226930348231799,
            "start_logit": 2.9707260131835938,
            "end_logit": 2.7720959186553955,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "lung",
            "probability": 0.02028345094465813,
            "start_logit": 2.782360076904297,
            "end_logit": 2.8482091426849365,
            "question_text": "List the most common cancers after a radiation exposure?"
        }
    ],
    "5cf0f567a49efeb44c00000b": [
        {
            "text": "MBF",
            "probability": 0.1624788049524597,
            "start_logit": 5.477203369140625,
            "end_logit": 4.441256523132324,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "SBF",
            "probability": 0.10956285409415056,
            "start_logit": 5.052073955535889,
            "end_logit": 4.472336769104004,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "SBF (composed of Swi4 and Swi6) and MBF",
            "probability": 0.1062099874951487,
            "start_logit": 5.052073955535889,
            "end_logit": 4.441256523132324,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Swi6) and MBF",
            "probability": 0.06344595534624745,
            "start_logit": 4.536844253540039,
            "end_logit": 4.441256523132324,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "SBF (composed of Swi4",
            "probability": 0.06259426681231807,
            "start_logit": 5.052073955535889,
            "end_logit": 3.9125120639801025,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "MBF (composed of Mbp1",
            "probability": 0.05673770812423767,
            "start_logit": 5.477203369140625,
            "end_logit": 3.389147996902466,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "SBF (composed of Swi4 and Swi6",
            "probability": 0.0528591896531566,
            "start_logit": 5.052073955535889,
            "end_logit": 3.7434699535369873,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "MBF (composed of Mbp1 and Swi6",
            "probability": 0.04806191945212596,
            "start_logit": 5.477203369140625,
            "end_logit": 3.2231991291046143,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Swi4 and Swi6) and MBF",
            "probability": 0.04228978046550606,
            "start_logit": 4.131201267242432,
            "end_logit": 4.441256523132324,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "SBF (composed of Swi4 and Swi6) and MBF (composed of Mbp1",
            "probability": 0.037088599169238616,
            "start_logit": 5.052073955535889,
            "end_logit": 3.389147996902466,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Mbp1",
            "probability": 0.03330326791211904,
            "start_logit": 4.944419860839844,
            "end_logit": 3.389147996902466,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "MBF and SBF",
            "probability": 0.0325024701214915,
            "start_logit": 4.619205951690674,
            "end_logit": 3.6900224685668945,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Swi6",
            "probability": 0.0315761433125692,
            "start_logit": 4.536844253540039,
            "end_logit": 3.7434699535369873,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "SBF (composed of Swi4 and Swi6) and MBF (composed of Mbp1 and Swi6",
            "probability": 0.03141736465563453,
            "start_logit": 5.052073955535889,
            "end_logit": 3.2231991291046143,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Mbp1 and Swi6",
            "probability": 0.02821085011717404,
            "start_logit": 4.944419860839844,
            "end_logit": 3.2231991291046143,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Swi4",
            "probability": 0.024923247467787846,
            "start_logit": 4.131201267242432,
            "end_logit": 3.9125120639801025,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Swi6) and MBF (composed of Mbp1",
            "probability": 0.022155370339854954,
            "start_logit": 4.536844253540039,
            "end_logit": 3.389147996902466,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Swi4 and Swi6",
            "probability": 0.0210470180699216,
            "start_logit": 4.131201267242432,
            "end_logit": 3.7434699535369873,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Swi6) and MBF (composed of Mbp1 and Swi6",
            "probability": 0.01876758261674033,
            "start_logit": 4.536844253540039,
            "end_logit": 3.2231991291046143,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Swi4 and Swi6) and MBF (composed of Mbp1",
            "probability": 0.014767619822117894,
            "start_logit": 4.131201267242432,
            "end_logit": 3.389147996902466,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        }
    ],
    "5e5b626fb761aafe0900000c": [
        {
            "text": "ABCB4",
            "probability": 0.5073049338432397,
            "start_logit": 3.0517594814300537,
            "end_logit": 2.117324113845825,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "ABCB4/MDR3 is critical for biliary phosphatidylcholine",
            "probability": 0.2804478606739713,
            "start_logit": 3.0517594814300537,
            "end_logit": 1.5245996713638306,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "phosphatidylcholine",
            "probability": 0.09351030415677168,
            "start_logit": 1.9534432888031006,
            "end_logit": 1.5245996713638306,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "ABCB4/MDR3 is critical for biliary phosphatidylcholine (PC)",
            "probability": 0.04555919619377298,
            "start_logit": 3.0517594814300537,
            "end_logit": -0.2927756607532501,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "ATP-binding cassette transporter ABCB4",
            "probability": 0.016895409478237096,
            "start_logit": -0.3503108322620392,
            "end_logit": 2.117324113845825,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "phosphatidylcholine (PC)",
            "probability": 0.015190896029584669,
            "start_logit": 1.9534432888031006,
            "end_logit": -0.2927756607532501,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "ATP-binding cassette transporter ABCB4/MDR3 is critical for biliary phosphatidylcholine",
            "probability": 0.009340105185822003,
            "start_logit": -0.3503108322620392,
            "end_logit": 1.5245996713638306,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "phospholipid translocatorThe ATP-binding cassette transporter ABCB4",
            "probability": 0.00622624846018314,
            "start_logit": -1.3485788106918335,
            "end_logit": 2.117324113845825,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "P-glycoprotein",
            "probability": 0.005474144739910338,
            "start_logit": 1.7399330139160156,
            "end_logit": -1.0999256372451782,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "P-glycoprotein 3 (MDR3) is a phospholipid",
            "probability": 0.004593769835871279,
            "start_logit": 1.7399330139160156,
            "end_logit": -1.2752606868743896,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "biliary phosphatidylcholine",
            "probability": 0.003133307049162506,
            "start_logit": -1.4425393342971802,
            "end_logit": 1.5245996713638306,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "P-glycoprotein 3 (MDR3) is a phospholipid translocatorThe multiple drug resistance",
            "probability": 0.002168175106204991,
            "start_logit": 1.7399330139160156,
            "end_logit": -2.026075839996338,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "ABCB4/MDR3 is critical for biliary phosphatidylcholine (PC) excretion",
            "probability": 0.0019642424460573887,
            "start_logit": 3.0517594814300537,
            "end_logit": -3.4366815090179443,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "cassette transporter ABCB4",
            "probability": 0.0017453560219732735,
            "start_logit": -2.620394229888916,
            "end_logit": 2.117324113845825,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "P-glycoprotein 3",
            "probability": 0.0015984006904598083,
            "start_logit": 1.7399330139160156,
            "end_logit": -2.330958127975464,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "ABCB4/MDR3 is critical for biliary phosphatidylcho",
            "probability": 0.0012007585470476402,
            "start_logit": 3.0517594814300537,
            "end_logit": -3.9288346767425537,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "cassette transporter ABCB4/MDR3 is critical for biliary phosphatidylcholine",
            "probability": 0.0009648661580494112,
            "start_logit": -2.620394229888916,
            "end_logit": 1.5245996713638306,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "P-glycoprotein 3 (MDR3) is a phospholipid translocatorThe multiple drug resistance 3",
            "probability": 0.0009573452986425278,
            "start_logit": 1.7399330139160156,
            "end_logit": -2.843552827835083,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "4",
            "probability": 0.0009219560744105668,
            "start_logit": -3.258610486984253,
            "end_logit": 2.117324113845825,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        },
        {
            "text": "P",
            "probability": 0.000802724010627581,
            "start_logit": 1.7399330139160156,
            "end_logit": -3.0197060108184814,
            "question_text": "What molecules are the multidrug transporter MDR3 targeting?"
        }
    ],
    "5e30ee25fbd6abf43b00003f": [
        {
            "text": "metabolic wasting",
            "probability": 0.18749981562716486,
            "start_logit": 4.789479732513428,
            "end_logit": 5.157537460327148,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "multiple allergies and metabolic wasting",
            "probability": 0.09167706712543454,
            "start_logit": 4.073974132537842,
            "end_logit": 5.157537460327148,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "dermatitis, multiple allergies and metabolic wasting",
            "probability": 0.08914555442546185,
            "start_logit": 4.0459723472595215,
            "end_logit": 5.157537460327148,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "multiple allergies",
            "probability": 0.07215548019486383,
            "start_logit": 4.073974132537842,
            "end_logit": 4.918088436126709,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "dermatitis",
            "probability": 0.07084933686444167,
            "start_logit": 4.0459723472595215,
            "end_logit": 4.927822589874268,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "dermatitis, multiple allergies",
            "probability": 0.07016302428180539,
            "start_logit": 4.0459723472595215,
            "end_logit": 4.918088436126709,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "severe dermatitis",
            "probability": 0.0459691868359179,
            "start_logit": 3.563568592071533,
            "end_logit": 4.977642059326172,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "severe dermatitis, multiple allergies and metabolic wasting",
            "probability": 0.04350961650418425,
            "start_logit": 3.563568592071533,
            "end_logit": 4.922652721405029,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "severe dermatitis, multiple allergies",
            "probability": 0.04328426725190756,
            "start_logit": 3.563568592071533,
            "end_logit": 4.917459964752197,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "metabolic wasting) in two consanguineous families.BACKGROUND: Severe dermatitis, multiple allergies, and metabolic wasting",
            "probability": 0.04265781133165997,
            "start_logit": 4.011123180389404,
            "end_logit": 4.455326557159424,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "skin dermatitis, multiple allergies",
            "probability": 0.040098612759739506,
            "start_logit": 3.5690293312072754,
            "end_logit": 4.835551738739014,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "skin dermatitis",
            "probability": 0.03687603666945469,
            "start_logit": 3.5690293312072754,
            "end_logit": 4.751771926879883,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "skin dermatitis, multiple allergies and metabolic wasting",
            "probability": 0.033298888587812464,
            "start_logit": 3.5690293312072754,
            "end_logit": 4.649734020233154,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "metabolic wasting) in two consanguineous families.BACKGROUND: Severe dermatitis, multiple allergies",
            "probability": 0.025221180098852342,
            "start_logit": 4.011123180389404,
            "end_logit": 3.929800271987915,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "metabolic wasting) in two consanguineous families.BACKGROUND: Severe dermatitis",
            "probability": 0.02506645600253866,
            "start_logit": 4.011123180389404,
            "end_logit": 3.9236466884613037,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "multiple allergies, and metabolic wasting",
            "probability": 0.019172642582015897,
            "start_logit": 3.211397171020508,
            "end_logit": 4.455326557159424,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "Severe dermatitis, multiple allergies, and metabolic wasting",
            "probability": 0.017049200336444217,
            "start_logit": 3.0940160751342773,
            "end_logit": 4.455326557159424,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "multiple allergies and metabolic wasting) in two consanguineous families.BACKGROUND: Severe dermatitis, multiple allergies",
            "probability": 0.016147104829330978,
            "start_logit": 3.5651798248291016,
            "end_logit": 3.929800271987915,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "multiple allergies and metabolic wasting) in two consanguineous families.BACKGROUND: Severe dermatitis",
            "probability": 0.01604804736282828,
            "start_logit": 3.5651798248291016,
            "end_logit": 3.9236466884613037,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "dermatitis, multiple allergies and metabolic wasting) in two consanguineous families.BACKGROUND: Severe dermatitis",
            "probability": 0.014110670328141197,
            "start_logit": 3.436523914337158,
            "end_logit": 3.9236466884613037,
            "question_text": "List features of the SAM syndrome."
        }
    ],
    "5e30f12afbd6abf43b000041": [
        {
            "text": "ipilimumab",
            "probability": 0.2634436065247087,
            "start_logit": 4.963322162628174,
            "end_logit": 4.840663433074951,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "ipilimumab plus nivolumab",
            "probability": 0.24926383470215502,
            "start_logit": 4.963322162628174,
            "end_logit": 4.785336017608643,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "nivolumab",
            "probability": 0.1939551414837666,
            "start_logit": 4.712437152862549,
            "end_logit": 4.785336017608643,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "nivolumab and ipilimumab",
            "probability": 0.12082982968327884,
            "start_logit": 4.48087739944458,
            "end_logit": 4.543652057647705,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "ipilimumab (CheckMate-227; NCT02477826), whereas atezolizumab",
            "probability": 0.042682473242797704,
            "start_logit": 4.491434574127197,
            "end_logit": 3.492500066757202,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "Nivolumab plus ipilimumab",
            "probability": 0.042262561855506746,
            "start_logit": 3.9518239498138428,
            "end_logit": 4.022223949432373,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "Nivolumab",
            "probability": 0.032411618609100086,
            "start_logit": 3.9518239498138428,
            "end_logit": 3.7568392753601074,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "nivolumab\u00a0+\u00a0ipilimumab",
            "probability": 0.029873714965022835,
            "start_logit": 3.779884099960327,
            "end_logit": 3.847241163253784,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "atezolizumab",
            "probability": 0.016145738862161942,
            "start_logit": 3.5193023681640625,
            "end_logit": 3.492500066757202,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "nivolumab plus ipilimumab",
            "probability": 0.008733170396006547,
            "start_logit": 3.268796920776367,
            "end_logit": 3.1284778118133545,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "b",
            "probability": 5.6867206448973696e-05,
            "start_logit": -3.477553606033325,
            "end_logit": 4.840663433074951,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "b plus nivolumab",
            "probability": 5.3806346395204e-05,
            "start_logit": -3.477553606033325,
            "end_logit": 4.785336017608643,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "ab",
            "probability": 4.646039379166922e-05,
            "start_logit": -3.624344825744629,
            "end_logit": 4.785336017608643,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "i",
            "probability": 4.337529825787605e-05,
            "start_logit": 4.963322162628174,
            "end_logit": -3.8710410594940186,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "ipilimumab versus chemotherapy",
            "probability": 3.767360438536116e-05,
            "start_logit": 3.9551236629486084,
            "end_logit": -3.0037729740142822,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "Nivolumab plus ipilimumab versus chemotherapy",
            "probability": 3.7549497169849095e-05,
            "start_logit": 3.9518239498138428,
            "end_logit": -3.0037729740142822,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "ipilimumab (CheckMate-227; NCT02477826),",
            "probability": 3.316848146802764e-05,
            "start_logit": 4.491434574127197,
            "end_logit": -3.6674435138702393,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "nivolumab and ipilimumab (CheckMate-227; NCT02477826),",
            "probability": 3.282015790671729e-05,
            "start_logit": 4.48087739944458,
            "end_logit": -3.6674435138702393,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "ipilimumab plus ni",
            "probability": 3.1825157644760325e-05,
            "start_logit": 4.963322162628174,
            "end_logit": -4.180674076080322,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        },
        {
            "text": "ni",
            "probability": 2.4763532026651036e-05,
            "start_logit": 4.712437152862549,
            "end_logit": -4.180674076080322,
            "question_text": "Which drugs were tested in the CheckMate 227 clinical trial?"
        }
    ],
    "5e46f9683f54159529000010": [
        {
            "text": "Radiation-induced fibrosis",
            "probability": 0.2872125823526038,
            "start_logit": 4.061605930328369,
            "end_logit": 4.457836151123047,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "fibrosis",
            "probability": 0.1937248933831654,
            "start_logit": 3.6678223609924316,
            "end_logit": 4.457836151123047,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "leukencephalopathy",
            "probability": 0.0793143383881479,
            "start_logit": 3.560981273651123,
            "end_logit": 3.671657085418701,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "radiation necrosis, microangiopathy, and progressive leukencephalopathy",
            "probability": 0.06807644322562882,
            "start_logit": 3.408193588256836,
            "end_logit": 3.671657085418701,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "progressive leukencephalopathy",
            "probability": 0.06801897839299799,
            "start_logit": 3.407349109649658,
            "end_logit": 3.671657085418701,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "microangiopathy, and progressive leukencephalopathy",
            "probability": 0.06692923109606135,
            "start_logit": 3.39119815826416,
            "end_logit": 3.671657085418701,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "radiation necrosis, microangiopathy",
            "probability": 0.047491930775016435,
            "start_logit": 3.408193588256836,
            "end_logit": 3.3115856647491455,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "microangiopathy",
            "probability": 0.04669160519306585,
            "start_logit": 3.39119815826416,
            "end_logit": 3.3115856647491455,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "radiation necrosis",
            "probability": 0.04536636871053827,
            "start_logit": 3.408193588256836,
            "end_logit": 3.2657968997955322,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "Radiation-induced second malignancies",
            "probability": 0.026264022501018367,
            "start_logit": 3.108956813812256,
            "end_logit": 3.018462657928467,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "myositis.Radiation-induced second malignancies",
            "probability": 0.014023885296978672,
            "start_logit": 2.4815187454223633,
            "end_logit": 3.018462657928467,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "osteoradionecrosis and myositis.Radiation-induced second malignancies",
            "probability": 0.012582950825827107,
            "start_logit": 2.3730995655059814,
            "end_logit": 3.018462657928467,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "osteitis, osteoradionecrosis and myositis.Radiation-induced second malignancies",
            "probability": 0.010051417053113907,
            "start_logit": 2.148470401763916,
            "end_logit": 3.018462657928467,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "colitis, osteitis, osteoradionecrosis and myositis.Radiation-induced second malignancies",
            "probability": 0.0070843499831296204,
            "start_logit": 1.7986449003219604,
            "end_logit": 3.018462657928467,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "Radiation-induced fibrosis (RIF)",
            "probability": 0.005724903981170825,
            "start_logit": 4.061605930328369,
            "end_logit": 0.5424392819404602,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "second malignancies",
            "probability": 0.005352200979851082,
            "start_logit": 1.518264651298523,
            "end_logit": 3.018462657928467,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "myositis",
            "probability": 0.004276478474728663,
            "start_logit": 2.4815187454223633,
            "end_logit": 1.8308305740356445,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "osteoradionecrosis",
            "probability": 0.004114895188408713,
            "start_logit": 2.3730995655059814,
            "end_logit": 1.900733232498169,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "fibrosis (RIF)",
            "probability": 0.0038614478665827258,
            "start_logit": 3.6678223609924316,
            "end_logit": 0.5424392819404602,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "osteoradionecrosis and myositis",
            "probability": 0.003837076331964292,
            "start_logit": 2.3730995655059814,
            "end_logit": 1.8308305740356445,
            "question_text": "List side effects of radiation therapy?"
        }
    ],
    "5e4027f948dab47f2600000d": [
        {
            "text": "sepsis",
            "probability": 0.2570345203372745,
            "start_logit": 3.9565789699554443,
            "end_logit": 4.124487400054932,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "Meningitis and sepsis",
            "probability": 0.24612955182873367,
            "start_logit": 3.91322660446167,
            "end_logit": 4.124487400054932,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "Meningitis",
            "probability": 0.24569205708851602,
            "start_logit": 3.91322660446167,
            "end_logit": 4.122708320617676,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "sepsis caused by serogroup B meningococcus are two severe diseases that still cause significant mortality.Sepsis and meningitis",
            "probability": 0.08618817966760041,
            "start_logit": 3.942901611328125,
            "end_logit": 3.045487403869629,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "sepsis caused by serogroup B meningococcus are two severe diseases that still cause significant mortality.Sepsis",
            "probability": 0.061857209932942935,
            "start_logit": 3.942901611328125,
            "end_logit": 2.713783025741577,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "meningitis",
            "probability": 0.038081283334560845,
            "start_logit": 3.126091480255127,
            "end_logit": 3.045487403869629,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "Sepsis and meningitis",
            "probability": 0.0223919934821547,
            "start_logit": 2.595072031021118,
            "end_logit": 3.045487403869629,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "septicaemia has recently entered a new era with the availability of two vaccines against capsular group B meningococcusMeningitis",
            "probability": 0.01997699394714632,
            "start_logit": 2.0651040077209473,
            "end_logit": 3.4613332748413086,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "Sepsis",
            "probability": 0.016070721611532283,
            "start_logit": 2.595072031021118,
            "end_logit": 2.713783025741577,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "Meningitis and sepsis caused by serogroup B meningococcus are two severe diseases that still cause significant mortality.Sepsis",
            "probability": 0.003267483928460859,
            "start_logit": 1.0020931959152222,
            "end_logit": 2.713783025741577,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "septicaemia",
            "probability": 0.001425998837395971,
            "start_logit": 2.733760118484497,
            "end_logit": 0.1529683619737625,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "meningitis and septicaemia",
            "probability": 0.0007498695203736195,
            "start_logit": 2.091031551361084,
            "end_logit": 0.1529683619737625,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "psis",
            "probability": 0.0001978909066250902,
            "start_logit": -3.2126708030700684,
            "end_logit": 4.124487400054932,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "ingitis and sepsis",
            "probability": 0.00019658408433760642,
            "start_logit": -3.021496295928955,
            "end_logit": 3.926687240600586,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "itis and sepsis",
            "probability": 0.00015946410006484506,
            "start_logit": -3.428567886352539,
            "end_logit": 4.124487400054932,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "itis",
            "probability": 0.00015918065297564524,
            "start_logit": -3.428567886352539,
            "end_logit": 4.122708320617676,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "ingitis",
            "probability": 0.0001240146559225863,
            "start_logit": -3.6782078742980957,
            "end_logit": 4.122708320617676,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "sepsis caused by serogroup B meningococcus",
            "probability": 0.0001040597156957901,
            "start_logit": 3.9565789699554443,
            "end_logit": -3.6875133514404297,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "Meningitis and sepsis caused by serogroup B meningococcus",
            "probability": 9.964486931180522e-05,
            "start_logit": 3.91322660446167,
            "end_logit": -3.6875133514404297,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "se",
            "probability": 9.329749837457346e-05,
            "start_logit": 3.942901611328125,
            "end_logit": -3.7830076217651367,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        }
    ],
    "5e52c1fd6d0a27794100004c": [
        {
            "text": "Epithelial ovarian cancer",
            "probability": 0.25135781413703984,
            "start_logit": 4.363705158233643,
            "end_logit": 5.030100345611572,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "Epithelial Ovarian Cancer.Epithelial ovarian cancer",
            "probability": 0.18306806356467326,
            "start_logit": 4.046685695648193,
            "end_logit": 5.030100345611572,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "ovarian cancer",
            "probability": 0.15754277171315237,
            "start_logit": 3.896524667739868,
            "end_logit": 5.030100345611572,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "melanoma",
            "probability": 0.10565370536058578,
            "start_logit": 4.224852085113525,
            "end_logit": 4.302242755889893,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "Epithelial Ovarian Cancer",
            "probability": 0.0719071311475134,
            "start_logit": 4.046685695648193,
            "end_logit": 4.095617771148682,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "Ovarian Cancer.Epithelial ovarian cancer",
            "probability": 0.049709328724732084,
            "start_logit": 2.7430202960968018,
            "end_logit": 5.030100345611572,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "Epithelial ovarian cancer (EOC)",
            "probability": 0.034460511367000984,
            "start_logit": 4.363705158233643,
            "end_logit": 3.043036937713623,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "Epithelial Ovarian Cancer.Epithelial ovarian cancer (EOC)",
            "probability": 0.02509816178607375,
            "start_logit": 4.046685695648193,
            "end_logit": 3.043036937713623,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "Epithelial ovarian",
            "probability": 0.023330221787066178,
            "start_logit": 4.363705158233643,
            "end_logit": 2.652972459793091,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "ovarian cancer (EOC)",
            "probability": 0.021598709767781655,
            "start_logit": 3.896524667739868,
            "end_logit": 3.043036937713623,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "Ovarian Cancer",
            "probability": 0.01952528010764369,
            "start_logit": 2.7430202960968018,
            "end_logit": 4.095617771148682,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "Epithelial Ovarian Cancer.Epithelial ovarian",
            "probability": 0.016991787344092686,
            "start_logit": 4.046685695648193,
            "end_logit": 2.652972459793091,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "ovarian",
            "probability": 0.014622612062551991,
            "start_logit": 3.896524667739868,
            "end_logit": 2.652972459793091,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "Epithelial Ovarian",
            "probability": 0.008213979661040979,
            "start_logit": 4.046685695648193,
            "end_logit": 1.9260798692703247,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "Ovarian Cancer.Epithelial ovarian cancer (EOC)",
            "probability": 0.006815021420542308,
            "start_logit": 2.7430202960968018,
            "end_logit": 3.043036937713623,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "Ovarian Cancer.Epithelial ovarian",
            "probability": 0.004613859600966678,
            "start_logit": 2.7430202960968018,
            "end_logit": 2.652972459793091,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "Ovarian",
            "probability": 0.0022303803686911424,
            "start_logit": 2.7430202960968018,
            "end_logit": 1.9260798692703247,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "Epithelial Ovarian Cancer.",
            "probability": 0.0013980127662121067,
            "start_logit": 4.046685695648193,
            "end_logit": 0.15529410541057587,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "Epithelial",
            "probability": 0.001077723453055123,
            "start_logit": 4.363705158233643,
            "end_logit": -0.42192623019218445,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        },
        {
            "text": "Epithelial Ovarian Cancer.Epithelial",
            "probability": 0.0007849238595839657,
            "start_logit": 4.046685695648193,
            "end_logit": -0.42192623019218445,
            "question_text": "List types of cancer where TBC1 domain family member 16 (TBC1D16) is involved"
        }
    ],
    "5e36e254b5b409ea53000010": [
        {
            "text": "pontocerebellar hypoplasia",
            "probability": 0.13558560965206914,
            "start_logit": 3.0018954277038574,
            "end_logit": 3.0973169803619385,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "congenital pontocerebellar hypoplasia",
            "probability": 0.1271122720698087,
            "start_logit": 2.9373629093170166,
            "end_logit": 3.0973169803619385,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "optic atrophy",
            "probability": 0.11464093800312017,
            "start_logit": 2.845409393310547,
            "end_logit": 3.0860047340393066,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "optic atrophy, Charcot-Marie-Tooth type 2, Leigh syndrome",
            "probability": 0.09198130533567653,
            "start_logit": 2.845409393310547,
            "end_logit": 2.8657851219177246,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "optic atrophy, Charcot-Marie-Tooth type 2, Leigh syndrome, progressive myoclonic ataxia",
            "probability": 0.0820097047480544,
            "start_logit": 2.845409393310547,
            "end_logit": 2.751037359237671,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "Leigh syndrome, progressive myoclonic ataxia and lethal congenital pontocerebellar hypoplasia",
            "probability": 0.051188129701731346,
            "start_logit": 2.0277998447418213,
            "end_logit": 3.0973169803619385,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "progressive myoclonic ataxia and lethal congenital pontocerebellar hypoplasia",
            "probability": 0.04536394645779324,
            "start_logit": 1.9070098400115967,
            "end_logit": 3.0973169803619385,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "Leigh syndrome",
            "probability": 0.04060843505316413,
            "start_logit": 2.0277998447418213,
            "end_logit": 2.8657851219177246,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "optic atrophy, Charcot-Marie-Tooth type 2",
            "probability": 0.03680098268469173,
            "start_logit": 2.845409393310547,
            "end_logit": 1.9497243165969849,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "Leigh syndrome, progressive myoclonic ataxia",
            "probability": 0.03620611554529466,
            "start_logit": 2.0277998447418213,
            "end_logit": 2.751037359237671,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "inherited optic atrophy",
            "probability": 0.035724962014828825,
            "start_logit": 1.6794540882110596,
            "end_logit": 3.0860047340393066,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "progressive myoclonic ataxia",
            "probability": 0.0320865852417708,
            "start_logit": 1.9070098400115967,
            "end_logit": 2.751037359237671,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "myoclonic ataxia and lethal congenital pontocerebellar hypoplasia",
            "probability": 0.029844060744570435,
            "start_logit": 1.4882780313491821,
            "end_logit": 3.0973169803619385,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "inherited optic atrophy, Charcot-Marie-Tooth type 2, Leigh syndrome",
            "probability": 0.02866365799538365,
            "start_logit": 1.6794540882110596,
            "end_logit": 2.8657851219177246,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "inherited optic atrophy, Charcot-Marie-Tooth type 2, Leigh syndrome, progressive myoclonic ataxia",
            "probability": 0.025556259727147656,
            "start_logit": 1.6794540882110596,
            "end_logit": 2.751037359237671,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "myoclonic ataxia",
            "probability": 0.021109142255341332,
            "start_logit": 1.4882780313491821,
            "end_logit": 2.751037359237671,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "Charcot-Marie-Tooth type 2, Leigh syndrome",
            "probability": 0.019664429440549837,
            "start_logit": 1.3026354312896729,
            "end_logit": 2.8657851219177246,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "Charcot-Marie-Tooth type 2, Leigh syndrome, progressive myoclonic ataxia",
            "probability": 0.017532628468069123,
            "start_logit": 1.3026354312896729,
            "end_logit": 2.751037359237671,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "lethal congenital pontocerebellar hypoplasia",
            "probability": 0.01685273514525321,
            "start_logit": 0.9168051481246948,
            "end_logit": 3.0973169803619385,
            "question_text": "List SLC25A46-related pathologies"
        },
        {
            "text": "inherited optic atrophy, Charcot-Marie-Tooth type 2",
            "probability": 0.011468099715681,
            "start_logit": 1.6794540882110596,
            "end_logit": 1.9497243165969849,
            "question_text": "List SLC25A46-related pathologies"
        }
    ],
    "5e5015436d0a277941000037": [
        {
            "text": "MobiDB",
            "probability": 0.7733438594050098,
            "start_logit": 4.7972412109375,
            "end_logit": 4.196679592132568,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "DisProt",
            "probability": 0.12148238278048058,
            "start_logit": 4.001221179962158,
            "end_logit": 3.141745090484619,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "DisProt database",
            "probability": 0.05362471052720341,
            "start_logit": 4.001221179962158,
            "end_logit": 2.3239858150482178,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB (URL: mobidb",
            "probability": 0.017123653434893728,
            "start_logit": 3.716533660888672,
            "end_logit": 1.467124104499817,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "disprot.org/assessment/.MobiDB",
            "probability": 0.011001451443082027,
            "start_logit": 0.5445446372032166,
            "end_logit": 4.196679592132568,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "Mob",
            "probability": 0.0034025764840811324,
            "start_logit": 4.7972412109375,
            "end_logit": -1.2295112609863281,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiD",
            "probability": 0.003305921980096711,
            "start_logit": 4.7972412109375,
            "end_logit": -1.2583287954330444,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB (URL: mobidb.bio.unipd.it)",
            "probability": 0.002939662783478034,
            "start_logit": 3.716533660888672,
            "end_logit": -0.2950417697429657,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "mobidb",
            "probability": 0.002903397439511241,
            "start_logit": 1.941954493522644,
            "end_logit": 1.467124104499817,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "SwissProt",
            "probability": 0.002152505022674879,
            "start_logit": 1.7344056367874146,
            "end_logit": 1.3754236698150635,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB: a comprehensive database of intrinsic protein disorder annotations",
            "probability": 0.0018787205884723797,
            "start_logit": 4.7972412109375,
            "end_logit": -1.8234531879425049,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "the DisProt",
            "probability": 0.001643921522924653,
            "start_logit": -0.3014635145664215,
            "end_logit": 3.141745090484619,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB (URL: mobidb.bio.unipd.it) database",
            "probability": 0.0009724456076263504,
            "start_logit": 3.716533660888672,
            "end_logit": -1.401277780532837,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB: a comprehensive database",
            "probability": 0.000881485101352958,
            "start_logit": 4.7972412109375,
            "end_logit": -2.5801913738250732,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB features experimental annotations for 17 285 proteins, covering the entire PDB and predictions for the SwissProt",
            "probability": 0.0008386535513019974,
            "start_logit": 0.7918157577514648,
            "end_logit": 1.3754236698150635,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "the DisProt database",
            "probability": 0.0007256592583928009,
            "start_logit": -0.3014635145664215,
            "end_logit": 2.3239858150482178,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "mobidb.bio.unipd.it)",
            "probability": 0.000498433902030766,
            "start_logit": 1.941954493522644,
            "end_logit": -0.2950417697429657,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB: a comprehensive",
            "probability": 0.00045724477663561177,
            "start_logit": 4.7972412109375,
            "end_logit": -3.2365806102752686,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB:",
            "probability": 0.00041771049800464475,
            "start_logit": 4.7972412109375,
            "end_logit": -3.3270108699798584,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB: a",
            "probability": 0.00040560389274658384,
            "start_logit": 4.7972412109375,
            "end_logit": -3.3564224243164062,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        }
    ],
    "5e4f0a4f6d0a277941000031": [
        {
            "text": "mu-, gamma-, epsilon",
            "probability": 0.11059600719802326,
            "start_logit": 3.0058841705322266,
            "end_logit": 1.6596986055374146,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "epsilon",
            "probability": 0.08189039336843042,
            "start_logit": 2.7053818702697754,
            "end_logit": 1.6596986055374146,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "epsilon chain using heavy chain specific gamma, alpha, mu, delta and epsilon",
            "probability": 0.07271059500305832,
            "start_logit": 2.4520671367645264,
            "end_logit": 1.7941187620162964,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "mu",
            "probability": 0.07107406812518831,
            "start_logit": 3.0058841705322266,
            "end_logit": 1.2175371646881104,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "epsilon chain using heavy chain specific gamma, alpha, mu, delta",
            "probability": 0.07086072468909221,
            "start_logit": 2.4520671367645264,
            "end_logit": 1.768347978591919,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "mu-, gamma",
            "probability": 0.059558939538745775,
            "start_logit": 3.0058841705322266,
            "end_logit": 1.040781021118164,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "mu, delta and epsilon",
            "probability": 0.0515256770379041,
            "start_logit": 2.1076602935791016,
            "end_logit": 1.7941187620162964,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "mu, delta",
            "probability": 0.05021478389564037,
            "start_logit": 2.1076602935791016,
            "end_logit": 1.768347978591919,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "mu-, gamma-, epsilon-, or alpha",
            "probability": 0.05016899938309755,
            "start_logit": 3.0058841705322266,
            "end_logit": 0.8692119121551514,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "mu, delta or epsilon chain using heavy chain specific gamma, alpha, mu, delta and epsilon",
            "probability": 0.040513200443698036,
            "start_logit": 1.8672078847885132,
            "end_logit": 1.7941187620162964,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "mu, delta or epsilon chain using heavy chain specific gamma, alpha, mu, delta",
            "probability": 0.03948248178678973,
            "start_logit": 1.8672078847885132,
            "end_logit": 1.768347978591919,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "gamma, alpha, mu, delta and epsilon",
            "probability": 0.03761267740492124,
            "start_logit": 1.7929211854934692,
            "end_logit": 1.7941187620162964,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "epsilon-, or alpha",
            "probability": 0.03714744499795859,
            "start_logit": 2.7053818702697754,
            "end_logit": 0.8692119121551514,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "gamma, alpha, mu, delta",
            "probability": 0.036655752552948555,
            "start_logit": 1.7929211854934692,
            "end_logit": 1.768347978591919,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "epsilon chain using heavy chain specific gamma",
            "probability": 0.03649523430851352,
            "start_logit": 2.4520671367645264,
            "end_logit": 1.1048133373260498,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "gamma-, epsilon",
            "probability": 0.03472412516081359,
            "start_logit": 1.8474348783493042,
            "end_logit": 1.6596986055374146,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "gamma, alpha, mu, delta or epsilon chain using heavy chain specific gamma, alpha, mu, delta and epsilon",
            "probability": 0.030160777094285975,
            "start_logit": 1.57212233543396,
            "end_logit": 1.7941187620162964,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "mu-, gamma-, epsilon-, or alpha-H chain",
            "probability": 0.029894521122425608,
            "start_logit": 3.0058841705322266,
            "end_logit": 0.3514898419380188,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "gamma, alpha, mu, delta or epsilon chain using heavy chain specific gamma, alpha, mu, delta",
            "probability": 0.029393440144416125,
            "start_logit": 1.57212233543396,
            "end_logit": 1.768347978591919,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "epsilon chain using heavy chain specific gamma, alpha, mu",
            "probability": 0.029320156744048875,
            "start_logit": 2.4520671367645264,
            "end_logit": 0.8859068751335144,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        }
    ],
    "5e55046fb761aafe09000004": [
        {
            "text": "MLE4901",
            "probability": 0.44071674848622094,
            "start_logit": 4.579483509063721,
            "end_logit": 4.20251989364624,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "AZD4901",
            "probability": 0.35949881929637895,
            "start_logit": 4.348966121673584,
            "end_logit": 4.229345798492432,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "ESN364",
            "probability": 0.1557291775169597,
            "start_logit": 4.039196491241455,
            "end_logit": 3.7025229930877686,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "SB222200 in the pubertal but not prepubertal monkeys.NK3R antagonist AZD4901",
            "probability": 0.036993516705123734,
            "start_logit": 2.074997901916504,
            "end_logit": 4.229345798492432,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "SB222200",
            "probability": 0.00287341839566539,
            "start_logit": 2.074997901916504,
            "end_logit": 1.6741055250167847,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "ESN364,",
            "probability": 0.0015854913999088388,
            "start_logit": 4.039196491241455,
            "end_logit": -0.8847010731697083,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "ESN",
            "probability": 0.0004771103205784733,
            "start_logit": 4.039196491241455,
            "end_logit": -2.0856029987335205,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "MLE490",
            "probability": 0.00034377439621280386,
            "start_logit": 4.579483509063721,
            "end_logit": -2.9536521434783936,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "M",
            "probability": 0.0003401740946494137,
            "start_logit": 4.579483509063721,
            "end_logit": -2.9641802310943604,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "AZD490",
            "probability": 0.00022596850268869132,
            "start_logit": 4.348966121673584,
            "end_logit": -3.1427247524261475,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "ES",
            "probability": 0.00019563022893718255,
            "start_logit": 4.039196491241455,
            "end_logit": -2.9771244525909424,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "MLE",
            "probability": 0.00018436491848074804,
            "start_logit": 4.579483509063721,
            "end_logit": -3.576720714569092,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "A",
            "probability": 0.00017093783821555035,
            "start_logit": 4.348966121673584,
            "end_logit": -3.4218204021453857,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "ZD4901",
            "probability": 0.00015931521322049173,
            "start_logit": -3.372615337371826,
            "end_logit": 4.229345798492432,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "AZD",
            "probability": 0.0001444157184565038,
            "start_logit": 4.348966121673584,
            "end_logit": -3.5904242992401123,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "1",
            "probability": 0.00011549938463913983,
            "start_logit": -3.694234848022461,
            "end_logit": 4.229345798492432,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "D4901",
            "probability": 9.81885639653067e-05,
            "start_logit": -3.8566102981567383,
            "end_logit": 4.229345798492432,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "364",
            "probability": 5.1254606396555386e-05,
            "start_logit": -3.9798717498779297,
            "end_logit": 3.7025229930877686,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "ESN36",
            "probability": 4.909226867232903e-05,
            "start_logit": 4.039196491241455,
            "end_logit": -4.359649181365967,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "4",
            "probability": 4.7102144629610145e-05,
            "start_logit": -4.064358711242676,
            "end_logit": 3.7025229930877686,
            "question_text": "List 3 NK3R antagonists."
        }
    ],
    "5e51c6036d0a27794100003c": [
        {
            "text": "macrocephaly, seizure, developmental delay",
            "probability": 0.1533907899554588,
            "start_logit": 2.5102803707122803,
            "end_logit": 2.845513105392456,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "developmental delay",
            "probability": 0.10001694165209359,
            "start_logit": 2.0826311111450195,
            "end_logit": 2.845513105392456,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "macrocephaly, seizure, developmental delay and dysmorphic facial features",
            "probability": 0.08906537454342808,
            "start_logit": 2.5102803707122803,
            "end_logit": 2.3018949031829834,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "macrocephaly",
            "probability": 0.08194139130022292,
            "start_logit": 2.5102803707122803,
            "end_logit": 2.2185285091400146,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "macrocephaly , seizure , developmental delay",
            "probability": 0.06994959424356167,
            "start_logit": 2.1209163665771484,
            "end_logit": 2.4496631622314453,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "dysmorphic facial features",
            "probability": 0.06302594102102849,
            "start_logit": 2.1644561290740967,
            "end_logit": 2.3018949031829834,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "developmental delay and dysmorphic facial features",
            "probability": 0.058074193186687426,
            "start_logit": 2.0826311111450195,
            "end_logit": 2.3018949031829834,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "intellectual disability, macrocephaly, seizure, developmental delay",
            "probability": 0.04836250170501634,
            "start_logit": 1.3560162782669067,
            "end_logit": 2.845513105392456,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "macrocephaly, seizure",
            "probability": 0.04626743036862602,
            "start_logit": 2.5102803707122803,
            "end_logit": 1.6469625234603882,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "macrocephaly , seizure , developmental delay and dysmorphic facial features",
            "probability": 0.042770045170216625,
            "start_logit": 2.1209163665771484,
            "end_logit": 1.957726240158081,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "macrocephaly/hemi/megalencephaly",
            "probability": 0.03788141075059349,
            "start_logit": 1.9583073854446411,
            "end_logit": 1.9989577531814575,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "intellectual disability , macrocephaly , seizure , developmental delay",
            "probability": 0.029468768341239827,
            "start_logit": 1.2564724683761597,
            "end_logit": 2.4496631622314453,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "intellectual disability, macrocephaly, seizure, developmental delay and dysmorphic facial features",
            "probability": 0.028081375221193118,
            "start_logit": 1.3560162782669067,
            "end_logit": 2.3018949031829834,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "macrocephaly/hemi/megalencephaly, and seizures",
            "probability": 0.026009352164598175,
            "start_logit": 1.9583073854446411,
            "end_logit": 1.6229534149169922,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "intellectual disability, macrocephaly",
            "probability": 0.025835258281277352,
            "start_logit": 1.3560162782669067,
            "end_logit": 2.2185285091400146,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "seizure, developmental delay",
            "probability": 0.024132520113929377,
            "start_logit": 0.6608518362045288,
            "end_logit": 2.845513105392456,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "macrocephaly , seizure",
            "probability": 0.020594960492922802,
            "start_logit": 2.1209163665771484,
            "end_logit": 1.2269346714019775,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "dysmorphic facial featuresSKS is characterized by intellectual disability, macrocephaly/hemi/megalencephaly",
            "probability": 0.0195536365433364,
            "start_logit": 2.09814453125,
            "end_logit": 1.1978213787078857,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "intellectual disability , macrocephaly , seizure , developmental delay and dysmorphic facial features",
            "probability": 0.018018411210176326,
            "start_logit": 1.2564724683761597,
            "end_logit": 1.957726240158081,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        },
        {
            "text": "intellectual disability , macrocephaly",
            "probability": 0.01756010373439339,
            "start_logit": 1.2564724683761597,
            "end_logit": 1.9319616556167603,
            "question_text": "List the clinical characteristics of the Smith-Kingsmore syndrome (SKS)"
        }
    ],
    "5e494b0e6d0a277941000007": [
        {
            "text": "atezolizumab",
            "probability": 0.3675842169314005,
            "start_logit": 3.856375217437744,
            "end_logit": 4.086127758026123,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "atezolizumab (TECENTRIQ\u00ae, Genentech), durvalumab",
            "probability": 0.19330383508014112,
            "start_logit": 3.856375217437744,
            "end_logit": 3.4434385299682617,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "avelumab",
            "probability": 0.15854265299170714,
            "start_logit": 3.456500291824341,
            "end_logit": 3.645073890686035,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "durvalumab (IMFINZI\u00ae, Astra-Zeneca), and avelumab",
            "probability": 0.14127794690942858,
            "start_logit": 3.3412058353424072,
            "end_logit": 3.645073890686035,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "durvalumab",
            "probability": 0.11547959457000781,
            "start_logit": 3.3412058353424072,
            "end_logit": 3.4434385299682617,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "durvalumab (IMFINZI\u00ae, Astra-Zeneca)",
            "probability": 0.006062656241260326,
            "start_logit": 3.3412058353424072,
            "end_logit": 0.4964927136898041,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "atezolizumab (TECENTRIQ\u00ae, Genentech)",
            "probability": 0.003531694878206765,
            "start_logit": 3.856375217437744,
            "end_logit": -0.5590468049049377,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "atezolizumab (TECENTRIQ\u00ae, Genentech),",
            "probability": 0.0017907506323210833,
            "start_logit": 3.856375217437744,
            "end_logit": -1.2381898164749146,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "avelumab (BAVENCIO\u00ae",
            "probability": 0.0015837938582665505,
            "start_logit": 3.456500291824341,
            "end_logit": -0.9611266255378723,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "durvalumab (IMFINZI\u00ae, Astra-Zeneca), and avelumab (BAVENCIO\u00ae",
            "probability": 0.0014113245893227527,
            "start_logit": 3.3412058353424072,
            "end_logit": -0.9611266255378723,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "atezolizumab (TECENTRIQ\u00ae",
            "probability": 0.0013339508974277226,
            "start_logit": 3.856375217437744,
            "end_logit": -1.532679557800293,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "(IMFINZI\u00ae, Astra-Zeneca), and avelumab",
            "probability": 0.0013308250649364426,
            "start_logit": -1.3237242698669434,
            "end_logit": 3.645073890686035,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "avelumab (BAVENCIO",
            "probability": 0.0012780186840155318,
            "start_logit": 3.456500291824341,
            "end_logit": -1.1756387948989868,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "atezolizumab (TECENTRIQ\u00ae, Genentech), durvalumab (IMFINZI\u00ae",
            "probability": 0.0012426373247223785,
            "start_logit": 3.856375217437744,
            "end_logit": -1.6035887002944946,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "durvalumab (IMFINZI\u00ae, Astra-Zeneca), and avelumab (BAVENCIO",
            "probability": 0.0011388471958965413,
            "start_logit": 3.3412058353424072,
            "end_logit": -1.1756387948989868,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "(TECENTRIQ\u00ae, Genentech), durvalumab",
            "probability": 0.0008095070921220525,
            "start_logit": -1.6192177534103394,
            "end_logit": 3.4434385299682617,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "durvalumab (IMFINZI\u00ae",
            "probability": 0.0007423507888346166,
            "start_logit": 3.3412058353424072,
            "end_logit": -1.6035887002944946,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "IMFINZI\u00ae, Astra-Zeneca), and avelumab",
            "probability": 0.0007089751371001134,
            "start_logit": -1.9534581899642944,
            "end_logit": 3.645073890686035,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "durvalumab (IMFINZI\u00ae, Astra-Zeneca),",
            "probability": 0.000469886786074309,
            "start_logit": 3.3412058353424072,
            "end_logit": -2.0609188079833984,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "TECENTRIQ\u00ae, Genentech), durvalumab",
            "probability": 0.0003765343468075925,
            "start_logit": -2.384634017944336,
            "end_logit": 3.4434385299682617,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        }
    ],
    "5e4be9496d0a27794100002a": [
        {
            "text": "cetuximab",
            "probability": 0.06326853469738389,
            "start_logit": 5.683766841888428,
            "end_logit": 5.678521633148193,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "cetuximab, panitumumab",
            "probability": 0.060431222388222,
            "start_logit": 5.683766841888428,
            "end_logit": 5.632639408111572,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "cetuximab, panitumumab, zalutumumab",
            "probability": 0.06015470608725524,
            "start_logit": 5.683766841888428,
            "end_logit": 5.628053188323975,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "Cetuximab",
            "probability": 0.05676037894254733,
            "start_logit": 5.607903480529785,
            "end_logit": 5.6458353996276855,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "panitumumab",
            "probability": 0.05449253426158194,
            "start_logit": 5.580324649810791,
            "end_logit": 5.632639408111572,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "panitumumab, zalutumumab",
            "probability": 0.054243191729545816,
            "start_logit": 5.580324649810791,
            "end_logit": 5.628053188323975,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "Cetuximab, Panitumumab-monoclonal antibodies and Gefitinib",
            "probability": 0.05385852449871601,
            "start_logit": 5.607903480529785,
            "end_logit": 5.593357563018799,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "Panitumumab-monoclonal antibodies and Gefitinib",
            "probability": 0.05130873998215729,
            "start_logit": 5.559403896331787,
            "end_logit": 5.593357563018799,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "Gefitinib",
            "probability": 0.04991420551931711,
            "start_logit": 5.531848430633545,
            "end_logit": 5.593357563018799,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "zalutumumab",
            "probability": 0.049547194187622004,
            "start_logit": 5.489772796630859,
            "end_logit": 5.628053188323975,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "cetuximab, panitumumab, zalutumumab and nimotuzumab",
            "probability": 0.049425222065282846,
            "start_logit": 5.683766841888428,
            "end_logit": 5.431594371795654,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "Cetuximab, Panitumumab",
            "probability": 0.049397938106711524,
            "start_logit": 5.607903480529785,
            "end_logit": 5.506905555725098,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "Panitumumab",
            "probability": 0.04705932785129277,
            "start_logit": 5.559403896331787,
            "end_logit": 5.506905555725098,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "Cetuximab, Panitumumab-monoclonal antibodies and Gefitinib, Erlotinib",
            "probability": 0.045098285554221476,
            "start_logit": 5.607903480529785,
            "end_logit": 5.415841102600098,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "nimotuzumab), EGFR tyrosine kinase inhibitors (gefitinib",
            "probability": 0.044823481053611336,
            "start_logit": 5.39597749710083,
            "end_logit": 5.621654987335205,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "panitumumab, zalutumumab and nimotuzumab",
            "probability": 0.044568113970563074,
            "start_logit": 5.580324649810791,
            "end_logit": 5.431594371795654,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "Panitumumab-monoclonal antibodies and Gefitinib, Erlotinib",
            "probability": 0.04296323058753298,
            "start_logit": 5.559403896331787,
            "end_logit": 5.415841102600098,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "Gefitinib, Erlotinib",
            "probability": 0.04179552103726729,
            "start_logit": 5.531848430633545,
            "end_logit": 5.415841102600098,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "zalutumumab and nimotuzumab",
            "probability": 0.04070971723945875,
            "start_logit": 5.489772796630859,
            "end_logit": 5.431594371795654,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "Erlotinib",
            "probability": 0.040179930239709304,
            "start_logit": 5.492426872253418,
            "end_logit": 5.415841102600098,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        }
    ],
    "5d36a9507bc3fee31f000005": [
        {
            "text": "thymocytes",
            "probability": 0.48187619725305275,
            "start_logit": 2.304839849472046,
            "end_logit": 1.654148817062378,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "thymocytes into naive T cells",
            "probability": 0.21411789695534417,
            "start_logit": 2.304839849472046,
            "end_logit": 0.8429883718490601,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "thymocytes into naive T",
            "probability": 0.06589235174445585,
            "start_logit": 2.304839849472046,
            "end_logit": -0.3355160355567932,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "naive T cells",
            "probability": 0.06498700737351969,
            "start_logit": 1.1125004291534424,
            "end_logit": 0.8429883718490601,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "T cells",
            "probability": 0.06371116099358881,
            "start_logit": 1.0926728248596191,
            "end_logit": 0.8429883718490601,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "naive T",
            "probability": 0.019999013672213385,
            "start_logit": 1.1125004291534424,
            "end_logit": -0.3355160355567932,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "T",
            "probability": 0.01960638643444526,
            "start_logit": 1.0926728248596191,
            "end_logit": -0.3355160355567932,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "thymocytes into naive T cells.The inhibition of dopamine synthesis in fetuses changes the pattern of T",
            "probability": 0.017292189992787525,
            "start_logit": 2.304839849472046,
            "end_logit": -1.6732834577560425,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "thymocytes into naive",
            "probability": 0.015393167380802802,
            "start_logit": 2.304839849472046,
            "end_logit": -1.7896146774291992,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "thy",
            "probability": 0.00978926191496456,
            "start_logit": 2.304839849472046,
            "end_logit": -2.2422523498535156,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "naive T cells.The inhibition of dopamine synthesis in fetuses changes the pattern of T",
            "probability": 0.005248359406406631,
            "start_logit": 1.1125004291534424,
            "end_logit": -1.6732834577560425,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "T cells.The inhibition of dopamine synthesis in fetuses changes the pattern of T",
            "probability": 0.005145321882140379,
            "start_logit": 1.0926728248596191,
            "end_logit": -1.6732834577560425,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "naive",
            "probability": 0.004671986304286773,
            "start_logit": 1.1125004291534424,
            "end_logit": -1.7896146774291992,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "antigen-specific human T cells",
            "probability": 0.0030094094939249524,
            "start_logit": -0.5849429965019226,
            "end_logit": -0.5320116877555847,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "cytes",
            "probability": 0.0025817945520707672,
            "start_logit": -2.9243626594543457,
            "end_logit": 1.654148817062378,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "thymocytes into naive T cells.",
            "probability": 0.0018365459632081037,
            "start_logit": 2.304839849472046,
            "end_logit": -3.915651798248291,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "antigen-specific human T",
            "probability": 0.0014677638742369313,
            "start_logit": -0.5849429965019226,
            "end_logit": -1.2500154972076416,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "tes",
            "probability": 0.0012929770364614966,
            "start_logit": -3.6159000396728516,
            "end_logit": 1.654148817062378,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "cytes into naive T cells",
            "probability": 0.0011472000962310562,
            "start_logit": -2.9243626594543457,
            "end_logit": 0.8429883718490601,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "naive T cells.The inhibition of dopamine synthesis in fetuses changes the pattern of T-lymphocyte",
            "probability": 0.0009340076758581034,
            "start_logit": 1.1125004291534424,
            "end_logit": -3.3994696140289307,
            "question_text": "Which cells mature in the human thymus?"
        }
    ],
    "5e30f8abfbd6abf43b000047": [
        {
            "text": "fms-like tyrosine kinase 3/AXL",
            "probability": 0.38694485119819694,
            "start_logit": 5.3224711418151855,
            "end_logit": 4.360635280609131,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "fms",
            "probability": 0.20643647095797413,
            "start_logit": 5.3224711418151855,
            "end_logit": 3.7323458194732666,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "fms-like tyrosine kinase 3",
            "probability": 0.1588296017315422,
            "start_logit": 5.3224711418151855,
            "end_logit": 3.4701850414276123,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "AXL",
            "probability": 0.14960152915558242,
            "start_logit": 4.372164249420166,
            "end_logit": 4.360635280609131,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FLT3/AXL",
            "probability": 0.04594400081718496,
            "start_logit": 4.109735012054443,
            "end_logit": 3.4425125122070312,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FLT3",
            "probability": 0.029864358882420977,
            "start_logit": 4.109735012054443,
            "end_logit": 3.0117549896240234,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "tyrosine kinase 3/AXL",
            "probability": 0.005600785716196651,
            "start_logit": 1.087095856666565,
            "end_logit": 4.360635280609131,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "kinase 3/AXL",
            "probability": 0.0033876502181984444,
            "start_logit": 0.5843254923820496,
            "end_logit": 4.360635280609131,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "fms-like tyrosine kinase",
            "probability": 0.0029843214808469984,
            "start_logit": 5.3224711418151855,
            "end_logit": -0.5042744874954224,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "tyrosine kinase 3",
            "probability": 0.0022989595595667395,
            "start_logit": 1.087095856666565,
            "end_logit": 3.4701850414276123,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "3/AXL",
            "probability": 0.0020258611132254645,
            "start_logit": 0.07018381357192993,
            "end_logit": 4.360635280609131,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "fms-like tyrosine kinase 3/AXL inhibitor,",
            "probability": 0.001904544305687778,
            "start_logit": 5.3224711418151855,
            "end_logit": -0.9534041285514832,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "kinase 3",
            "probability": 0.0013905318375373131,
            "start_logit": 0.5843254923820496,
            "end_logit": 3.4701850414276123,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "3",
            "probability": 0.0008315570365664515,
            "start_logit": 0.07018381357192993,
            "end_logit": 3.4701850414276123,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "AXL inhibitor,",
            "probability": 0.0007363394023545448,
            "start_logit": 4.372164249420166,
            "end_logit": -0.9534041285514832,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "f",
            "probability": 0.0002804206727498758,
            "start_logit": 5.3224711418151855,
            "end_logit": -2.8691112995147705,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FLT3 inhibitor gilteritinib to confer the resistance to PI3K/Akt",
            "probability": 0.0002713646777042992,
            "start_logit": 2.0493404865264893,
            "end_logit": 0.371192067861557,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "fms-like",
            "probability": 0.0002672281818922698,
            "start_logit": 5.3224711418151855,
            "end_logit": -2.917299270629883,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "like tyrosine kinase 3/AXL",
            "probability": 0.00022489942864533424,
            "start_logit": -2.127912998199463,
            "end_logit": 4.360635280609131,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FLT3 inhibitors, in particular to the FLT3",
            "probability": 0.00017472362592636925,
            "start_logit": 0.44014570116996765,
            "end_logit": 1.5401287078857422,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        }
    ],
    "5e4163b848dab47f2600000f": [
        {
            "text": "measlesMeasles",
            "probability": 0.2669328255892485,
            "start_logit": 5.367964267730713,
            "end_logit": 5.446320056915283,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "Mumps",
            "probability": 0.19407306944902217,
            "start_logit": 5.140581130981445,
            "end_logit": 5.354940891265869,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "measlesMeasles are a systemic infectious disease caused by a single stranded ribonucleic acid virus (measles",
            "probability": 0.1585475184297451,
            "start_logit": 5.367964267730713,
            "end_logit": 4.925377368927002,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "measles virus) from the paramyxovirus family.Mumps",
            "probability": 0.12449095468615347,
            "start_logit": 4.696579456329346,
            "end_logit": 5.354940891265869,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "measles",
            "probability": 0.09416106345747494,
            "start_logit": 5.367964267730713,
            "end_logit": 4.404329776763916,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "measlesMeasles are a systemic infectious disease caused by a single stranded ribonucleic acid virus (measles virus",
            "probability": 0.08607362729874544,
            "start_logit": 5.367964267730713,
            "end_logit": 4.314526081085205,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "measles virus",
            "probability": 0.043983662139898405,
            "start_logit": 4.696579456329346,
            "end_logit": 4.314526081085205,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "Mumps is a Paramyxoviridae virus. Since chronic paramyxovirus infection with measles",
            "probability": 0.02905967953761148,
            "start_logit": 5.140581130981445,
            "end_logit": 3.4560577869415283,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "Measles are a systemic infectious disease caused by a single stranded ribonucleic acid virus (measles",
            "probability": 0.0005734548659700078,
            "start_logit": -0.2541661262512207,
            "end_logit": 4.925377368927002,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "measles is known to be accompanied by increased production of antiviral antibodiesNipah virus",
            "probability": 0.0005444895248274606,
            "start_logit": 3.3398165702819824,
            "end_logit": 1.2795641422271729,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "measles is known to be accompanied by increased production of antiviral antibodiesNipah",
            "probability": 0.00045207296261926097,
            "start_logit": 3.3398165702819824,
            "end_logit": 1.0935590267181396,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "Measles are a systemic infectious disease caused by a single stranded ribonucleic acid virus (measles virus",
            "probability": 0.00031132206227514294,
            "start_logit": -0.2541661262512207,
            "end_logit": 4.314526081085205,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "measlesMeasles are a systemic infectious disease caused by a single stranded ribonucleic acid virus (measles virus)",
            "probability": 0.00026283753205665186,
            "start_logit": 5.367964267730713,
            "end_logit": -1.4768961668014526,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "measles virus)",
            "probability": 0.00013431009672149594,
            "start_logit": 4.696579456329346,
            "end_logit": -1.4768961668014526,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "measles virus) from the paramyxovirus family.",
            "probability": 0.00010350327818507914,
            "start_logit": 4.696579456329346,
            "end_logit": -1.7374441623687744,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "paramyxovirus such as measlesMeasles",
            "probability": 0.00010066123434819388,
            "start_logit": -2.5150272846221924,
            "end_logit": 5.446320056915283,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "les",
            "probability": 5.223793867620289e-05,
            "start_logit": -3.1709790229797363,
            "end_logit": 5.446320056915283,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "(measles virus) from the paramyxovirus family.Mumps",
            "probability": 5.144861872614611e-05,
            "start_logit": -3.094825267791748,
            "end_logit": 5.354940891265869,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "lesMeasles",
            "probability": 4.657122322730479e-05,
            "start_logit": -3.2858052253723145,
            "end_logit": 5.446320056915283,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "me",
            "probability": 4.469007446757101e-05,
            "start_logit": 5.367964267730713,
            "end_logit": -3.248680830001831,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        }
    ],
    "5e342175fbd6abf43b000064": [
        {
            "text": "presacral mass",
            "probability": 0.18569209239506537,
            "start_logit": 4.500020503997803,
            "end_logit": 5.188037395477295,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "sacral bony defect, and presacral mass",
            "probability": 0.18348522502859776,
            "start_logit": 4.488064765930176,
            "end_logit": 5.188037395477295,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "anorectal malformation, sacral bony defect, and presacral mass",
            "probability": 0.17404990603808798,
            "start_logit": 4.435272693634033,
            "end_logit": 5.188037395477295,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "sacral bony defect",
            "probability": 0.13969993199211972,
            "start_logit": 4.488064765930176,
            "end_logit": 4.91540002822876,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "anorectal malformation, sacral bony defect",
            "probability": 0.13251617416588202,
            "start_logit": 4.435272693634033,
            "end_logit": 4.91540002822876,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "anorectal malformation",
            "probability": 0.09972465745810388,
            "start_logit": 4.435272693634033,
            "end_logit": 4.631108283996582,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "sacral bony defects",
            "probability": 0.014795782297133063,
            "start_logit": 3.396411895751953,
            "end_logit": 3.7618982791900635,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "presacral mass (most commonly an anterior sacral meningocele) and sacral bony defects",
            "probability": 0.010825584364490434,
            "start_logit": 3.083981990814209,
            "end_logit": 3.7618982791900635,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "anorectal malformations, presacral mass",
            "probability": 0.00845661716327689,
            "start_logit": 3.0464000701904297,
            "end_logit": 3.5525171756744385,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "anorectal malformations",
            "probability": 0.0078694360191863,
            "start_logit": 3.181112766265869,
            "end_logit": 3.345841646194458,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "anorectal malformation, and presence of a pre-sacral mass",
            "probability": 0.006992542819863816,
            "start_logit": 3.3653807640075684,
            "end_logit": 3.043431520462036,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "sacral agenesis, anorectal malformation",
            "probability": 0.006346271738676769,
            "start_logit": 3.204550266265869,
            "end_logit": 3.107285261154175,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "sacral agenesis",
            "probability": 0.00599351069373399,
            "start_logit": 3.204550266265869,
            "end_logit": 3.0500950813293457,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "sacral agenesis, anorectal malformation, and presence of a pre-sacral mass",
            "probability": 0.005953705340404594,
            "start_logit": 3.204550266265869,
            "end_logit": 3.043431520462036,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "sacral anomalies, anorectal malformations",
            "probability": 0.004066068679302055,
            "start_logit": 2.5208029747009277,
            "end_logit": 3.345841646194458,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "anorectal malformations and a presacral mass",
            "probability": 0.004041942689094927,
            "start_logit": 3.181112766265869,
            "end_logit": 2.6795806884765625,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "sacral anomalies",
            "probability": 0.0026828626552470587,
            "start_logit": 2.5208029747009277,
            "end_logit": 2.930049419403076,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "pre-sacral mass",
            "probability": 0.0024740574475560985,
            "start_logit": 2.3263959884643555,
            "end_logit": 3.043431520462036,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "presacral mass (most commonly an anterior sacral meningocele",
            "probability": 0.002207527259622339,
            "start_logit": 3.083981990814209,
            "end_logit": 2.1718590259552,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "anorectal malformations, presacral mass (most commonly an anterior sacral meningocele",
            "probability": 0.0021261037545546643,
            "start_logit": 3.0464000701904297,
            "end_logit": 2.1718590259552,
            "question_text": "List features of the Currarino triad."
        }
    ],
    "5e36a901b5b409ea53000005": [
        {
            "text": "uc.339",
            "probability": 0.5300650729280862,
            "start_logit": 2.5523853302001953,
            "end_logit": 2.505668878555298,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "uc.339 in lung cancer.Our results support a key role for uc.339",
            "probability": 0.3723801398816447,
            "start_logit": 2.5523853302001953,
            "end_logit": 2.1525843143463135,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "339",
            "probability": 0.05341135187295757,
            "start_logit": 1.2040122747421265,
            "end_logit": 1.5590654611587524,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "339 in lung cancer.Our results support a key role for uc.339",
            "probability": 0.032266610600070626,
            "start_logit": 0.10650308430194855,
            "end_logit": 2.1525843143463135,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "339 promotes carcinogenesis by modulating tumor suppressor microRNAs.The transcribed ultraconserved regions",
            "probability": 0.00448529442920285,
            "start_logit": 1.2040122747421265,
            "end_logit": -0.918153703212738,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "Transcribed ultraconserved region 339",
            "probability": 0.0015561203799264135,
            "start_logit": -2.331815242767334,
            "end_logit": 1.5590654611587524,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "339 promotes carcinogenesis by modulating tumor suppressor microRNAs.",
            "probability": 0.0010543586155201008,
            "start_logit": 1.2040122747421265,
            "end_logit": -2.36602520942688,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "support a key role for uc.339",
            "probability": 0.0005048817003414416,
            "start_logit": -4.404045581817627,
            "end_logit": 2.505668878555298,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "a key role for uc.339",
            "probability": 0.00047531626461307303,
            "start_logit": -4.464389324188232,
            "end_logit": 2.505668878555298,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "results support a key role for uc.339",
            "probability": 0.00045558874747947495,
            "start_logit": -4.506779193878174,
            "end_logit": 2.505668878555298,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "key role for uc.339",
            "probability": 0.0004372417371080088,
            "start_logit": -4.5478835105896,
            "end_logit": 2.505668878555298,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "339 promotes carcinogenesis by modulating tumor suppressor microRNAs",
            "probability": 0.00041839994771054434,
            "start_logit": 1.2040122747421265,
            "end_logit": -3.2902753353118896,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "uc.339 in lung cancer.Our results",
            "probability": 0.00038144513353994386,
            "start_logit": 2.5523853302001953,
            "end_logit": -4.731119155883789,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "support a key role for uc.339 in lung cancer.Our results support a key role for uc.339",
            "probability": 0.0003546883728034947,
            "start_logit": -4.404045581817627,
            "end_logit": 2.1525843143463135,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "a key role for uc.339 in lung cancer.Our results support a key role for uc.339",
            "probability": 0.00033391812844203435,
            "start_logit": -4.464389324188232,
            "end_logit": 2.1525843143463135,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "results support a key role for uc.339 in lung cancer.Our results support a key role for uc.339",
            "probability": 0.0003200591968411525,
            "start_logit": -4.506779193878174,
            "end_logit": 2.1525843143463135,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "key role for uc.339 in lung cancer.Our results support a key role for uc.339",
            "probability": 0.00030717009579022656,
            "start_logit": -4.5478835105896,
            "end_logit": 2.1525843143463135,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "ultraconserved region 339",
            "probability": 0.00030425559694974703,
            "start_logit": -3.963898181915283,
            "end_logit": 1.5590654611587524,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "339 promotes carcinogenesis by modulating tumor suppressor microRNAs.The",
            "probability": 0.00026211468291897894,
            "start_logit": 1.2040122747421265,
            "end_logit": -3.7579309940338135,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "339 promotes carcinogenesis by modulating tumor suppressor microRNAs.The transcribed",
            "probability": 0.00022597168805368187,
            "start_logit": 1.2040122747421265,
            "end_logit": -3.9063034057617188,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        }
    ],
    "5e3a6a4eb5b409ea53000016": [
        {
            "text": "internuclear ophthalmoplegia",
            "probability": 0.21306864253583038,
            "start_logit": 2.513969898223877,
            "end_logit": 2.674712896347046,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "gaze palsy associated with internuclear ophthalmoplegia",
            "probability": 0.18183434219345498,
            "start_logit": 2.3554515838623047,
            "end_logit": 2.674712896347046,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "gaze palsy",
            "probability": 0.17576462394693732,
            "start_logit": 2.3554515838623047,
            "end_logit": 2.6407625675201416,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "Unilateral gaze palsy associated with internuclear ophthalmoplegia",
            "probability": 0.09528865762161662,
            "start_logit": 1.7092663049697876,
            "end_logit": 2.674712896347046,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "Unilateral gaze palsy",
            "probability": 0.09210787616485108,
            "start_logit": 1.7092663049697876,
            "end_logit": 2.6407625675201416,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "internuclear ophthalmoplegia (INO) with an associated left conjugate horizontal gaze palsy",
            "probability": 0.07387640315229582,
            "start_logit": 2.2382242679595947,
            "end_logit": 1.8912376165390015,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "diplopia on right horizontal gaze due to a left internuclear ophthalmoplegia",
            "probability": 0.04534269987523331,
            "start_logit": 1.6609176397323608,
            "end_logit": 1.9803999662399292,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "internuclear ophthalmoplegia syndrome",
            "probability": 0.039603832923119614,
            "start_logit": 2.191077470779419,
            "end_logit": 1.3149168491363525,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "conjugate horizontal gaze palsy",
            "probability": 0.01839368655589188,
            "start_logit": 0.847838282585144,
            "end_logit": 1.8912376165390015,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "ophthalmoplegia",
            "probability": 0.01495584566799151,
            "start_logit": 0.5517706871032715,
            "end_logit": 1.9803999662399292,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "ophthalmoplegia (INO) with an associated left conjugate horizontal gaze palsy",
            "probability": 0.01368006807316888,
            "start_logit": 0.5517706871032715,
            "end_logit": 1.8912376165390015,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "diplopia",
            "probability": 0.010750566261483942,
            "start_logit": 1.6609176397323608,
            "end_logit": 0.5411092042922974,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "left internuclear ophthalmoplegia",
            "probability": 0.004731509067461481,
            "start_logit": -0.5990873575210571,
            "end_logit": 1.9803999662399292,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "left conjugate horizontal gaze palsy",
            "probability": 0.004595249607470232,
            "start_logit": -0.5391461253166199,
            "end_logit": 1.8912376165390015,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "left internuclear ophthalmoplegia (INO) with an associated left conjugate horizontal gaze palsy",
            "probability": 0.0043278974368008045,
            "start_logit": -0.5990873575210571,
            "end_logit": 1.8912376165390015,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "gaze",
            "probability": 0.003392595290224696,
            "start_logit": 2.3554515838623047,
            "end_logit": -1.3067879676818848,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "internuclear ophthalmoplegia (INO) with an associated left conjugate horizontal gaze",
            "probability": 0.0027644008495146485,
            "start_logit": 2.2382242679595947,
            "end_logit": -1.394331932067871,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "ophthalmoplegia syndrome",
            "probability": 0.002016856809071434,
            "start_logit": -0.7863081693649292,
            "end_logit": 1.3149168491363525,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "Unilateral gaze",
            "probability": 0.0017778591610323774,
            "start_logit": 1.7092663049697876,
            "end_logit": -1.3067879676818848,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "eyeballs, which was first reported and named by Fisher in 1967. BACKGROUND AND PURPOSE: Unilateral gaze palsy",
            "probability": 0.0017263868065488706,
            "start_logit": -2.2676634788513184,
            "end_logit": 2.6407625675201416,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        }
    ],
    "5e639b111af46fc130000012": [
        {
            "text": "Sarcoma",
            "probability": 0.06638939312580237,
            "start_logit": 5.069882869720459,
            "end_logit": 5.274248123168945,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "sarcomas, brain tumors, leukemia, lymphoma",
            "probability": 0.06623666609817307,
            "start_logit": 5.077476501464844,
            "end_logit": 5.2643513679504395,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "adrenal cortical carcinoma",
            "probability": 0.06508140604765361,
            "start_logit": 5.072012901306152,
            "end_logit": 5.2522196769714355,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "Sarcomas, Breast cancer",
            "probability": 0.0594065896279452,
            "start_logit": 5.069882869720459,
            "end_logit": 5.163115978240967,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "sarcomas, brain tumors, leukemia, lymphoma, lung carcinoma",
            "probability": 0.05850423593559314,
            "start_logit": 5.077476501464844,
            "end_logit": 5.14021635055542,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "lymphoma, and adrenal cortical carcinoma",
            "probability": 0.05470268560361864,
            "start_logit": 4.898286819458008,
            "end_logit": 5.2522196769714355,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "lymphoma",
            "probability": 0.053104017274141525,
            "start_logit": 4.898286819458008,
            "end_logit": 5.222559452056885,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "sarcoma",
            "probability": 0.05221551627794359,
            "start_logit": 5.077476501464844,
            "end_logit": 5.026496887207031,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "carcinoma of the breast followed by sarcomas, brain tumors, leukemia, lymphoma",
            "probability": 0.049330620795042156,
            "start_logit": 4.782787322998047,
            "end_logit": 5.2643513679504395,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "leukemia, lymphoma, and adrenal cortical carcinoma",
            "probability": 0.04586207420893271,
            "start_logit": 4.722012519836426,
            "end_logit": 5.2522196769714355,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "sarcomas, brain tumors, leukemia",
            "probability": 0.045345989093351684,
            "start_logit": 5.077476501464844,
            "end_logit": 4.885438919067383,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "leukemia, lymphoma",
            "probability": 0.044521769893835245,
            "start_logit": 4.722012519836426,
            "end_logit": 5.222559452056885,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "adrenalcortical carcinoma syndrome.sarcomas, brain tumors, leukemia, lymphoma",
            "probability": 0.04414525002326911,
            "start_logit": 4.71351957321167,
            "end_logit": 5.222559452056885,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "carcinoma of the breast followed by sarcomas, brain tumors, leukemia, lymphoma, lung carcinoma",
            "probability": 0.043571792601470115,
            "start_logit": 4.782787322998047,
            "end_logit": 5.14021635055542,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "lymphoma, lung carcinoma",
            "probability": 0.043304782293997646,
            "start_logit": 4.77664041519165,
            "end_logit": 5.14021635055542,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "adrenocortical carcinomsarcoma, breast cancer",
            "probability": 0.04288414674399124,
            "start_logit": 4.810647487640381,
            "end_logit": 5.0964484214782715,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "sarcomas, brain tumors",
            "probability": 0.041724992664287586,
            "start_logit": 5.077476501464844,
            "end_logit": 4.802217483520508,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "lymphoma, lung carcinoma, and adrenocortical carcinomsarcoma, breast cancer",
            "probability": 0.04145030108726928,
            "start_logit": 4.77664041519165,
            "end_logit": 5.0964484214782715,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "lung carcinoma",
            "probability": 0.04117545446442819,
            "start_logit": 4.726219654083252,
            "end_logit": 5.14021635055542,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        },
        {
            "text": "Sarcomas, Breast cancers, brain tumors",
            "probability": 0.04104231613925415,
            "start_logit": 5.069882869720459,
            "end_logit": 4.793314456939697,
            "question_text": "List the cancers that are associated with SBLA syndrome."
        }
    ],
    "5e475d3035b8f0833c000002": [
        {
            "text": "male gender",
            "probability": 0.08696849198737312,
            "start_logit": 2.9370484352111816,
            "end_logit": 2.4488556385040283,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "Neutrophilia and male gender",
            "probability": 0.08502527617637871,
            "start_logit": 2.9144511222839355,
            "end_logit": 2.4488556385040283,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "Anorexia, migratory Pain, local Peritonism, Elevated C-reactive protein, Neutrophilia and male gender",
            "probability": 0.0686975269525659,
            "start_logit": 2.7012157440185547,
            "end_logit": 2.4488556385040283,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "Anorexia, migratory Pain",
            "probability": 0.06746395051632537,
            "start_logit": 2.7012157440185547,
            "end_logit": 2.4307358264923096,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "migratory Pain, local Peritonism, Elevated C-reactive protein, Neutrophilia and male gender",
            "probability": 0.0629766092380905,
            "start_logit": 2.6142659187316895,
            "end_logit": 2.4488556385040283,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "migratory Pain",
            "probability": 0.061845761234725294,
            "start_logit": 2.6142659187316895,
            "end_logit": 2.4307358264923096,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "local Peritonism, Elevated C-reactive protein, Neutrophilia and male gender",
            "probability": 0.059452754243442915,
            "start_logit": 2.5566844940185547,
            "end_logit": 2.4488556385040283,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "Neutrophilia",
            "probability": 0.049762709625839265,
            "start_logit": 2.9144511222839355,
            "end_logit": 1.913172960281372,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "Anorexia, migratory Pain, local Peritonism",
            "probability": 0.049366307130653306,
            "start_logit": 2.7012157440185547,
            "end_logit": 2.118410587310791,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "male gender (Dude). RESULTS The final components of the new CPR, the APPEND score, were Anorexia, migratory Pain",
            "probability": 0.046896193509685095,
            "start_logit": 2.9370484352111816,
            "end_logit": 1.831246256828308,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "Anorexia",
            "probability": 0.04571092773623562,
            "start_logit": 2.7012157440185547,
            "end_logit": 2.0414798259735107,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "migratory Pain, local Peritonism",
            "probability": 0.045255233654063774,
            "start_logit": 2.6142659187316895,
            "end_logit": 2.118410587310791,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "local Peritonism",
            "probability": 0.042722977899504015,
            "start_logit": 2.5566844940185547,
            "end_logit": 2.118410587310791,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "Anorexia, migratory Pain, local Peritonism, Elevated C-reactive protein, Neutrophilia",
            "probability": 0.04020657432105507,
            "start_logit": 2.7012157440185547,
            "end_logit": 1.913172960281372,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "migratory Pain, local Peritonism, Elevated C-reactive protein, Neutrophilia",
            "probability": 0.03685829508197098,
            "start_logit": 2.6142659187316895,
            "end_logit": 1.913172960281372,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "local Peritonism, Elevated C-reactive protein, Neutrophilia",
            "probability": 0.03479588986850897,
            "start_logit": 2.5566844940185547,
            "end_logit": 1.913172960281372,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "Elevated C-reactive protein, Neutrophilia and male gender",
            "probability": 0.03284131403728513,
            "start_logit": 1.9631898403167725,
            "end_logit": 2.4488556385040283,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "male gender (Dude). RESULTS The final components of the new CPR, the APPEND score, were Anorexia",
            "probability": 0.03101302363349669,
            "start_logit": 2.9370484352111816,
            "end_logit": 1.4177169799804688,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "C-reactive protein, Neutrophilia and male gender",
            "probability": 0.026655095207602595,
            "start_logit": 1.7544828653335571,
            "end_logit": 2.4488556385040283,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "Anorexia, migratory Pain, local Peritonism, Elevated C-reactive protein",
            "probability": 0.025485087945197757,
            "start_logit": 2.7012157440185547,
            "end_logit": 1.4572359323501587,
            "question_text": "Which factors are included in the the APPEND score?"
        }
    ],
    "5e493a3e6d0a277941000002": [
        {
            "text": "SR-lncRNA-1",
            "probability": 0.17169487697074828,
            "start_logit": 3.6678466796875,
            "end_logit": 2.988476276397705,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "Hotair",
            "probability": 0.13916954034440548,
            "start_logit": 2.9198684692382812,
            "end_logit": 3.526428461074829,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "SR-lncRNA-1 and SR-lncRNA-2",
            "probability": 0.12270216211256832,
            "start_logit": 3.6678466796875,
            "end_logit": 2.652517318725586,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "Mir155hg, as well as two new lncRNAs (SR-lncRNA-1",
            "probability": 0.11995594049156078,
            "start_logit": 3.274723768234253,
            "end_logit": 3.0230047702789307,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "SR-lncRNA-2",
            "probability": 0.09902022843410664,
            "start_logit": 3.363462448120117,
            "end_logit": 2.7424657344818115,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "Mir155hg",
            "probability": 0.08639393674627938,
            "start_logit": 3.274723768234253,
            "end_logit": 2.6947977542877197,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "Hotair, Mir155hg, as well as two new lncRNAs (SR-lncRNA-1",
            "probability": 0.08412209149824333,
            "start_logit": 2.9198684692382812,
            "end_logit": 3.0230047702789307,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "Hotair, Mir155hg",
            "probability": 0.06058590030708198,
            "start_logit": 2.9198684692382812,
            "end_logit": 2.6947977542877197,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "Mir155hg , as well as two new lncRNAs ( SR-lncRNA-1",
            "probability": 0.032943014234400075,
            "start_logit": 2.016906976699829,
            "end_logit": 2.988476276397705,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "lncRNA-2",
            "probability": 0.032821725323043616,
            "start_logit": 2.2592289447784424,
            "end_logit": 2.7424657344818115,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "lncRNA-1",
            "probability": 0.016215774683575584,
            "start_logit": 1.2735837697982788,
            "end_logit": 3.0230047702789307,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "lncRNA-1 and SR-lncRNA-2",
            "probability": 0.012249014423847808,
            "start_logit": 1.2735837697982788,
            "end_logit": 2.7424657344818115,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "SR-lncRNA",
            "probability": 0.005455321012146614,
            "start_logit": 3.44887638092041,
            "end_logit": -0.24168089032173157,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "Mir155hg, as well as two new lncRNAs (SR-lncRNA",
            "probability": 0.0045833897854330565,
            "start_logit": 3.274723768234253,
            "end_logit": -0.24168089032173157,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "Hotair, Mir155hg, as well as two new lncRNAs (SR-lncRNA",
            "probability": 0.0032142162640910557,
            "start_logit": 2.9198684692382812,
            "end_logit": -0.24168089032173157,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "Mir155hg,",
            "probability": 0.003011435487397931,
            "start_logit": 3.274723768234253,
            "end_logit": -0.6617028713226318,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "Hotair, Mir155hg,",
            "probability": 0.0021118441535604325,
            "start_logit": 2.9198684692382812,
            "end_logit": -0.6617028713226318,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "SR",
            "probability": 0.0013761887940925747,
            "start_logit": 3.611454963684082,
            "end_logit": -1.7815330028533936,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "Hotair , Mir155hg , as well as two new lncRNAs ( SR-lncRNA-1",
            "probability": 0.0013655809478503667,
            "start_logit": -1.1662923097610474,
            "end_logit": 2.988476276397705,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "SR-lncRNA-1 and SR-lncRNA",
            "probability": 0.0010078179855662782,
            "start_logit": 3.611454963684082,
            "end_logit": -2.0930633544921875,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        }
    ],
    "5e6e4a6c51b80c9423000002": [
        {
            "text": "MLL1",
            "probability": 0.5283419115972517,
            "start_logit": 3.552616596221924,
            "end_logit": 2.2342700958251953,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "MLL1 (mixed-lineage leukaemia 1) and multiple regulatory subunits in which WDR5",
            "probability": 0.16369192814473604,
            "start_logit": 3.552616596221924,
            "end_logit": 1.0625126361846924,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Mll4",
            "probability": 0.10969479120979496,
            "start_logit": 2.6379613876342773,
            "end_logit": 1.5768835544586182,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "WDR5",
            "probability": 0.03347537087250588,
            "start_logit": 1.9654403924942017,
            "end_logit": 1.0625126361846924,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Mll4 (Kmt2d), a member of the COMPASS The lysine methyltransferase KMT2C",
            "probability": 0.02953567048702982,
            "start_logit": 2.6379613876342773,
            "end_logit": 0.2647803723812103,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "MLL1 (mixed-lineage leukaemia 1)",
            "probability": 0.02417366950844392,
            "start_logit": 3.552616596221924,
            "end_logit": -0.8502095341682434,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "WDR5 (WD40 repeat-containing protein 5), RBBP5",
            "probability": 0.019105851249612883,
            "start_logit": 1.9654403924942017,
            "end_logit": 0.501697301864624,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "KMT2C",
            "probability": 0.012715026650545812,
            "start_logit": 1.795147180557251,
            "end_logit": 0.2647803723812103,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "DPY30",
            "probability": 0.010065285407088228,
            "start_logit": 0.9303250312805176,
            "end_logit": 0.8959104418754578,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "ASH2 (absent, small or homoeotic discs 2) and DPY30",
            "probability": 0.008804136732063008,
            "start_logit": 0.7964543104171753,
            "end_logit": 0.8959104418754578,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Mll4 (Kmt2d)",
            "probability": 0.008442141457571103,
            "start_logit": 2.6379613876342773,
            "end_logit": -0.9875823259353638,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "RBBP5",
            "probability": 0.008202155712644205,
            "start_logit": 1.119842767715454,
            "end_logit": 0.501697301864624,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "KMT2C (also known as MLL3",
            "probability": 0.007385227934574425,
            "start_logit": 1.795147180557251,
            "end_logit": -0.2785223424434662,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "RBBP5 (retinoblastoma-binding protein 5), ASH2",
            "probability": 0.007279755900617676,
            "start_logit": 1.119842767715454,
            "end_logit": 0.3823976218700409,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "MLL3",
            "probability": 0.006127892045950181,
            "start_logit": 1.6085162162780762,
            "end_logit": -0.2785223424434662,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "ASH2",
            "probability": 0.005268306028758595,
            "start_logit": 0.7964543104171753,
            "end_logit": 0.3823976218700409,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Mll4 (Kmt2d),",
            "probability": 0.005084984912868441,
            "start_logit": 2.6379613876342773,
            "end_logit": -1.4945262670516968,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Set1)-like complexes that are composed of catalytic subunits such as MLL1",
            "probability": 0.0047943188370854345,
            "start_logit": -1.1496953964233398,
            "end_logit": 2.2342700958251953,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "catalytic subunits such as MLL1",
            "probability": 0.004241862279404363,
            "start_logit": -1.2721246480941772,
            "end_logit": 2.2342700958251953,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "KMT2C (also known as MLL3),",
            "probability": 0.003569713031453324,
            "start_logit": 1.795147180557251,
            "end_logit": -1.005518913269043,
            "question_text": "List the components of the COMPASS complex"
        }
    ],
    "5e6e5d1d51b80c9423000003": [
        {
            "text": "schizophrenia",
            "probability": 0.2831517539290124,
            "start_logit": 3.878386974334717,
            "end_logit": 4.076857089996338,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "bipolar, schizophrenia",
            "probability": 0.20639981875159552,
            "start_logit": 3.5622191429138184,
            "end_logit": 4.076857089996338,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "schizophrenia, and attention-deficit/hyperactivity disorder",
            "probability": 0.15270124981518685,
            "start_logit": 3.878386974334717,
            "end_logit": 3.459357500076294,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "attention-deficit/hyperactivity disorder",
            "probability": 0.14229249950429437,
            "start_logit": 3.807788372039795,
            "end_logit": 3.459357500076294,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "bipolar, schizophrenia, and attention-deficit/hyperactivity disorder",
            "probability": 0.11130960641302712,
            "start_logit": 3.5622191429138184,
            "end_logit": 3.459357500076294,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "bipolar",
            "probability": 0.09363840770298354,
            "start_logit": 3.5622191429138184,
            "end_logit": 3.286482572555542,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "hyperactivity disorder",
            "probability": 0.0037378120267456075,
            "start_logit": 0.1684039980173111,
            "end_logit": 3.459357500076294,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "schizophrenia,",
            "probability": 0.0019126412310055284,
            "start_logit": 3.878386974334717,
            "end_logit": -0.920640766620636,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "bipolar, schizophrenia,",
            "probability": 0.0013941951548544537,
            "start_logit": 3.5622191429138184,
            "end_logit": -0.920640766620636,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "schizophrenia, and attention-deficit/hyperactivity",
            "probability": 0.0006682608801402877,
            "start_logit": 3.878386974334717,
            "end_logit": -1.9722025394439697,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "attention-deficit/hyperactivity",
            "probability": 0.0006227094478348156,
            "start_logit": 3.807788372039795,
            "end_logit": -1.9722025394439697,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "bipolar, schizophrenia, and attention-deficit/hyperactivity",
            "probability": 0.00048712014891603533,
            "start_logit": 3.5622191429138184,
            "end_logit": -1.9722025394439697,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "bipolar,",
            "probability": 0.0004535992564138045,
            "start_logit": 3.5622191429138184,
            "end_logit": -2.043499231338501,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "schizophrenia, and attention",
            "probability": 0.0003034398511100826,
            "start_logit": 3.878386974334717,
            "end_logit": -2.761697769165039,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "attention",
            "probability": 0.00028275613274889136,
            "start_logit": 3.807788372039795,
            "end_logit": -2.761697769165039,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "bipolar, schizophrenia, and attention",
            "probability": 0.00022118856550270153,
            "start_logit": 3.5622191429138184,
            "end_logit": -2.761697769165039,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "zophrenia",
            "probability": 0.0001517493366426818,
            "start_logit": -3.65312123298645,
            "end_logit": 4.076857089996338,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "schizophrenia and ADHD",
            "probability": 0.00010573780497238139,
            "start_logit": 3.5645036697387695,
            "end_logit": -3.50203537940979,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "s",
            "probability": 8.295512704924849e-05,
            "start_logit": 3.878386974334717,
            "end_logit": -4.058581352233887,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "chizophrenia",
            "probability": 8.249891996352407e-05,
            "start_logit": -4.262566089630127,
            "end_logit": 4.076857089996338,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        }
    ],
    "5e7f5a18835f4e4777000013": [
        {
            "text": "H1N1",
            "probability": 0.47991145562123977,
            "start_logit": 3.243745803833008,
            "end_logit": 3.4537856578826904,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "H1N1 vaccine strain, 17 \u03bcg of haemagglutinin per H3N2",
            "probability": 0.262788773414097,
            "start_logit": 3.243745803833008,
            "end_logit": 2.851534605026245,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "H3N2",
            "probability": 0.2049131132830998,
            "start_logit": 2.994981288909912,
            "end_logit": 2.851534605026245,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "H1N1 vaccine strain",
            "probability": 0.018185993868118255,
            "start_logit": 3.243745803833008,
            "end_logit": 0.1808357685804367,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "H1N1 vaccine strain, 17 \u03bcg of haemagglutinin per H3N2 vaccine strain",
            "probability": 0.008738914078479883,
            "start_logit": 3.243745803833008,
            "end_logit": -0.5520300269126892,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "H3N2 vaccine strain",
            "probability": 0.0068142868786599505,
            "start_logit": 2.994981288909912,
            "end_logit": -0.5520300269126892,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "H1N1 vaccine",
            "probability": 0.004828419887516776,
            "start_logit": 3.243745803833008,
            "end_logit": -1.1452966928482056,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "fluvirin: 18 \u03bcg of haemagglutinin per H1N1",
            "probability": 0.0022800911134788415,
            "start_logit": -2.105640411376953,
            "end_logit": 3.4537856578826904,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "1",
            "probability": 0.0016370300816936027,
            "start_logit": -2.436972141265869,
            "end_logit": 3.4537856578826904,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "H3N2 vaccine strain, and 15 \u03bcg of haemagglutinin per B vaccine strain",
            "probability": 0.0012760004494091497,
            "start_logit": 2.994981288909912,
            "end_logit": -2.227320909500122,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "H3N2 vaccine strain, and 15 \u03bcg of haemagglutinin per B",
            "probability": 0.001153869407015912,
            "start_logit": 2.994981288909912,
            "end_logit": -2.327930450439453,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "H",
            "probability": 0.0010795353175741455,
            "start_logit": 3.243745803833008,
            "end_logit": -2.6432852745056152,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "H1N1 vaccine strain, 17 \u03bcg of haemagglutinin per H3N2 vaccine",
            "probability": 0.0010632140626948346,
            "start_logit": 3.243745803833008,
            "end_logit": -2.6585195064544678,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "18 \u03bcg of haemagglutinin per H1N1",
            "probability": 0.001002280439440556,
            "start_logit": -2.9275779724121094,
            "end_logit": 3.4537856578826904,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "1 vaccine strain, 17 \u03bcg of haemagglutinin per H3N2",
            "probability": 0.0008964010385069072,
            "start_logit": -2.436972141265869,
            "end_logit": 2.851534605026245,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "H3N2 vaccine",
            "probability": 0.0008290555979340183,
            "start_logit": 2.994981288909912,
            "end_logit": -2.6585195064544678,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "vaccine strain, 17 \u03bcg of haemagglutinin per H3N2",
            "probability": 0.0008276652228157779,
            "start_logit": -2.516751289367676,
            "end_logit": 2.851534605026245,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "H1N1 vaccine strain,",
            "probability": 0.0006731385005712162,
            "start_logit": 3.243745803833008,
            "end_logit": -3.1156201362609863,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "haemagglutinin per H1N1",
            "probability": 0.0005930999877040622,
            "start_logit": -3.4522480964660645,
            "end_logit": 3.4537856578826904,
            "question_text": "List the vaccine strains contained in Fluvirin."
        },
        {
            "text": "inactivated influenza vaccine (fluvirin: 18 \u03bcg of haemagglutinin per H1N1",
            "probability": 0.0005076617499489718,
            "start_logit": -3.6077957153320312,
            "end_logit": 3.4537856578826904,
            "question_text": "List the vaccine strains contained in Fluvirin."
        }
    ],
    "5e7f5b43835f4e4777000014": [
        {
            "text": "Victoria and Yamagata",
            "probability": 0.48921149545473147,
            "start_logit": 3.0489025115966797,
            "end_logit": 3.25736927986145,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "Yamagata",
            "probability": 0.38081630173576153,
            "start_logit": 2.79842472076416,
            "end_logit": 3.25736927986145,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "Victoria",
            "probability": 0.11026112295072324,
            "start_logit": 3.0489025115966797,
            "end_logit": 1.767425775527954,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "both B-strain lineage viruses (Victoria and Yamagata",
            "probability": 0.0034602781114002005,
            "start_logit": -1.9025434255599976,
            "end_logit": 3.25736927986145,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "Victoria and Yamagata)",
            "probability": 0.0032777759359805697,
            "start_logit": 3.0489025115966797,
            "end_logit": -1.748260498046875,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "B-strain lineage viruses (Victoria and Yamagata",
            "probability": 0.0025818925330277076,
            "start_logit": -2.1953697204589844,
            "end_logit": 3.25736927986145,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "Yamagata)",
            "probability": 0.0025515150838766377,
            "start_logit": 2.79842472076416,
            "end_logit": -1.748260498046875,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "viruses (Victoria and Yamagata",
            "probability": 0.001249204096026508,
            "start_logit": -2.9213857650756836,
            "end_logit": 3.25736927986145,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "A-strain viruses and both B-strain lineage viruses (Victoria and Yamagata",
            "probability": 0.0012333950166902874,
            "start_logit": -2.93412184715271,
            "end_logit": 3.25736927986145,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "both B-strain lineage viruses (Victoria",
            "probability": 0.0007798961263781231,
            "start_logit": -1.9025434255599976,
            "end_logit": 1.767425775527954,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "two A-strain viruses and both B-strain lineage viruses (Victoria and Yamagata",
            "probability": 0.000748866193324371,
            "start_logit": -3.4330873489379883,
            "end_logit": 3.25736927986145,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "B-strain lineage viruses (Victoria",
            "probability": 0.0005819208515636057,
            "start_logit": -2.1953697204589844,
            "end_logit": 1.767425775527954,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "V",
            "probability": 0.0005688126768153625,
            "start_logit": 3.0489025115966797,
            "end_logit": -3.4996297359466553,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "hemagglutinin per strain of the two A-strain viruses and both B-strain lineage viruses (Victoria and Yamagata",
            "probability": 0.0005679440453128971,
            "start_logit": -3.709624767303467,
            "end_logit": 3.25736927986145,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "strain of the two A-strain viruses and both B-strain lineage viruses (Victoria and Yamagata",
            "probability": 0.0005050869021422366,
            "start_logit": -3.8269171714782715,
            "end_logit": 3.25736927986145,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "viruses and both B-strain lineage viruses (Victoria and Yamagata",
            "probability": 0.00041712234040258044,
            "start_logit": -4.01826810836792,
            "end_logit": 3.25736927986145,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "(Victoria and Yamagata",
            "probability": 0.0003381377756327063,
            "start_logit": -4.228194236755371,
            "end_logit": 3.25736927986145,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "Victoria and Yamagata).",
            "probability": 0.0002896906047563453,
            "start_logit": 3.0489025115966797,
            "end_logit": -4.174367427825928,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "viruses (Victoria",
            "probability": 0.0002815523504706183,
            "start_logit": -2.9213857650756836,
            "end_logit": 1.767425775527954,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        },
        {
            "text": "A-strain viruses and both B-strain lineage viruses (Victoria",
            "probability": 0.0002779892149829526,
            "start_logit": -2.93412184715271,
            "end_logit": 1.767425775527954,
            "question_text": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine."
        }
    ],
    "5e44baaa48dab47f2600001a": [
        {
            "text": "HER2",
            "probability": 0.34405619876728283,
            "start_logit": -0.533617377281189,
            "end_logit": -1.5008628368377686,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "EGFR/HER2",
            "probability": 0.2501807397169888,
            "start_logit": -0.8522387742996216,
            "end_logit": -1.5008628368377686,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "HER2 dual tyrosine kinase",
            "probability": 0.09121523540157929,
            "start_logit": -0.533617377281189,
            "end_logit": -2.8284459114074707,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "epidermal growth factor receptor 2",
            "probability": 0.07848075895556028,
            "start_logit": -1.3269070386886597,
            "end_logit": -2.1855247020721436,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "EGFR/HER2 dual tyrosine kinase",
            "probability": 0.06632723127206859,
            "start_logit": -0.8522387742996216,
            "end_logit": -2.8284459114074707,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "HER2 dual tyrosine kinase inhibitor",
            "probability": 0.04103498706257936,
            "start_logit": -0.533617377281189,
            "end_logit": -3.6272428035736084,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "EGFR/HER2 dual tyrosine kinase inhibitor",
            "probability": 0.029838623615490008,
            "start_logit": -0.8522387742996216,
            "end_logit": -3.6272428035736084,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "HER2 dual tyrosine kinase inhibitor SHR1258",
            "probability": 0.020596613198962964,
            "start_logit": -0.533617377281189,
            "end_logit": -4.3165411949157715,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "tyrosine kinase inhibitor developed for the treatment of human epidermal growth factor receptor 2",
            "probability": 0.015739792295806316,
            "start_logit": -2.9335684776306152,
            "end_logit": -2.1855247020721436,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "EGFR/HER2 dual tyrosine kinase inhibitor SHR1258",
            "probability": 0.014976843737283215,
            "start_logit": -0.8522387742996216,
            "end_logit": -4.3165411949157715,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "HER2 dual",
            "probability": 0.008360523530343236,
            "start_logit": -0.533617377281189,
            "end_logit": -5.218146800994873,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "kinase",
            "probability": 0.006650090809690072,
            "start_logit": -3.147223711013794,
            "end_logit": -2.8334310054779053,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "EGFR/HER2 dual",
            "probability": 0.006079361362291087,
            "start_logit": -0.8522387742996216,
            "end_logit": -5.218146800994873,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "EGFR",
            "probability": 0.005402501407467761,
            "start_logit": -2.026099681854248,
            "end_logit": -4.162323474884033,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "pan-ErbB receptor tyrosine kinase",
            "probability": 0.00493272607753631,
            "start_logit": -3.445962429046631,
            "end_logit": -2.8334310054779053,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "kinase inhibitor developed for the treatment of human epidermal growth factor receptor 2",
            "probability": 0.004553615042471504,
            "start_logit": -4.173839092254639,
            "end_logit": -2.1855247020721436,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "tyrosine kinase",
            "probability": 0.004345971510796573,
            "start_logit": -3.577589988708496,
            "end_logit": -2.8284459114074707,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "dual tyrosine kinase",
            "probability": 0.002878651926067808,
            "start_logit": -3.9895172119140625,
            "end_logit": -2.8284459114074707,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "kinase inhibitor",
            "probability": 0.0023142141265883203,
            "start_logit": -3.147223711013794,
            "end_logit": -3.888991355895996,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "receptor tyrosine kinase",
            "probability": 0.0020353201831454955,
            "start_logit": -4.331201076507568,
            "end_logit": -2.8334310054779053,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        }
    ],
    "5e35c75d158f994d3a000001": [
        {
            "text": "TALEN",
            "probability": 0.35037079154010986,
            "start_logit": 1.8492060899734497,
            "end_logit": 1.2486658096313477,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "TALEN and CRISPR/Cas9",
            "probability": 0.2817884050439665,
            "start_logit": 1.8492060899734497,
            "end_logit": 1.0308302640914917,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "CRISPR/Cas9",
            "probability": 0.10570790275168618,
            "start_logit": 0.868729293346405,
            "end_logit": 1.0308302640914917,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "TALEN and CRISPR/Cas9 systems",
            "probability": 0.057148420463993155,
            "start_logit": 1.8492060899734497,
            "end_logit": -0.564674437046051,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "TALEN and CRISPR/Cas9 systems to induce targeted mutations and homologous recombination-mediated transgenesis",
            "probability": 0.053688686315076825,
            "start_logit": 1.8492060899734497,
            "end_logit": -0.6271238923072815,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "TALEN and CRISPR",
            "probability": 0.030678495849109647,
            "start_logit": 1.8492060899734497,
            "end_logit": -1.1867642402648926,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "TALEN and CRISPR/Cas9 systems to induce targeted mutations",
            "probability": 0.021979963763564512,
            "start_logit": 1.8492060899734497,
            "end_logit": -1.5201948881149292,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "CRISPR/Cas9 systems",
            "probability": 0.021438212377396074,
            "start_logit": 0.868729293346405,
            "end_logit": -0.564674437046051,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "CRISPR/Cas9 systems to induce targeted mutations and homologous recombination-mediated transgenesis",
            "probability": 0.020140354713936593,
            "start_logit": 0.868729293346405,
            "end_logit": -0.6271238923072815,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "CRISPR",
            "probability": 0.011508491469972668,
            "start_logit": 0.868729293346405,
            "end_logit": -1.1867642402648926,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "TALEN and CRISPR/Cas9 systems to induce targeted mutations and homologous recombination",
            "probability": 0.010803053528082229,
            "start_logit": 1.8492060899734497,
            "end_logit": -2.230497360229492,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "CRISPR/Cas9 systems to induce targeted mutations",
            "probability": 0.008245392040321682,
            "start_logit": 0.868729293346405,
            "end_logit": -1.5201948881149292,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "homologous recombination-mediated transgenesis",
            "probability": 0.008027273376289024,
            "start_logit": -0.05115129053592682,
            "end_logit": -0.6271238923072815,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "Cas9",
            "probability": 0.007622689487549679,
            "start_logit": -1.7608211040496826,
            "end_logit": 1.0308302640914917,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "CRISPR/Cas9 systems to induce targeted mutations and homologous recombination",
            "probability": 0.004052573176634429,
            "start_logit": 0.868729293346405,
            "end_logit": -2.230497360229492,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "homologous recombination",
            "probability": 0.001615220448116036,
            "start_logit": -0.05115129053592682,
            "end_logit": -2.230497360229492,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "Cas9 systems",
            "probability": 0.0015459282784647597,
            "start_logit": -1.7608211040496826,
            "end_logit": -0.564674437046051,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "Cas9 systems to induce targeted mutations and homologous recombination-mediated transgenesis",
            "probability": 0.001452338625183794,
            "start_logit": -1.7608211040496826,
            "end_logit": -0.6271238923072815,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "homologous recombination-mediated transgenesis in the sea anemone Nematostella vectensis",
            "probability": 0.0013765781565823643,
            "start_logit": -0.05115129053592682,
            "end_logit": -2.3903679847717285,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "TALE",
            "probability": 0.0008092285939636853,
            "start_logit": 1.8492060899734497,
            "end_logit": -4.822000026702881,
            "question_text": "List targeted genome editing methodologies"
        }
    ],
    "5e3e8b1c48dab47f26000008": [
        {
            "text": "increases its steady-state levels",
            "probability": 0.6026801456420059,
            "start_logit": 3.251788377761841,
            "end_logit": 2.588543653488159,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "increases its steady-state levels ostensibly by occluding access to proteases in a phosphorylation-dependent manner",
            "probability": 0.18849464160925694,
            "start_logit": 3.251788377761841,
            "end_logit": 1.4262266159057617,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "increases",
            "probability": 0.12801173612230526,
            "start_logit": 3.251788377761841,
            "end_logit": 1.0392789840698242,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "destabilizing effect",
            "probability": 0.03067013614659428,
            "start_logit": 1.752758264541626,
            "end_logit": 1.1094765663146973,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "increases its steady-state levels ostensibly by occluding access to proteases",
            "probability": 0.021109754813096026,
            "start_logit": 3.251788377761841,
            "end_logit": -0.7631077170372009,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "destabilizing",
            "probability": 0.012865263756339947,
            "start_logit": 1.752758264541626,
            "end_logit": 0.24071809649467468,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "levels",
            "probability": 0.0030819302656507714,
            "start_logit": -2.0240421295166016,
            "end_logit": 2.588543653488159,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "increases its steady-state levels ostensibly by occluding access to proteases in a phosphorylation-dependent",
            "probability": 0.002496480806690365,
            "start_logit": 3.251788377761841,
            "end_logit": -2.897960901260376,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "recruitment of dimers on accumulating wild-type Tau increases its steady-state levels",
            "probability": 0.002332568916539233,
            "start_logit": -2.3026280403137207,
            "end_logit": 2.588543653488159,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "increases its steady-state levels ostensibly",
            "probability": 0.0015602826860649747,
            "start_logit": 3.251788377761841,
            "end_logit": -3.367975950241089,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "steady-state levels",
            "probability": 0.001075258805840881,
            "start_logit": -3.0770368576049805,
            "end_logit": 2.588543653488159,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "elevation itself is not pathogenic, but recruitment of dimers on accumulating wild-type Tau increases its steady-state levels",
            "probability": 0.0010319255757463145,
            "start_logit": -3.1181716918945312,
            "end_logit": 2.588543653488159,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "levels ostensibly by occluding access to proteases in a phosphorylation-dependent manner",
            "probability": 0.0009639065515750989,
            "start_logit": -2.0240421295166016,
            "end_logit": 1.4262266159057617,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "occluding access to proteases in a phosphorylation-dependent manner",
            "probability": 0.0008985381032170483,
            "start_logit": -2.0942673683166504,
            "end_logit": 1.4262266159057617,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "toxicity",
            "probability": 0.0005148451305536267,
            "start_logit": -0.9219012260437012,
            "end_logit": -0.3030425012111664,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "recruitment of dimers on accumulating wild-type Tau increases",
            "probability": 0.0004954472099176783,
            "start_logit": -2.3026280403137207,
            "end_logit": 1.0392789840698242,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "phosphorylation-dependent manner",
            "probability": 0.00045184037101054565,
            "start_logit": -2.781707525253296,
            "end_logit": 1.4262266159057617,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "regulate",
            "probability": 0.0004297362047416204,
            "start_logit": -0.0702042430639267,
            "end_logit": -1.335434079170227,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "stabilizes the mutant protein, elevated D14-3-3\u025b has a destabilizing effect",
            "probability": 0.0004236158181288809,
            "start_logit": -2.5294594764709473,
            "end_logit": 1.1094765663146973,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "elevated D14-3-3\u025b has a destabilizing effect",
            "probability": 0.000411945464724935,
            "start_logit": -2.5573954582214355,
            "end_logit": 1.1094765663146973,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        }
    ],
    "5e4b52e36d0a27794100001b": [
        {
            "text": "trifluridine/tipiracil",
            "probability": 0.21385054155271907,
            "start_logit": 5.519711494445801,
            "end_logit": 5.498216152191162,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "trifluridine",
            "probability": 0.207171055658771,
            "start_logit": 5.519711494445801,
            "end_logit": 5.4664835929870605,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "Trifluridine/tipiracil",
            "probability": 0.18244280210670005,
            "start_logit": 5.377302646636963,
            "end_logit": 5.481784343719482,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "tipiracil",
            "probability": 0.1781432812176574,
            "start_logit": 5.353454113006592,
            "end_logit": 5.481784343719482,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "Trifluridine",
            "probability": 0.17656270645932592,
            "start_logit": 5.377302646636963,
            "end_logit": 5.449023723602295,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "trifluridine and tipiracil",
            "probability": 0.025583478548752054,
            "start_logit": 4.370460033416748,
            "end_logit": 4.524137020111084,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "TAS-102",
            "probability": 0.006102870835352453,
            "start_logit": 2.998593807220459,
            "end_logit": 4.462815761566162,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "trifluridine/tipiracil (TAS-102",
            "probability": 0.003559447569405764,
            "start_logit": 5.519711494445801,
            "end_logit": 1.4025441408157349,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "tipiracil (TAS-102",
            "probability": 0.0025396350340077998,
            "start_logit": 5.182126522064209,
            "end_logit": 1.4025441408157349,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "trifluridine, FTD) with a thymidine phosphorylase inhibitor (tipiracil",
            "probability": 0.002001968555532929,
            "start_logit": 3.626633882522583,
            "end_logit": 2.7201473712921143,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "trifluridine/tipiracil (TAS-102, Lonsurf\u00ae),",
            "probability": 0.00037501015954195924,
            "start_logit": 5.519711494445801,
            "end_logit": -0.8478633761405945,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "Trifluridine/tipiracil (TAS-102",
            "probability": 0.000293995746450574,
            "start_logit": 5.1855034828186035,
            "end_logit": -0.757043182849884,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "tipiracil (TAS-102, Lonsurf\u00ae),",
            "probability": 0.0002675665031471756,
            "start_logit": 5.182126522064209,
            "end_logit": -0.8478633761405945,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "Trifluridine/tipiracil (TAS-102, Lonsurf\u00ae),",
            "probability": 0.00026608049243344247,
            "start_logit": 5.1855034828186035,
            "end_logit": -0.8568096160888672,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "Trifluridine/tipiracil (FTD/TPI; TAS-102, Lonsurf\u00ae),",
            "probability": 0.00022416242506273992,
            "start_logit": 5.377302646636963,
            "end_logit": -1.2200367450714111,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "tipiracil (FTD/TPI; TAS-102, Lonsurf\u00ae),",
            "probability": 0.00021887972265975867,
            "start_logit": 5.353454113006592,
            "end_logit": -1.2200367450714111,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "triflurid",
            "probability": 0.00018586617879657734,
            "start_logit": 5.519711494445801,
            "end_logit": -1.549789547920227,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "trifluridine/tipiraci",
            "probability": 9.68799631677368e-05,
            "start_logit": 5.519711494445801,
            "end_logit": -2.2013437747955322,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "tipiraci",
            "probability": 6.912301523105312e-05,
            "start_logit": 5.182126522064209,
            "end_logit": -2.2013437747955322,
            "question_text": "Which drugs are included in the drug LONSURF?"
        },
        {
            "text": "102",
            "probability": 4.464825528482198e-05,
            "start_logit": -1.9191055297851562,
            "end_logit": 4.462815761566162,
            "question_text": "Which drugs are included in the drug LONSURF?"
        }
    ],
    "5d38673da1e1595105000002": [
        {
            "text": "miR-146a",
            "probability": 0.6259332869726172,
            "start_logit": 4.051486492156982,
            "end_logit": 3.7796714305877686,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "miR-143-3p.The NF-\u03baB family member RelB regulates microRNA miR-146a",
            "probability": 0.12587696694732722,
            "start_logit": 2.447547674179077,
            "end_logit": 3.7796714305877686,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "146a",
            "probability": 0.05361024129035339,
            "start_logit": 1.5939828157424927,
            "end_logit": 3.7796714305877686,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "microRNA miR-146a",
            "probability": 0.04277980753600892,
            "start_logit": 1.3683089017868042,
            "end_logit": 3.7796714305877686,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "miR-143-5p alone directly targets COX-2, and it exhibits a stronger tumor suppressive effect than miR-143",
            "probability": 0.03747580832825293,
            "start_logit": 2.6801557540893555,
            "end_logit": 2.335453987121582,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "miR-143",
            "probability": 0.029698232541353523,
            "start_logit": 2.447547674179077,
            "end_logit": 2.335453987121582,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "143-3p.The NF-\u03baB family member RelB regulates microRNA miR-146a",
            "probability": 0.022021115695267136,
            "start_logit": 0.7042444944381714,
            "end_logit": 3.7796714305877686,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "miR-143-3p",
            "probability": 0.018110968608609813,
            "start_logit": 2.447547674179077,
            "end_logit": 1.8408842086791992,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "miR-143-5p",
            "probability": 0.01195733835633969,
            "start_logit": 2.6801557540893555,
            "end_logit": 1.193103551864624,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "143",
            "probability": 0.005195455773984072,
            "start_logit": 0.7042444944381714,
            "end_logit": 2.335453987121582,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "microRNA-16 targeting of COX-2.. We identified miR-16",
            "probability": 0.004411901610048697,
            "start_logit": 0.8615898489952087,
            "end_logit": 2.014630079269409,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "143-5p alone directly targets COX-2, and it exhibits a stronger tumor suppressive effect than miR-143",
            "probability": 0.0042457574213976106,
            "start_logit": 0.50238037109375,
            "end_logit": 2.335453987121582,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "miR-26b",
            "probability": 0.003255029741685965,
            "start_logit": 1.3327564001083374,
            "end_logit": 1.2393591403961182,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "143-3p",
            "probability": 0.00316836149420755,
            "start_logit": 0.7042444944381714,
            "end_logit": 1.8408842086791992,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "miR-16",
            "probability": 0.0029001451166838104,
            "start_logit": 0.44204482436180115,
            "end_logit": 2.014630079269409,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "miR-146",
            "probability": 0.0026057157738425844,
            "start_logit": 4.051486492156982,
            "end_logit": -1.7018649578094482,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "143-5p alone directly targets COX-2, and it exhibits a stronger tumor suppressive effect than miR-143-3p",
            "probability": 0.0025892038952699146,
            "start_logit": 0.50238037109375,
            "end_logit": 1.8408842086791992,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "microRNA-16",
            "probability": 0.001735685215633258,
            "start_logit": 0.8615898489952087,
            "end_logit": 1.0817265510559082,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "143-5p",
            "probability": 0.0013546861383725696,
            "start_logit": 0.50238037109375,
            "end_logit": 1.193103551864624,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        },
        {
            "text": "miR-26a and miR-26b",
            "probability": 0.001074291542743833,
            "start_logit": 0.22421640157699585,
            "end_logit": 1.2393591403961182,
            "question_text": "Which micro-RNAs (miR) are associated with the human cycloxygenase-2 (COX-2) gene promoter?"
        }
    ],
    "5e5e50751af46fc13000000b": [
        {
            "text": "mupirocin",
            "probability": 0.11599366519879982,
            "start_logit": 4.616397857666016,
            "end_logit": 4.494687557220459,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "clarithromycin",
            "probability": 0.11566012802777162,
            "start_logit": 4.326226711273193,
            "end_logit": 4.781979084014893,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "azithromycin, clarithromycin",
            "probability": 0.08729060864092045,
            "start_logit": 4.044813632965088,
            "end_logit": 4.781979084014893,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "clarithromycin, erythromycin, fusidic acid, mupirocin",
            "probability": 0.0867789805576745,
            "start_logit": 4.326226711273193,
            "end_logit": 4.494687557220459,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "azithromycin",
            "probability": 0.06712049216331518,
            "start_logit": 4.044813632965088,
            "end_logit": 4.519225597381592,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "azithromycin, clarithromycin, erythromycin, fusidic acid, mupirocin",
            "probability": 0.06549352970021914,
            "start_logit": 4.044813632965088,
            "end_logit": 4.494687557220459,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "mupirocin, retapamulin, rifampin",
            "probability": 0.06344962052769695,
            "start_logit": 4.616397857666016,
            "end_logit": 3.8913981914520264,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "fusidic acid, mupirocin",
            "probability": 0.05810777989398555,
            "start_logit": 3.925161838531494,
            "end_logit": 4.494687557220459,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "clarithromycin, erythromycin",
            "probability": 0.04640842852731692,
            "start_logit": 4.326226711273193,
            "end_logit": 3.8688042163848877,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "erythromycin, fusidic acid, mupirocin",
            "probability": 0.039379373432643264,
            "start_logit": 3.536104440689087,
            "end_logit": 4.494687557220459,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "mupirocin, retapamulin, rifampin, and telithromycin",
            "probability": 0.0377408962992762,
            "start_logit": 4.616397857666016,
            "end_logit": 3.371896266937256,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "azithromycin, clarithromycin, erythromycin",
            "probability": 0.03502520740116632,
            "start_logit": 4.044813632965088,
            "end_logit": 3.8688042163848877,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "rifampin",
            "probability": 0.033695710101637695,
            "start_logit": 3.9835221767425537,
            "end_logit": 3.8913981914520264,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "fusidic acid, mupirocin, retapamulin, rifampin",
            "probability": 0.03178549947241835,
            "start_logit": 3.925161838531494,
            "end_logit": 3.8913981914520264,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "erythromycin, fusidic acid, mupirocin, retapamulin, rifampin",
            "probability": 0.02154088584611377,
            "start_logit": 3.536104440689087,
            "end_logit": 3.8913981914520264,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "erythromycin",
            "probability": 0.021059648611390903,
            "start_logit": 3.536104440689087,
            "end_logit": 3.8688042163848877,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "rifampin, and telithromycin",
            "probability": 0.020042772361755227,
            "start_logit": 3.9835221767425537,
            "end_logit": 3.371896266937256,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "clarithromycin, erythromycin, fusidic acid",
            "probability": 0.019672822277892226,
            "start_logit": 4.326226711273193,
            "end_logit": 3.010561227798462,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "fusidic acid, mupirocin, retapamulin, rifampin, and telithromycin",
            "probability": 0.018906547106701532,
            "start_logit": 3.925161838531494,
            "end_logit": 3.371896266937256,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        },
        {
            "text": "azithromycin, clarithromycin, erythromycin, fusidic acid",
            "probability": 0.014847403851304185,
            "start_logit": 4.044813632965088,
            "end_logit": 3.010561227798462,
            "question_text": "What classes of drugs does Retapamulin belong to?"
        }
    ],
    "5e47546d3f54159529000019": [
        {
            "text": "Crohn's Disease",
            "probability": 0.525800463334815,
            "start_logit": 5.293727397918701,
            "end_logit": 4.7322001457214355,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "Crohn's",
            "probability": 0.33489407624451023,
            "start_logit": 5.293727397918701,
            "end_logit": 4.281092643737793,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "ulcerative colitis",
            "probability": 0.06793054064995896,
            "start_logit": 4.140908241271973,
            "end_logit": 3.83858323097229,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "Ulcerative Colitis",
            "probability": 0.04972788262997534,
            "start_logit": 3.732780694961548,
            "end_logit": 3.934790849685669,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "Ulcerative Colitis Endoscopic Index of Severity, Ulcerative Colitis",
            "probability": 0.01918663125165429,
            "start_logit": 3.732780694961548,
            "end_logit": 2.982438802719116,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "Crohn's Disease Activity Index (CDAI) <220 or Rachmilewitz Index (RI) <11",
            "probability": 0.0005639198289082883,
            "start_logit": 5.293727397918701,
            "end_logit": -2.105564832687378,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "Disease",
            "probability": 0.0003302348290660393,
            "start_logit": -2.079145669937134,
            "end_logit": 4.7322001457214355,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "C",
            "probability": 0.00025424367451506704,
            "start_logit": 5.293727397918701,
            "end_logit": -2.902183771133423,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "Crohn's Disease Activity Index (CDAI) <220",
            "probability": 0.00020270614292576276,
            "start_logit": 5.293727397918701,
            "end_logit": -3.1287195682525635,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "Rachmilewitz Endoscopic Index\u2009\u2265\u20097 points). METHODS: Thirty patients with mild to moderate IBD (Crohn's",
            "probability": 0.00020020740823034782,
            "start_logit": -2.128488302230835,
            "end_logit": 4.281092643737793,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "Crohn",
            "probability": 0.0001909084309094738,
            "start_logit": 5.293727397918701,
            "end_logit": -3.188683032989502,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "colitis",
            "probability": 0.0001740852455763228,
            "start_logit": -1.8257876634597778,
            "end_logit": 3.83858323097229,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "Colitis Disease Activity Index, and Schroeder Index - and all nine endoscopic indices - Ulcerative Colitis",
            "probability": 0.00011500157189462894,
            "start_logit": -2.836090326309204,
            "end_logit": 4.434286594390869,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "Colitis",
            "probability": 0.00010882145412976214,
            "start_logit": -2.391831874847412,
            "end_logit": 3.934790849685669,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "Crohn's Disease Activity Index",
            "probability": 7.933566509441052e-05,
            "start_logit": 5.293727397918701,
            "end_logit": -4.066789150238037,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "hn's Disease",
            "probability": 6.977059090958567e-05,
            "start_logit": -3.633737087249756,
            "end_logit": 4.7322001457214355,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "mild to moderate IBD (Crohn's Disease",
            "probability": 5.177139082562674e-05,
            "start_logit": -3.932111978530884,
            "end_logit": 4.7322001457214355,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "hn's",
            "probability": 4.443844998443954e-05,
            "start_logit": -3.633737087249756,
            "end_logit": 4.281092643737793,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "Colitis Endoscopic Index of Severity, Ulcerative Colitis",
            "probability": 4.198684927312767e-05,
            "start_logit": -2.391831874847412,
            "end_logit": 2.982438802719116,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "mild to moderate IBD (Crohn's",
            "probability": 3.297435684342763e-05,
            "start_logit": -3.932111978530884,
            "end_logit": 4.281092643737793,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        }
    ],
    "5e80669e835f4e4777000025": [
        {
            "text": "captoprilenalapril",
            "probability": 0.41903129748112955,
            "start_logit": 5.259659290313721,
            "end_logit": 5.468983173370361,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "captoprilenalapril, lisinopril",
            "probability": 0.23405436023219622,
            "start_logit": 5.259659290313721,
            "end_logit": 4.886590957641602,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "captoprilenalapril, lisinopril, or ramipril",
            "probability": 0.1352454135388132,
            "start_logit": 5.259659290313721,
            "end_logit": 4.338128566741943,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "lisinopril",
            "probability": 0.10532441249150963,
            "start_logit": 4.461151123046875,
            "end_logit": 4.886590957641602,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "lisinopril, or ramipril",
            "probability": 0.06086040742422063,
            "start_logit": 4.461151123046875,
            "end_logit": 4.338128566741943,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "ramipril",
            "probability": 0.04057493918712725,
            "start_logit": 4.055718898773193,
            "end_logit": 4.338128566741943,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "captoprilenalapril,",
            "probability": 0.0009745939265180365,
            "start_logit": 5.259659290313721,
            "end_logit": -0.5946968197822571,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "captopril",
            "probability": 0.0008320670461117873,
            "start_logit": 5.259659290313721,
            "end_logit": -0.752804696559906,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "rilenalapril",
            "probability": 0.000396472632080102,
            "start_logit": -1.7034345865249634,
            "end_logit": 5.468983173370361,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "ril",
            "probability": 0.0003746116827463791,
            "start_logit": -1.7601516246795654,
            "end_logit": 5.468983173370361,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "angiotensin-converting enzyme inhibitor captoprilenalapril",
            "probability": 0.00035123535341404676,
            "start_logit": -1.8245850801467896,
            "end_logit": 5.468983173370361,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "lapril",
            "probability": 0.00032969730805441325,
            "start_logit": -1.8878666162490845,
            "end_logit": 5.468983173370361,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "captoprilenalapril, lisinopril,",
            "probability": 0.0002516794586660889,
            "start_logit": 5.259659290313721,
            "end_logit": -1.948561429977417,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "rilenalapril, lisinopril",
            "probability": 0.00022145397923471841,
            "start_logit": -1.7034345865249634,
            "end_logit": 4.886590957641602,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "captop",
            "probability": 0.0002099659830508065,
            "start_logit": 5.259659290313721,
            "end_logit": -2.129772186279297,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "ril, lisinopril",
            "probability": 0.0002092433149212649,
            "start_logit": -1.7601516246795654,
            "end_logit": 4.886590957641602,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "angiotensin-converting enzyme inhibitor captoprilenalapril, lisinopril",
            "probability": 0.00019618621909251583,
            "start_logit": -1.8245850801467896,
            "end_logit": 4.886590957641602,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "cap",
            "probability": 0.0001892068787967717,
            "start_logit": 5.259659290313721,
            "end_logit": -2.2338767051696777,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "enalapril",
            "probability": 0.00018859994610988587,
            "start_logit": -2.446413516998291,
            "end_logit": 5.468983173370361,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "lapril, lisinopril",
            "probability": 0.00018415591620677958,
            "start_logit": -1.8878666162490845,
            "end_logit": 4.886590957641602,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        }
    ],
    "5e4609b83f54159529000005": [
        {
            "text": "proliferative vitreoretinopathy",
            "probability": 0.49880026876214645,
            "start_logit": 1.9995808601379395,
            "end_logit": 1.0026112794876099,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "vitreoretinopathy",
            "probability": 0.2173984257874037,
            "start_logit": 1.1691068410873413,
            "end_logit": 1.0026112794876099,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "Retinopathy",
            "probability": 0.059485325893510216,
            "start_logit": 0.03307415544986725,
            "end_logit": 0.8426418900489807,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "proliferative vitreoretinopathy of the left eye",
            "probability": 0.047929876698012776,
            "start_logit": 1.9995808601379395,
            "end_logit": -1.339855432510376,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "aplastic anemia, and Coats' plus syndrome. Retinopathy",
            "probability": 0.027474219242988786,
            "start_logit": -0.7394074201583862,
            "end_logit": 0.8426418900489807,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "severe proliferative vitreoretinopathy",
            "probability": 0.024907306379632718,
            "start_logit": -0.9974637031555176,
            "end_logit": 1.0026112794876099,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "cotton wool spots",
            "probability": 0.022019911087917808,
            "start_logit": -0.37612199783325195,
            "end_logit": 0.2580554783344269,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "vitreoretinopathy of the left eye",
            "probability": 0.020889883977390302,
            "start_logit": 1.1691068410873413,
            "end_logit": -1.339855432510376,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "retinal hemorrhages, vessel sclerosis, and cotton wool spots",
            "probability": 0.017557856925846143,
            "start_logit": -0.6025675535202026,
            "end_logit": 0.2580554783344269,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "pulmonary fibrosis, aplastic anemia, and Coats' plus syndrome. Retinopathy",
            "probability": 0.008618218353473315,
            "start_logit": -1.8987771272659302,
            "end_logit": 0.8426418900489807,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "idiopathic pulmonary fibrosis, aplastic anemia, and Coats' plus syndrome. Retinopathy",
            "probability": 0.008424541877228815,
            "start_logit": -1.921506404876709,
            "end_logit": 0.8426418900489807,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "retinal hemorrhages, vessel sclerosis",
            "probability": 0.008271390062791954,
            "start_logit": -0.6025675535202026,
            "end_logit": -0.4946434795856476,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "Coats' plus syndrome. Retinopathy",
            "probability": 0.0080982821674998,
            "start_logit": -1.9610035419464111,
            "end_logit": 0.8426418900489807,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "retinal hemorrhages",
            "probability": 0.005230117020334232,
            "start_logit": -0.6025675535202026,
            "end_logit": -0.9530124068260193,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "vessel sclerosis, and cotton wool spots",
            "probability": 0.005140792061962237,
            "start_logit": -1.8308619260787964,
            "end_logit": 0.2580554783344269,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "dyskeratosis congenita, as well as a subset of idiopathic pulmonary fibrosis, aplastic anemia",
            "probability": 0.005100869861847284,
            "start_logit": -0.5436064004898071,
            "end_logit": -1.0369961261749268,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "dyskeratosis congenita, as well as a subset of idiopathic pulmonary fibrosis",
            "probability": 0.004880198378745291,
            "start_logit": -0.5436064004898071,
            "end_logit": -1.081221342086792,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "aplastic anemia",
            "probability": 0.004193811836991289,
            "start_logit": -0.7394074201583862,
            "end_logit": -1.0369961261749268,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "cotton wool spots in the right eye associated with peripheral retinal nonperfusion",
            "probability": 0.002925590110419872,
            "start_logit": -0.37612199783325195,
            "end_logit": -1.7603954076766968,
            "question_text": "List characteristic features of the Revesz syndrome."
        },
        {
            "text": "dyskeratosis congenita",
            "probability": 0.0026531135138572154,
            "start_logit": -0.5436064004898071,
            "end_logit": -1.6906733512878418,
            "question_text": "List characteristic features of the Revesz syndrome."
        }
    ],
    "5d387360a1e1595105000007": [
        {
            "text": "reduced activation of the AKT/mTOR pathway, which is known to enhance Th17 differentiation",
            "probability": 0.274698793888141,
            "start_logit": 5.0919413566589355,
            "end_logit": 4.8665385246276855,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "reduced Il17 transcription",
            "probability": 0.27322523162200557,
            "start_logit": 5.121741771697998,
            "end_logit": 4.831359386444092,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "enhance Th17 differentiation",
            "probability": 0.09056078228312317,
            "start_logit": 3.9822874069213867,
            "end_logit": 4.8665385246276855,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "reduced Il17 transcription through decreased activation of the cAMP response element modulator \u03b1 (CREM-\u03b1) and reduced activation of the AKT",
            "probability": 0.06838391950676427,
            "start_logit": 5.121741771697998,
            "end_logit": 3.4462006092071533,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "reduced activation of the AKT",
            "probability": 0.06637611560438983,
            "start_logit": 5.0919413566589355,
            "end_logit": 3.4462006092071533,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "reduced activation of the AKT/mTOR pathway",
            "probability": 0.061370281780195775,
            "start_logit": 5.0919413566589355,
            "end_logit": 3.3677890300750732,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "reduced Il17 transcription through decreased activation of the cAMP response element modulator \u03b1 (CREM-\u03b1)",
            "probability": 0.03235375536719724,
            "start_logit": 5.121741771697998,
            "end_logit": 2.6977930068969727,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "decreased activation of the cAMP response element modulator \u03b1 (CREM-\u03b1) and reduced activation of the AKT",
            "probability": 0.024657861126934924,
            "start_logit": 4.1016998291015625,
            "end_logit": 3.4462006092071533,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "decreased activation of the cAMP response element modulator \u03b1 (CREM-\u03b1) and reduced activation of the AKT/mTOR pathway",
            "probability": 0.022798259158100714,
            "start_logit": 4.1016998291015625,
            "end_logit": 3.3677890300750732,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "reduced",
            "probability": 0.01709138270264477,
            "start_logit": 5.121741771697998,
            "end_logit": 2.0596373081207275,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "decreased activation of the cAMP response element modulator \u03b1 (CREM-\u03b1)",
            "probability": 0.011666111163754841,
            "start_logit": 4.1016998291015625,
            "end_logit": 2.6977930068969727,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "differentiation",
            "probability": 0.00911586010582052,
            "start_logit": 1.6862819194793701,
            "end_logit": 4.8665385246276855,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "inhibited crocin-mediated HO-1 expression",
            "probability": 0.008659992089178616,
            "start_logit": 2.5953407287597656,
            "end_logit": 3.9061777591705322,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "phosphorylation of Akt",
            "probability": 0.00736028744272665,
            "start_logit": 2.9972176551818848,
            "end_logit": 3.3416860103607178,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "inhibited crocin-mediated HO-1 expression, Nrf2 activation",
            "probability": 0.006897957072557086,
            "start_logit": 2.5953407287597656,
            "end_logit": 3.6786892414093018,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "reduced Il17 transcription through decreased activation of the cAMP response element modulator \u03b1 (CREM-\u03b1) and reduced",
            "probability": 0.005200937041080155,
            "start_logit": 5.121741771697998,
            "end_logit": 0.869901716709137,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "reduced activation of the AKT/mTOR pathway,",
            "probability": 0.005163232058658301,
            "start_logit": 5.0919413566589355,
            "end_logit": 0.892426073551178,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "AKT/mTOR pathway, which is known to enhance Th17 differentiation",
            "probability": 0.005106589575556751,
            "start_logit": 1.1067979335784912,
            "end_logit": 4.8665385246276855,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "inhibited crocin-mediated HO-1 expression, Nrf2 activation, and phosphorylation of Akt",
            "probability": 0.004924496620054457,
            "start_logit": 2.5953407287597656,
            "end_logit": 3.3416860103607178,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "reduced Il17 transcription through decreased activation",
            "probability": 0.004388153791115082,
            "start_logit": 5.121741771697998,
            "end_logit": 0.6999714970588684,
            "question_text": "What are the effects of CAMK4 inhibition?"
        }
    ],
    "5e4949d36d0a277941000006": [
        {
            "text": "Cornelia de Lange Syndrome (CdLS), and Warsaw Breakage Syndrome",
            "probability": 0.14281942719265295,
            "start_logit": 3.315640926361084,
            "end_logit": 3.4095566272735596,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Cornelia de Lange Syndrome",
            "probability": 0.13815184458222277,
            "start_logit": 3.315640926361084,
            "end_logit": 3.376328945159912,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Roberts syndrome (RBS), Cornelia de Lange Syndrome (CdLS), and Warsaw Breakage Syndrome",
            "probability": 0.12652339780339983,
            "start_logit": 3.1944870948791504,
            "end_logit": 3.4095566272735596,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Warsaw Breakage Syndrome",
            "probability": 0.12554979991994972,
            "start_logit": 3.1867623329162598,
            "end_logit": 3.4095566272735596,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Roberts syndrome (RBS), Cornelia de Lange Syndrome",
            "probability": 0.12238839724354553,
            "start_logit": 3.1944870948791504,
            "end_logit": 3.376328945159912,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Roberts syndrome",
            "probability": 0.09338018055933606,
            "start_logit": 3.1944870948791504,
            "end_logit": 3.1058084964752197,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Cornelia de Lange Syndrome (CdLS), and Warsaw Breakage Syndrome (WABS)",
            "probability": 0.06982013398739328,
            "start_logit": 3.315640926361084,
            "end_logit": 2.6938979625701904,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Warsaw Breakage Syndrome (WABS)",
            "probability": 0.061377531228134295,
            "start_logit": 3.1867623329162598,
            "end_logit": 2.6938979625701904,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Cornelia de Lange Syndrome (CdLS)",
            "probability": 0.03337637640470919,
            "start_logit": 3.315640926361084,
            "end_logit": 1.9558238983154297,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Roberts syndrome (RBS), Cornelia de Lange Syndrome (CdLS)",
            "probability": 0.029568054095278337,
            "start_logit": 3.1944870948791504,
            "end_logit": 1.9558238983154297,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "CdLS), and Warsaw Breakage Syndrome",
            "probability": 0.012798061715075774,
            "start_logit": 0.9033535718917847,
            "end_logit": 3.4095566272735596,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Roberts syndrome (RBS)",
            "probability": 0.012313913035259343,
            "start_logit": 3.1944870948791504,
            "end_logit": 1.0798591375350952,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Cornelia de Lange Syndrome (CdLS",
            "probability": 0.00856135315205956,
            "start_logit": 3.315640926361084,
            "end_logit": 0.5952337980270386,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Roberts syndrome (RBS), Cornelia de Lange Syndrome (CdLS",
            "probability": 0.007584482810817115,
            "start_logit": 3.1944870948791504,
            "end_logit": 0.5952337980270386,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "CdLS), and Warsaw Breakage Syndrome (WABS)",
            "probability": 0.006256588485823911,
            "start_logit": 0.9033535718917847,
            "end_logit": 2.6938979625701904,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "CdLS)",
            "probability": 0.0029908600913016482,
            "start_logit": 0.9033535718917847,
            "end_logit": 1.9558238983154297,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Cornelia de Lange Syndrome (CdLS), and Warsaw Breakage Syndrome (WABS",
            "probability": 0.001882940830537913,
            "start_logit": 3.315640926361084,
            "end_logit": -0.9191896319389343,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Roberts syndrome (RBS), Cornelia de Lange Syndrome (CdLS), and Warsaw Breakage Syndrome (WABS",
            "probability": 0.0016680928948206004,
            "start_logit": 3.1944870948791504,
            "end_logit": -0.9191896319389343,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "Warsaw Breakage Syndrome (WABS",
            "probability": 0.0016552569155472722,
            "start_logit": 3.1867623329162598,
            "end_logit": -0.9191896319389343,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "(RBS), Cornelia de Lange Syndrome (CdLS), and Warsaw Breakage Syndrome",
            "probability": 0.0013333070521348454,
            "start_logit": -1.3582777976989746,
            "end_logit": 3.4095566272735596,
            "question_text": "List cohesinopathies"
        }
    ],
    "5e3c841148dab47f26000002": [
        {
            "text": "multiple sclerosis",
            "probability": 0.3757151180681632,
            "start_logit": 4.456248760223389,
            "end_logit": 3.9815056324005127,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer disease",
            "probability": 0.25883118096437163,
            "start_logit": 4.223640441894531,
            "end_logit": 3.841458797454834,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer disease (AD) patientsThe hypothetical roles of arsenic in multiple sclerosis",
            "probability": 0.22133072049521477,
            "start_logit": 4.223640441894531,
            "end_logit": 3.684940814971924,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer's disease",
            "probability": 0.10745943050020552,
            "start_logit": 3.7679526805877686,
            "end_logit": 3.418083906173706,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer",
            "probability": 0.018651570518519987,
            "start_logit": 4.223640441894531,
            "end_logit": 1.2112131118774414,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "multiple sclerosis (MS)",
            "probability": 0.010078131555312451,
            "start_logit": 4.456248760223389,
            "end_logit": 0.36304232478141785,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer's",
            "probability": 0.00393040517983206,
            "start_logit": 3.7679526805877686,
            "end_logit": 0.10971304029226303,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "neurofibrillary tangles (NFTs) in the brain of Alzheimer disease",
            "probability": 0.0016148961778891838,
            "start_logit": -0.8532649278640747,
            "end_logit": 3.841458797454834,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer's disease (AD) is the most common cause of progressive dementia",
            "probability": 0.0007095813071229829,
            "start_logit": 3.7679526805877686,
            "end_logit": -1.602109670639038,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "multiple",
            "probability": 0.00031004825543903277,
            "start_logit": 4.335315227508545,
            "end_logit": -2.9974193572998047,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer disease (AD) patientsThe hypothetical roles of arsenic in multiple",
            "probability": 0.00027728702539101766,
            "start_logit": 4.223640441894531,
            "end_logit": -2.9974193572998047,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "amyloid P protein are all found in lesions of multiple sclerosis",
            "probability": 0.0002476565125201373,
            "start_logit": -2.8682949542999268,
            "end_logit": 3.9815056324005127,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "rosis",
            "probability": 0.00022467501162447008,
            "start_logit": -2.9656827449798584,
            "end_logit": 3.9815056324005127,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer disease (AD)",
            "probability": 0.0001395915555598089,
            "start_logit": 4.223640441894531,
            "end_logit": -3.6837518215179443,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "neurofibrillary tangles (NFTs) in the brain of Alzheimer",
            "probability": 0.0001163706390774248,
            "start_logit": -0.8532649278640747,
            "end_logit": 1.2112131118774414,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "disease",
            "probability": 8.313190054410852e-05,
            "start_logit": -3.8198623657226562,
            "end_logit": 3.841458797454834,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer disease (AD) patients",
            "probability": 8.2436127209996e-05,
            "start_logit": 4.223640441894531,
            "end_logit": -4.210448741912842,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Al",
            "probability": 8.168375566005953e-05,
            "start_logit": 4.223640441894531,
            "end_logit": -4.2196173667907715,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "disease (AD) patientsThe hypothetical roles of arsenic in multiple sclerosis",
            "probability": 7.1087429941823e-05,
            "start_logit": -3.8198623657226562,
            "end_logit": 3.684940814971924,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "amyloid-forming proteins tau, \u03b1B crystallin, and amyloid P protein are all found in lesions of multiple sclerosis",
            "probability": 4.4997020400626104e-05,
            "start_logit": -4.573741436004639,
            "end_logit": 3.9815056324005127,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        }
    ],
    "5e4703d13f54159529000016": [
        {
            "text": "resveratrol",
            "probability": 0.5892060034212562,
            "start_logit": 5.4627814292907715,
            "end_logit": 5.292647361755371,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "resveratrol and 3,3'-diindolylmethane",
            "probability": 0.27370145599719287,
            "start_logit": 5.4627814292907715,
            "end_logit": 4.525909423828125,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "3,3'-diindolylmethane",
            "probability": 0.08942539170977283,
            "start_logit": 4.3441481590271,
            "end_logit": 4.525909423828125,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "diindolylmethane",
            "probability": 0.01704708569016386,
            "start_logit": 2.686722755432129,
            "end_logit": 4.525909423828125,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "resveratrol and 3,3'-diindolylmethane,",
            "probability": 0.0071061957396379,
            "start_logit": 5.4627814292907715,
            "end_logit": 0.8748385310173035,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "A combination of resveratrol",
            "probability": 0.006620607829538539,
            "start_logit": 0.97419273853302,
            "end_logit": 5.292647361755371,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "A combination of resveratrol and 3,3'-diindolylmethane",
            "probability": 0.0030754438889102134,
            "start_logit": 0.97419273853302,
            "end_logit": 4.525909423828125,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "resveratrol and 3,3'-diindolylmethane, a potent radioprotector",
            "probability": 0.0025088665840690477,
            "start_logit": 5.4627814292907715,
            "end_logit": -0.16629742085933685,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "3,3'-diindolylmethane,",
            "probability": 0.002321779163607941,
            "start_logit": 4.3441481590271,
            "end_logit": 0.8748385310173035,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "Amifostine",
            "probability": 0.0019261176777288444,
            "start_logit": 2.3389906883239746,
            "end_logit": 2.6931686401367188,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "combination of resveratrol",
            "probability": 0.001875153270938411,
            "start_logit": -0.2873040437698364,
            "end_logit": 5.292647361755371,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "combination of resveratrol and 3,3'-diindolylmethane",
            "probability": 0.0008710572830107494,
            "start_logit": -0.2873040437698364,
            "end_logit": 4.525909423828125,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "resveratrol and 3,3'-diindolylmethane, a potent radioprotector.",
            "probability": 0.0008352459922596468,
            "start_logit": 5.4627814292907715,
            "end_logit": -1.2661575078964233,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "3,3'-diindolylmethane, a potent radioprotector",
            "probability": 0.0008197120333559182,
            "start_logit": 4.3441481590271,
            "end_logit": -0.16629742085933685,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "resveratrol and 3",
            "probability": 0.0006563320669452391,
            "start_logit": 5.4627814292907715,
            "end_logit": -1.5072169303894043,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "diindolylmethane,",
            "probability": 0.0004425987697556387,
            "start_logit": 2.686722755432129,
            "end_logit": 0.8748385310173035,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "re",
            "probability": 0.00041409694015141606,
            "start_logit": 5.4627814292907715,
            "end_logit": -1.9677836894989014,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "veratrol",
            "probability": 0.0003860635753501065,
            "start_logit": -1.8677476644515991,
            "end_logit": 5.292647361755371,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "rol",
            "probability": 0.0003844585314834031,
            "start_logit": -1.8719137907028198,
            "end_logit": 5.292647361755371,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "melatonin",
            "probability": 0.0003763338348709559,
            "start_logit": 1.7151343822479248,
            "end_logit": 1.6842398643493652,
            "question_text": "List radioprotection agents."
        }
    ],
    "5e52900d6d0a277941000041": [
        {
            "text": "PAR1&2",
            "probability": 0.404668764782411,
            "start_logit": 3.73211407661438,
            "end_logit": 1.6962065696716309,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "PAR1",
            "probability": 0.3777445267796869,
            "start_logit": 3.73211407661438,
            "end_logit": 1.6273558139801025,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "PAR",
            "probability": 0.038190305652353505,
            "start_logit": 3.73211407661438,
            "end_logit": -0.6642805933952332,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "PAR2 PH-domain-binding motifs in both pathological and physiological invasion processes.PH motifs in PAR1&2",
            "probability": 0.02950679250010969,
            "start_logit": 1.1136656999588013,
            "end_logit": 1.6962065696716309,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "PAR2 PH-domain-binding motifs in both pathological and physiological invasion processes.PH motifs in PAR1",
            "probability": 0.02754358710075766,
            "start_logit": 1.1136656999588013,
            "end_logit": 1.6273558139801025,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "PAR1&2 endow breast cancer growth.Here we show signal-binding motifs in PAR1&2",
            "probability": 0.022781283802398525,
            "start_logit": 3.73211407661438,
            "end_logit": -1.1809229850769043,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "PAR1 and PAR2 PH-domain-binding motifs in both pathological and physiological invasion processes.PH motifs in PAR1&2",
            "probability": 0.018774823872933555,
            "start_logit": 0.6615620255470276,
            "end_logit": 1.6962065696716309,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "PAR1&2 endow breast cancer growth.Here we show signal-binding motifs in PAR1",
            "probability": 0.018547634671483147,
            "start_logit": 3.73211407661438,
            "end_logit": -1.3865200281143188,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "PAR1 and PAR2 PH-domain-binding motifs in both pathological and physiological invasion processes.PH motifs in PAR1",
            "probability": 0.01752565944412993,
            "start_logit": 0.6615620255470276,
            "end_logit": 1.6273558139801025,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "PAR1&2 endow breast cancer growth.Here we show signal-binding motifs in PAR",
            "probability": 0.010590982572137754,
            "start_logit": 3.73211407661438,
            "end_logit": -1.946859359741211,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "PAR1&2 endow breast cancer",
            "probability": 0.009355824131556523,
            "start_logit": 3.73211407661438,
            "end_logit": -2.0708632469177246,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "PAR1&2 endow breast cancer growth",
            "probability": 0.008685070701720251,
            "start_logit": 3.73211407661438,
            "end_logit": -2.145256757736206,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "PAR2",
            "probability": 0.004699842163650986,
            "start_logit": 1.1136656999588013,
            "end_logit": -0.14088499546051025,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "PAR1 and PAR2",
            "probability": 0.0029904541082466417,
            "start_logit": 0.6615620255470276,
            "end_logit": -0.14088499546051025,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "PAR2 PH-domain-binding motifs in both pathological and physiological invasion processes.PH motifs in PAR",
            "probability": 0.002784681009431695,
            "start_logit": 1.1136656999588013,
            "end_logit": -0.6642805933952332,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "PAR1 and PAR2 PH-domain-binding motifs in both pathological and physiological invasion processes.PH motifs in PAR",
            "probability": 0.001771859665674896,
            "start_logit": 0.6615620255470276,
            "end_logit": -0.6642805933952332,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "PH motifs in PAR1&2",
            "probability": 0.0012177669412778553,
            "start_logit": -2.0739359855651855,
            "end_logit": 1.6962065696716309,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "PH motifs in PAR1",
            "probability": 0.0011367440163272625,
            "start_logit": -2.0739359855651855,
            "end_logit": 1.6273558139801025,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "2",
            "probability": 0.0008012076240571697,
            "start_logit": -2.4925899505615234,
            "end_logit": 1.6962065696716309,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        },
        {
            "text": "PAR2 PH-domain-binding motifs in both pathological and physiological invasion processes.PH motifs in PAR1&2 endow breast cancer",
            "probability": 0.0006821884596548835,
            "start_logit": 1.1136656999588013,
            "end_logit": -2.0708632469177246,
            "question_text": "PH motifs in which genes endow breast cancer growth?"
        }
    ],
    "5e52c5166d0a27794100004d": [
        {
            "text": "relapsing-remitting",
            "probability": 0.2227637227906888,
            "start_logit": 4.038444995880127,
            "end_logit": 3.756274938583374,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "primary progressive multiple sclerosis). The majority of people with relapsing-remitting",
            "probability": 0.1479255081001428,
            "start_logit": 3.629042148590088,
            "end_logit": 3.756274938583374,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "secondary progressive multiple sclerosis",
            "probability": 0.10235669252526872,
            "start_logit": 3.564528465270996,
            "end_logit": 3.4525434970855713,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "primary progressive",
            "probability": 0.0936193390451763,
            "start_logit": 3.629042148590088,
            "end_logit": 3.2988030910491943,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "relapsing-remitting multiple sclerosis",
            "probability": 0.0825090144865659,
            "start_logit": 4.038444995880127,
            "end_logit": 2.763070821762085,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "secondary progressive",
            "probability": 0.06461202115834805,
            "start_logit": 3.564528465270996,
            "end_logit": 2.9924802780151367,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "primary progressive multiple sclerosis). The majority of people with relapsing-remitting multiple sclerosis",
            "probability": 0.054789836234849724,
            "start_logit": 3.629042148590088,
            "end_logit": 2.763070821762085,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "primary progressive multiple sclerosis",
            "probability": 0.03278314038996531,
            "start_logit": 3.629042148590088,
            "end_logit": 2.2494804859161377,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "relapsing-remitting course and, less frequently, a progressive accumulation of disability from disease onset (primary progressive",
            "probability": 0.03271839323049847,
            "start_logit": 2.577742576599121,
            "end_logit": 3.2988030910491943,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "secondary progressive multiple sclerosis. relapsing-remitting MS",
            "probability": 0.02607813297820201,
            "start_logit": 3.564528465270996,
            "end_logit": 2.085176944732666,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "secondary progressive multiple sclerosis. relapsing-remitting",
            "probability": 0.025558150300484077,
            "start_logit": 3.564528465270996,
            "end_logit": 2.0650360584259033,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "relapsing-remitting MS (RRMS) C and D groupsMultiple sclerosis",
            "probability": 0.02433436327446252,
            "start_logit": 3.583709716796875,
            "end_logit": 1.9967880249023438,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "primary progressive MS A and B groups, the relapsing-remitting",
            "probability": 0.017239712796107826,
            "start_logit": 3.018470525741577,
            "end_logit": 2.217353343963623,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "relapsing-remitting MS",
            "probability": 0.015972351479819732,
            "start_logit": 3.0742905139923096,
            "end_logit": 2.085176944732666,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "primary progressive MS A and B",
            "probability": 0.014927082300095146,
            "start_logit": 3.018470525741577,
            "end_logit": 2.073314905166626,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "relapsing-remitting course and, less frequently, a progressive accumulation of disability from disease onset (primary progressive multiple sclerosis",
            "probability": 0.011457159274452153,
            "start_logit": 2.577742576599121,
            "end_logit": 2.2494804859161377,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "secondary progressive multiple sclerosis. relapsing-remitting MS, primary and secondary progressive",
            "probability": 0.01061379232482102,
            "start_logit": 3.564528465270996,
            "end_logit": 1.1862341165542603,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "primary progressive MS A and B groups, the relapsing-remitting MS",
            "probability": 0.006985059155066154,
            "start_logit": 3.018470525741577,
            "end_logit": 1.3139111995697021,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "relapsing-remitting MS, primary and secondary progressive",
            "probability": 0.0065007422765869585,
            "start_logit": 3.0742905139923096,
            "end_logit": 1.1862341165542603,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "primary progressive MS A",
            "probability": 0.006255785878398382,
            "start_logit": 3.018470525741577,
            "end_logit": 1.2036445140838623,
            "question_text": "List the stages/types of Multiple Sclerosis."
        }
    ],
    "5e6e8897c6a8763d23000003": [
        {
            "text": "S63845A-1210477",
            "probability": 0.7345164075984062,
            "start_logit": 5.119504451751709,
            "end_logit": 5.4423699378967285,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "S63845,Mcl-1 inhibitor S63845A-1210477",
            "probability": 0.06838986622933606,
            "start_logit": 2.745516777038574,
            "end_logit": 5.4423699378967285,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "S63845",
            "probability": 0.0563238372131803,
            "start_logit": 5.119504451751709,
            "end_logit": 2.8742754459381104,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "1210477",
            "probability": 0.04873058817545279,
            "start_logit": 2.4065990447998047,
            "end_logit": 5.4423699378967285,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "S63845A",
            "probability": 0.038008530936155485,
            "start_logit": 5.119504451751709,
            "end_logit": 2.4809682369232178,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "S63845A-1210477,",
            "probability": 0.012165977470345672,
            "start_logit": 5.119504451751709,
            "end_logit": 1.3418009281158447,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "A-1210477",
            "probability": 0.01044298293789046,
            "start_logit": 2.0956029891967773,
            "end_logit": 4.212989330291748,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "A-1210477 (an MCL-1 inhibitor)a highly specific MCL-1 inhibitor, S63845",
            "probability": 0.006044916232896629,
            "start_logit": 2.0956029891967773,
            "end_logit": 3.666276693344116,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "S63845,Mcl-1 inhibitor S63845",
            "probability": 0.005244239138410581,
            "start_logit": 2.745516777038574,
            "end_logit": 2.8742754459381104,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "Mcl-1 inhibitor S63845A-1210477",
            "probability": 0.004518987164782019,
            "start_logit": 0.028580008074641228,
            "end_logit": 5.4423699378967285,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "S63845,Mcl-1 inhibitor S63845A",
            "probability": 0.003538924821021106,
            "start_logit": 2.745516777038574,
            "end_logit": 2.4809682369232178,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "1210477 (an MCL-1 inhibitor)a highly specific MCL-1 inhibitor, S63845",
            "probability": 0.003310342207786634,
            "start_logit": 1.4934369325637817,
            "end_logit": 3.666276693344116,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "-1210477",
            "probability": 0.0019142453629145818,
            "start_logit": 0.3989962041378021,
            "end_logit": 4.212989330291748,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "63845A-1210477",
            "probability": 0.00180627213473233,
            "start_logit": -0.8884427547454834,
            "end_logit": 5.4423699378967285,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "S63845,Mcl-1 inhibitor S63845A-1210477,",
            "probability": 0.0011327583198127355,
            "start_logit": 2.745516777038574,
            "end_logit": 1.3418009281158447,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "-1210477 (an MCL-1 inhibitor)a highly specific MCL-1 inhibitor, S63845",
            "probability": 0.0011080601143227526,
            "start_logit": 0.3989962041378021,
            "end_logit": 3.666276693344116,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "inhibitor S63845A-1210477",
            "probability": 0.0010901292265912865,
            "start_logit": -1.393411636352539,
            "end_logit": 5.4423699378967285,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "1210477,",
            "probability": 0.0008071368205342978,
            "start_logit": 2.4065990447998047,
            "end_logit": 1.3418009281158447,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "S",
            "probability": 0.0004545766178985922,
            "start_logit": 5.119504451751709,
            "end_logit": -1.9452311992645264,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "S63845A-1210477, a selective",
            "probability": 0.00045122127752974834,
            "start_logit": 5.119504451751709,
            "end_logit": -1.9526398181915283,
            "question_text": "List Mcl-1 inhibitors."
        }
    ],
    "5e7659db835f4e4777000001": [
        {
            "text": "Rotarix",
            "probability": 0.6124191502295054,
            "start_logit": 5.56506872177124,
            "end_logit": 5.548161506652832,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "RotaTeq and Rotarix",
            "probability": 0.29481845703659537,
            "start_logit": 4.834011554718018,
            "end_logit": 5.548161506652832,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "RotaTeq",
            "probability": 0.07933202176131834,
            "start_logit": 4.834011554718018,
            "end_logit": 4.235443592071533,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "Rotarix,",
            "probability": 0.0074977271144133365,
            "start_logit": 5.56506872177124,
            "end_logit": 1.1453444957733154,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "RotaTeq and Rotarix,",
            "probability": 0.0036094043406781225,
            "start_logit": 4.834011554718018,
            "end_logit": 1.1453444957733154,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "Rotarix, are licensed for global use; however, the protection they confer to unvaccinated individuals through indirect effects remains unknown.",
            "probability": 0.0007673113308698183,
            "start_logit": 5.56506872177124,
            "end_logit": -1.1341180801391602,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "rotavirus vaccines, RotaTeq and Rotarix",
            "probability": 0.0005041404999936037,
            "start_logit": -1.5372484922409058,
            "end_logit": 5.548161506652832,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "vaccines, RotaTeq and Rotarix",
            "probability": 0.0001361625159484855,
            "start_logit": -2.846254348754883,
            "end_logit": 5.548161506652832,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "rotavirus vaccines, RotaTeq",
            "probability": 0.00013565800974017726,
            "start_logit": -1.5372484922409058,
            "end_logit": 4.235443592071533,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "RotaTe",
            "probability": 0.0001258554538244313,
            "start_logit": 4.834011554718018,
            "end_logit": -2.2108194828033447,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": ", RotaTeq and Rotarix",
            "probability": 0.00012355694644650183,
            "start_logit": -2.943401336669922,
            "end_logit": 5.548161506652832,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "Rot",
            "probability": 0.00011449872164081357,
            "start_logit": 5.56506872177124,
            "end_logit": -3.036447048187256,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "q and Rotarix",
            "probability": 9.917081294440545e-05,
            "start_logit": -3.163259744644165,
            "end_logit": 5.548161506652832,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "x",
            "probability": 6.842069734586448e-05,
            "start_logit": -3.534428119659424,
            "end_logit": 5.548161506652832,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "RotaTeq and Rot",
            "probability": 5.5119661810309204e-05,
            "start_logit": 4.834011554718018,
            "end_logit": -3.036447048187256,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "Rotarix, are licensed for global use;",
            "probability": 4.829382122254976e-05,
            "start_logit": 5.56506872177124,
            "end_logit": -3.899707078933716,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "Two rotavirus vaccines, RotaTeq and Rotarix",
            "probability": 3.900706594713752e-05,
            "start_logit": -4.096360683441162,
            "end_logit": 5.548161506652832,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "vaccines, RotaTeq",
            "probability": 3.663965881539183e-05,
            "start_logit": -2.846254348754883,
            "end_logit": 4.235443592071533,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "Rotari",
            "probability": 3.6156665881919907e-05,
            "start_logit": 5.56506872177124,
            "end_logit": -4.189149379730225,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": ", RotaTeq",
            "probability": 3.324765505790304e-05,
            "start_logit": -2.943401336669922,
            "end_logit": 4.235443592071533,
            "question_text": "Name two rotavirus vaccines."
        }
    ],
    "5e80e449835f4e477700002c": [
        {
            "text": "pancreas",
            "probability": 0.2360295409091767,
            "start_logit": 4.830626010894775,
            "end_logit": 4.5691657066345215,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "pneumocytes and surface enterocytes of the small intestine",
            "probability": 0.08625038739523568,
            "start_logit": 4.207159042358398,
            "end_logit": 4.185930252075195,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "islets of pancreas",
            "probability": 0.08103420686847251,
            "start_logit": 3.761540412902832,
            "end_logit": 4.5691657066345215,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "pancreas, but not in hepatocytes",
            "probability": 0.07520932349624329,
            "start_logit": 4.830626010894775,
            "end_logit": 3.4254839420318604,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "small intestine",
            "probability": 0.06986014986095651,
            "start_logit": 3.9963998794555664,
            "end_logit": 4.185930252075195,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "hepatocytes",
            "probability": 0.05761691672608742,
            "start_logit": 4.564167022705078,
            "end_logit": 3.4254839420318604,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "lung, kidney, heart, and islets of pancreas",
            "probability": 0.05565899035499085,
            "start_logit": 3.3859126567840576,
            "end_logit": 4.5691657066345215,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "enterocytes of the small intestine",
            "probability": 0.048141068697118955,
            "start_logit": 3.624040126800537,
            "end_logit": 4.185930252075195,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "pneumocytes",
            "probability": 0.0434704861289199,
            "start_logit": 4.207159042358398,
            "end_logit": 3.500757932662964,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "heart, and islets of pancreas",
            "probability": 0.04212788695147866,
            "start_logit": 3.1073789596557617,
            "end_logit": 4.5691657066345215,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "kidney, heart, and islets of pancreas",
            "probability": 0.04124500459922418,
            "start_logit": 3.0861990451812744,
            "end_logit": 4.5691657066345215,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "islets of pancreas, but not in hepatocytes",
            "probability": 0.02582103856642928,
            "start_logit": 3.761540412902832,
            "end_logit": 3.4254839420318604,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "pancreas,",
            "probability": 0.0239937219316353,
            "start_logit": 4.830626010894775,
            "end_logit": 2.283000946044922,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "pneumocytes and surface enterocytes",
            "probability": 0.022209720352938313,
            "start_logit": 4.207159042358398,
            "end_logit": 2.8292057514190674,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "lung, kidney, heart, and islets of pancreas, but not in hepatocytes",
            "probability": 0.01773538598159447,
            "start_logit": 3.3859126567840576,
            "end_logit": 3.4254839420318604,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "pneumocytes and surface enterocytes of the small intestine.endothelial cells",
            "probability": 0.017025032279116538,
            "start_logit": 4.207159042358398,
            "end_logit": 2.5633604526519775,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "islets",
            "probability": 0.016215142909713785,
            "start_logit": 3.761540412902832,
            "end_logit": 2.960239887237549,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "small intestine.endothelial cells",
            "probability": 0.013789750310992829,
            "start_logit": 3.9963998794555664,
            "end_logit": 2.5633604526519775,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "heart, and islets of pancreas, but not in hepatocytes",
            "probability": 0.013423785284428095,
            "start_logit": 3.1073789596557617,
            "end_logit": 3.4254839420318604,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "kidney, heart, and islets of pancreas, but not in hepatocytes",
            "probability": 0.013142460395246606,
            "start_logit": 3.0861990451812744,
            "end_logit": 3.4254839420318604,
            "question_text": "Which tissues express the ACE2 protein?"
        }
    ],
    "5e7768f9835f4e477700000b": [
        {
            "text": "Exubera\u00ae",
            "probability": 0.9202435721653438,
            "start_logit": 5.292290687561035,
            "end_logit": 5.737386226654053,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "Afrezza\u00ae",
            "probability": 0.052328392543698296,
            "start_logit": 4.0231547355651855,
            "end_logit": 4.13942289352417,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "Exubera",
            "probability": 0.018772680187648907,
            "start_logit": 5.292290687561035,
            "end_logit": 1.8451504707336426,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "Exubera\u00ae,",
            "probability": 0.006681770712455697,
            "start_logit": 5.292290687561035,
            "end_logit": 0.812130868434906,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "Afrezza",
            "probability": 0.0011918562277552296,
            "start_logit": 4.0231547355651855,
            "end_logit": 0.357395738363266,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "\u00ae",
            "probability": 0.0003716393341200113,
            "start_logit": -2.522179126739502,
            "end_logit": 5.737386226654053,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "ubera\u00ae",
            "probability": 9.820290713265292e-05,
            "start_logit": -3.85306715965271,
            "end_logit": 5.737386226654053,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "first inhalable insulin, Exubera\u00ae",
            "probability": 8.962040085108511e-05,
            "start_logit": -3.9445199966430664,
            "end_logit": 5.737386226654053,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "Ex",
            "probability": 6.135204915024188e-05,
            "start_logit": 5.292290687561035,
            "end_logit": -3.8783788681030273,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "frezza\u00ae",
            "probability": 4.4129463147676546e-05,
            "start_logit": -3.0550119876861572,
            "end_logit": 4.13942289352417,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "ra\u00ae",
            "probability": 3.082473560045308e-05,
            "start_logit": -5.011785507202148,
            "end_logit": 5.737386226654053,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "inhalable insulin, Exubera\u00ae",
            "probability": 1.88549974086186e-05,
            "start_logit": -5.50332498550415,
            "end_logit": 5.737386226654053,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "the first inhalable insulin, Exubera\u00ae",
            "probability": 1.198025741423762e-05,
            "start_logit": -5.95684289932251,
            "end_logit": 5.737386226654053,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "Exubera\u00ae, due to suboptimal market acceptance,",
            "probability": 1.152320746099867e-05,
            "start_logit": 5.292290687561035,
            "end_logit": -5.550644397735596,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "Afrezza\u00ae and several others awaiting approval.",
            "probability": 9.125527513592e-06,
            "start_logit": 4.0231547355651855,
            "end_logit": -4.514795780181885,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "insulin, Exubera\u00ae",
            "probability": 7.4624181748268464e-06,
            "start_logit": -6.43022346496582,
            "end_logit": 5.737386226654053,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "A",
            "probability": 7.297526108085568e-06,
            "start_logit": 4.0231547355651855,
            "end_logit": -4.738336086273193,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "za\u00ae",
            "probability": 6.82152117964433e-06,
            "start_logit": -4.922057151794434,
            "end_logit": 4.13942289352417,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "uation of the first inhalable insulin, Exubera\u00ae",
            "probability": 6.471094488644564e-06,
            "start_logit": -6.572757720947266,
            "end_logit": 5.737386226654053,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "discontinuation of the first inhalable insulin, Exubera\u00ae",
            "probability": 6.422723347243275e-06,
            "start_logit": -6.580260753631592,
            "end_logit": 5.737386226654053,
            "question_text": "Name two inhalable insulin products."
        }
    ]
}
